0001010412-14-000185.txt : 20141114 0001010412-14-000185.hdr.sgml : 20141114 20141114134757 ACCESSION NUMBER: 0001010412-14-000185 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141114 DATE AS OF CHANGE: 20141114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sundance Strategies, Inc. CENTRAL INDEX KEY: 0001171838 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 880515333 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50547 FILM NUMBER: 141222660 BUSINESS ADDRESS: STREET 1: 4626 NORTH 300 WEST, SUITE 365 CITY: PROVO STATE: UT ZIP: 84604 BUSINESS PHONE: 801-705-8968 MAIL ADDRESS: STREET 1: 4626 NORTH 300 WEST, SUITE 365 CITY: PROVO STATE: UT ZIP: 84604 FORMER COMPANY: FORMER CONFORMED NAME: JAVA EXPRESS INC DATE OF NAME CHANGE: 20020422 10-Q 1 qtr2093014lwbclean6withallco.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 10-Q



[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2014


[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


For the transition period from ____________ to____________


Commission File No. 000-50547


SUNDANCE STRATEGIES, INC.

(Exact name of Registrant as specified in its charter)


Nevada

88-0515333

(State or Other Jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

  


4626 North 300 West, Suite No. 365

Provo, Utah 84604

(Address of Principal Executive Offices)


(801) 705-8968

(Registrant’s telephone number, including area code)


N/A

(Former name, former address and former fiscal year,

if changed since last report)


Indicate by check mark whether the Registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X] No [  ]


Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).  Yes [X]   No [  ]


Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer [  ]      Accelerated filer [  ]       Non-accelerated filer [  ]      Smaller reporting company [X]


Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]




APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Indicate by check mark whether the Registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Not applicable.


APPLICABLE ONLY TO CORPORATE ISSUERS


Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date: November 14, 2014 - 43,185,941 shares of common stock.

 



NAME REFERENCES


In this Quarterly Report, references to “Sundance Strategies,” the “Company,” “we,” “our,” “us” and words of similar import, refer to “Sundance Strategies, Inc.,” the Registrant, and where applicable, include the current and intended business operations of ANEW LIFE, INC., a Utah corporation and our wholly-owned subsidiary (“ANEW LIFE”), our acquisition of which, by merger, occurred on March 29, 2013.  


FORWARD-LOOKING STATEMENTS


This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Quarterly Report. These factors include, but are not limited to, economic conditions generally in the United States and internationally, and in the industry and markets in which we have and may participate in the future, competition within our chosen industry, our current and intended business, our assets and plans, the effect of applicable United States and foreign laws, rules and regulations on our business and our failure to successfully develop, compete in and finance our current and intended business operations.


You should read any other cautionary statements made in this Quarterly Report as being applicable to all related forward-looking statements wherever they appear in this Quarterly Report. We cannot assure you that the forward-looking statements in this Quarterly Report will prove to be accurate, and therefore, prospective investors are encouraged not to place undue reliance on forward-looking statements. You should read this Quarterly Report completely, and it should be considered in light of all other information contained in the reports or registration statement that we file with the Securities and Exchange Commission (the “SEC”), including all risk factors outlined therein. Other than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future.




2





JUMPSTART OUR BUSINESS STARTUPS ACT DISCLOSURE


We qualify as an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act by the Jumpstart Our Business Startups Act (the “JOBS Act”). An issuer qualifies as an “emerging growth company” if it has total annual gross revenues of less than $1.0 billion during its most recently completed fiscal year, and will continue to be deemed an emerging growth company until the earliest of:


 

the last day of the fiscal year of the issuer during which it had total annual gross revenues of $1.0 billion or more;


 

the last day of the fiscal year of the issuer following the fifth anniversary of the date of the first sale of common equity securities of the issuer pursuant to an effective registration statement;


 

the date on which the issuer has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or


 

the date on which the issuer is deemed to be a “large accelerated filer,” as defined in Section 240.12b-2 of the Exchange Act.


As an emerging growth company, we are exempt from various reporting requirements. Specifically, we are exempt from the following provisions:


 

Section 404(b) of the Sarbanes-Oxley Act of 2002, which requires evaluations and reporting related to an issuer’s internal controls;


 

Section 14A(a) of the Exchange Act, which requires an issuer to seek shareholder approval of the compensation of its executives not less frequently than once every three years; and


 

Section 14A(b) of the Exchange Act, which requires an issuer to seek shareholder approval of its so-called “golden parachute” compensation, or compensation upon termination of an employee’s employment.


Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards that have different effective dates for public and private companies until such time as those standards apply to private companies.  We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.






3




PART I


Item 1.  Financial Statements


The Condensed Consolidated Financial Statements of the Registrant required to be filed with this 10-Q Quarterly Report were prepared by management and commence below, together with related notes. In the opinion of management, the Condensed Consolidated Financial Statements fairly present the financial condition of the Registrant and include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Registrant’s Condensed Consolidated Financial Statements. The results from operations for the three month and six month periods ended September 30, 2014, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2015. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the March 31, 2014, Consolidated Financial Statements and footnotes thereto included in the Registrant’s Form 10-K Annual Report for the fiscal year ended March 31, 2014, as amended, which were filed with the SEC on July 16, 2014, and July 21, 2014, respectively, and which are referenced in Part II, Item 6 hereof.




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2014

(Unaudited)


 

Page(s)

 

 

Condensed Consolidated Balance Sheets as of September 30, 2014 and March 31, 2014

5

 

 

Condensed Consolidated Statements of Operations for the Three and Six Months Ended September 30, 2014 and 2013

6

 

 

Condensed Consolidated Statements of Cash Flows for the Six Months Ended September 30, 2014 and 2013

7

 

 

Notes to the Condensed Consolidated Financial Statements

8 - 12





4





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Balance Sheets

September 30, 2014 and March 31, 2014

(Unaudited)

 

 

September 30,

2014

 

March 31,

2014

ASSETS

Current Assets

 

 

 

 

Cash and Cash Equivalents

$

      119,662

 

$

       375,212

 

Prepaid Expenses

 

       7,625

 

 

         2,000

 

Other Current Assets

 

      28,600

 

 

 

Total Current Assets

 

     155,887

 

 

    377,212

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

 

Investment in Net Insurance Benefits

 

   13,399,562

 

 

12,243,411

 

Advance for Investment in Net Insurance Benefits

 

  4,376,419

 

 

   3,584,862

 

Note Receivable

 

     211,000

 

 

    861,000

 

Other assets

 

     14,047

 

 

 13,767

 

 

 

 

 

 

 

Total Other Long-term Assets

 

 18,001,028

 

 

 16,703,040

 

 

 

 

 

 

 

Total Assets

$

   18,156,915

 

$

  17,080,252

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

 

 

 

 

 

 

Accounts Payable

$

     170,826

 

$

      52,915

 

Accrued Expenses

 

  146,809

 

 

             -

 

Notes Payable

 

1,326,876

 

 

     -

 

Notes Payable-Related Party

 

    730,000

 

 

 90,000

Total Current Liabilities

 

   2,374,511

 

 

   142,915

 

 

 

 

 

 

 

 

Notes Payable, including accrued interest

 

              -

 

 

1,455,904

 

 

 

 

 

 

 

Total Liabilities

 

     2,374,511

 

 

   1,598,819

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding

 

         -

 

 

           -

 

Common Stock, authorized 500,000,000 shares, par value $0.001; 43,185,941 and 43,015,941 shares issued and outstanding, respectively

 

 43,186

 

 

43,017

 

Subscription Receivable

 

         -

 

 

   (1,500)

 

Additional Paid In Capital

 

16,111,277

 

 

   15,050,705

 

Additional Paid In Capital- Stock to be Issued

 

            -

 

 

  700,000

 

Accumulated Deficit

 

    (372,059)

 

 

       (310,789)

Total Stockholders' Equity

 

   15,782,404

 

 

      15,481,433

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Equity

$

    18,156,915

 

$

   17,080,252


The accompanying notes are an integral part of these condensed consolidated financial statements.



5





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Operations

For the Three and Six Months Ended September 30, 2014 and 2013

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months

 

Three Months

 

Six Months

 

Six Months

 

 

Ended

 

Ended

 

Ended

 

Ended

 

 

September 30,

 

September 30,

 

September 30,

 

September 30,

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income on Investment in Net Insurance Benefits

 

$    

  592,653

 

$    

               -   

 

$    

    1,156,151

 

$    

             -   

 

 

 

 

 

 

 

 

 

 

 

 

 

General and Administrative Expenses

 

 

583,006

 

 

     310,809

 

 

     1,199,372

 

 

 1,344,674

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) from Operations

 

 

      9,647

 

 

  (310,809)

 

 

    (43,221)

 

 

(1,344,674)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

 

 

 

 

 

 

 

 

   Other, net

 

 

            -

 

 

           -

 

 

       6,303

 

 

          -

Interest Income

 

 

        4,478

 

 

          -

 

 

      8,820

 

 

             21

Interest Expense

 

 

     (17,031)

 

 

    (30,709)

 

 

    (33,172)

 

 

    (60,782)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Expense

 

 

   (12,553)

 

 

  (30,709)

 

 

    (18,049)

 

 

    (60,761)

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss Before Income Taxes

 

 

     (2,906)

 

 

 (341,518)

 

 

  (61,270)

 

 

(1,405,435)

Income Tax Provision

 

 

          -

 

 

          -

 

 

          -

 

 

         -

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$    

           (2,906)

 

$    

  (341,518)

 

$    

   (61,270)

 

$    

(1,405,435)

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

Loss Per Share

 

$

     (0.01)

 

$    

    (0.01)

 

$    

       (0.01)

 

$    

       (0.03)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Number of Shares Outstanding

 

 

 43,163,575

 

 

 42,261,441

 

 

  43,090,561

 

 

41,781,441




The accompanying notes are an integral part of these condensed consolidated financial statements.




6





SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

Condensed Consolidated Statements of Cash Flows

Six Months Ended September 30, 2014 and 2013

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

Six Months Ended

 

 

 

 

September 30,

 

September 30,

 

 

 

 

2014

 

2013

 

 

 

 

 

 

 

 

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

$

     (61,270)

 

$

   (1,405,435)

 

Adjustments to reconcile to cash from operating activities:

 

 

 

 

 

 

 

Share Based Compensation - Options

 

                212,242

 

 

                659,867

 

 

Advance for Investments in Net Insurance Benefits

 

    (691,557)

 

 

   (6,414,063)

 

 

Other Current Assets

 

      (28,600)

 

 

 

 

 

Accrued Interest Income

 

           (280)

 

 

                           -

 

 

Prepaid Expenses

 

(5,625)

 

 

-

 

 

Accounts Payable

 

                117,911

 

 

                  (6,286)

 

 

Accrued Expenses

 

                  17,780

 

 

                  20,782

 

 

Investment in Net Insurance Benefits

 

 (1,156,151)

 

 

                           -

 

 

 

 

 

 

 

 

 

 

 

        Net Cash from Operating Activities

 

    (1,595,550)

 

 

      (7,145,135)

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from Notes Receivables

 

                550,000

 

 

                           -

 

 

 

 

 

 

 

 

 

 

 

         Net Cash from Investing Activities

 

                550,000

 

 

                           -

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from Issuance of Common Stock – net of issuance costs

 

                           -

 

 

              6,826,775

 

Proceeds from Issuance of Notes Payable-Related Party

 

                640,000

 

 

                           -

 

Common Stock Issued for Cash

 

                150,000

 

 

                           -

 

Common Stock to be Issued

 

                           -

 

 

                752,500

 

 

 

 

 

 

 

 

 

 

 

         Net Cash from Financing Activities

 

                790,000

 

 

              7,579,275

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

        (255,550)

 

 

                434,140

Cash at Beginning of Period

 

                375,212

 

 

                545,417

 

 

 

 

 

 

 

 

 

Cash at End of Period

$

                119,662

 

$

                979,557

 

 

 

 

 

 

 

 

 

Non Cash Financing Activities

 

 

 

 

 

 

 

Notes Receivables Exchanged for Advance for Investment in Net Insurance Benefits

$

                100,000

 

$

                         -   

 

 

Fair Value of Warrants Issued as Stock Issuance Costs

$

                           -

 

$

                139,251




The accompanying notes are an integral part of these condensed consolidated financial statements.



7




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

September 30, 2014


(1) ORGANIZATION AND BASIS OF PRESENTATION


The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company’s annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the March 31, 2014, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company’s condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.  These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.


Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, for the purpose of selling coffee and other related items to the general public from retail coffee shop locations. These endeavors ceased in 2006, and it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc.  On March 29, 2013, Sundance Strategies, Inc., a Nevada corporation (“Sundance Strategies”), its newly formed and wholly-owned subsidiary, Anew Acquisition Corp., a Utah corporation (“Merger Subsidiary”), and ANEW LIFE, INC., a Utah corporation (“ANEW LIFE”), completed an Agreement and Plan of Merger, whereby the Merger Subsidiary merged with and into ANEW LIFE, and ANEW LIFE was the surviving company under the merger and became a wholly-owned subsidiary of Sundance Strategies on the closing of the merger (the “Merger”). The Merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of ANEW LIFE, which was incorporated on January 31, 2013.


Sundance Strategies, Inc. and subsidiary (the “Company” or “we”) is engaged in the business of directly purchasing from third parties and purchasing, acquiring and assisting third parties in assembling portfolios of high quality life insurance policies and residual interest in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations from the secondary and tertiary marketplace often referred to as the “life settlements market.”  Currently, the Company is focused on the acquisition of Net Insurance Benefits (“NIB” or “NIBs”).   NIBs are residual interests in or financial products tied to life settlement policies.  The Company purchases NIBs on life settlement policies from third parties in pools of multiple policies, but does not typically take possession or control of the policies, other than the policies held as collateral for advances to third parties, of which the Company does take temporary possession until collateral is returned for NIBs.




8




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

September 30, 2014

 

(2) NEW ACCOUNTING PRONOUNCEMENTS


In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2016. Early adoption is not permitted and companies can transition to the new standard under the full retrospective method or the modified retrospective method. The Company does not believe adoption of this ASU will have a material impact on its financial statements.


In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.


(3) INVESTMENT IN NET INSURANCE BENEFITS


The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance policies that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”).  Future expected cash flows are defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments.  At the time of purchase of an investment in NIBs we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our cost basis. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations.  Subsequent to the purchase, and on a quarterly basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion.  Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income.  Management has concluded that there was no change in estimated cash flows as of September 30, 2014.


The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company’s balance sheet does not increase when premiums or other expenses are paid.  The face value of the underlying life insurance policies approximated $217 million (includes estimated return of premiums) as of September 30, 2014. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of September 30, 2014.  The estimated fair value of the Company’s investment in NIBs approximated carrying value at September 30, 2014, with fair value calculated using level 3 inputs.  As of September 30, 2014 and March 31, 2014, investments in NIBs were as follows:



9




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

September 30, 2014


(3) INVESTMENT IN NET INSURANCE BENEFITS (continued)


 

September 30, 2014

March 31,

2014

Beginning Balance

 $  12,243,411

$   12,243,411

Additional investments

          -

         -

Accretion of interest income

    1,156,151

         -

Distributions of investments

          -

         -

Impairment of investments

          -

         -

Total

 $  13,399,562

$ 12,243,411


We evaluate the carrying value of our investment in NIBs for OTTI on a regular basis and, if necessary, adjust our carrying value in the investment in NIBs using new or updated information that affects our assumptions about remaining life expectancy, credit worthiness of the policy issuer, funds needed to maintain the asset until maturity, utilization of MRI, discount rates and potential return. We recognize OTTI on investment in NIBs if the expected discounted cash flows (using the effective yield) expected to be received are less than the carrying amount of the investment.  OTTI of the investment in NIBs could be generally caused by the insured significantly exceeding the estimate of the original life expectancy, which causes the original policy costs and projected future premiums to exceed the estimated maturity value, a change in credit worthiness of the policy issuer, increased or changes to applicable regulation of the investment, counter party performance risk, shortage of funds needed to maintain the asset until maturity and changes in discount rates. There are also risks associated with the policy holder’s ability to repay such financing and the occurrence of events of default under such financing. We have not recognized any OTTI from January 31, 2013 (inception) to the period ended September 30, 2014.


(4) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS


On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets, that are consideration and collateral for certain cash advances and expense payments made by the Company. The end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into “Qualified NIBs” before the original due date of December 31, 2013, which was subsequently extended to September 30, 2014 (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), having a combined face amount of $400,000,000 (with “Qualified NIBs” meaning that the NIBs would have premium financing secured for up to five years; that any grouping of NIBs would have not less than 10 policies; that the average age of the insureds under the life insurance policies would be approximately 81 years; and that the NIBs would have mortality re-insurance coverage). All remaining NIBs that are not converted to “Qualified NIBs” and all other assets conveyed to the Company as collateral to assure delivery of the Qualified NIBs will be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000.  In the event Del Mar was unable to provide the Qualified NIBs by the original date of December 31, 2013, which was subsequently extended to September 30, 2014 (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), the Company will have the option of selling any of the collateral assets acquired up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, the Company will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have no due date, but will be paid out of death benefits received, and incur interest of 4.0% per annum. Total interest and principal amounts are due upon maturity. Del Mar is continuing its efforts in delivering the Qualified NIBs. The Company has received $90,600,000 in Qualified NIBs under the Del Mar ATA.




10




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

September 30, 2014


(4) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (continued)


As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (“Europa Agreement” and “Europa”). The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. The total restructuring fee will be up to $4,000,000. In the event that any cash consideration by the Company under the Del Mar ATA exceeds the defined $8,000,000 cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $24,000,000 under the Del Mar ATA, which is comprised of $12,000,000 in cash consideration and $12,000,000 in promissory notes.


On October 29, 2013, the Company and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up-front cash payment due from the Company under the Del Mar ATA and Europa Agreement shall not exceed $12,000,000; that the Company would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $8,000,000, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.


Also on October 29, 2013, the Company entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $25,000 to such consultant for services related to the purchase of Qualified NIBs associated with the $400,000,000 in life insurance policies under the Del Mar ATA.


On January 14, 2014, the Company completed the closing of $90.6 million of Qualified NIBs. These Qualified NIBs are part of the $400 million transaction of additional NIBs in portfolios from the Company’s second acquisition in June 7, 2013, related to the Del Mar ATA.


(5) NOTE RECEIVABLE


On October 23, 2013, the Company made a loan totaling $650,000 in the form of a note receivable to Del Mar. The note incurred interest at 3%, compounding annually.  On April 28, 2014, the Company received full payment of the $650,000 Del Mar note receivable entered into on October 23, 2013. Of the $650,000, the Company received cash payments totaling $550,000; and $100,000 was applied to advances for investment in NIBs.


(6) NOTES PAYBALE-RELATED PARTY


During the six months ended September 30, 2014, the Company borrowed $740,000 from related parties and paid back $100,000, bringing the total notes payable-related party loan balance to $730,000 at September 30, 2014.  The notes do not incur interest, are payable on demand and are not collateralized.  




11




SUNDANCE STRATEGIES, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

September 30, 2014


 (7) STOCK TRANSACTIONS


During July 2014, the Company issued 30,000 shares of common stock for $150,000 and issued 140,000 shares of common stock for $700,000.   The $700,000 in cash was received prior to March 31, 2014.


On June 24, 2014, the Company entered into a private stock offering subscription agreement to issue 660,000 shares at $5 per share for a total of $3,300,000, which subscription was due and payable on August 15, 2014.  The Company has been advised that there will be a further delay in the payment of this subscription as a result of the time and issues involved in a foreign probate of the subscriber’s estate, and there is no assurance that this subscription will be paid.  


(8) GOING CONCERN


The Company’s financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. At September 30, 2014, the Company had accumulated losses of $372,059, working capital deficit of $2,218,624, and has yet to receive cash payments on interest income on Investment in NIBS. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.


The Company’s continued existence is dependent on its ability to generate sufficient cash flow to cover operating expenses and to invest in future operations. Management is actively pursuing opportunities to expand existing operations. The Company does not anticipate having adequate revenues from operations until three to four years, and until a revenue stream has been established, the Company will require debt or equity funding to fund its current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is possible.


(9) SUBSEQUENT EVENTS


On or about November 11, 2014, the Company, Del Mar and Europa have tentatively agreed to extend the delivery date of the remaining $309,400,000 in Qualified NIBs due under the Del Mar ATA until January 31, 2015, for which documentation is presently being prepared.

 





12




Item 2. Management’s Discussions and Analysis of Financial Condition and Results of Operations.


Forward-looking Statements


This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this report. These factors include, but are not limited to, economic conditions generally in the United States and internationally, and in the industry and markets in which we have and may participate in the future, competition within our chosen industry, our current and intended business, our assets and plans, the effect of applicable United States and foreign laws, rules and regulations on our business and our failure to successfully develop, compete in and finance our current and intended business operations.


You should read any other cautionary statements made in this Quarterly Report as being applicable to all related forward-looking statements wherever they appear in this Quarterly Report. We cannot assure you that the forward-looking statements in this Quarterly Report will prove to be accurate, and therefore, prospective investors are encouraged not to place undue reliance on forward-looking statements. You should read this Quarterly Report completely, and it should be considered in light of all other information contained in the reports or registration statement that we file with the SEC, including all risk factors outlined therein. Other than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future.


Plan of Operation


We are engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” These life insurance interests are anticipated to be held to maturity. Our plan of operation for the next 12 months is to continue the acquisition of these life insurance interests whereby we will acquire the interests in life insurance policies at a discount to their face value for investment purposes. We began purchasing the net insurance benefits in life insurance policies (“NIBs”) during our fiscal year ended March 31, 2013. This is not a market sector without competition, and at present, we are a minor competitor. We will need substantial funds to effectively compete in this industry and no assurance can be given that we will be able to adequately fund our current and intended operations, whether through revenues generated from our current interest in NIBs acquired in fiscal 2013, and 2014, or through debt or equity financing. At our discretion, we may be required to expend not less than approximately $56 million on premiums, interest and servicing costs over the next five years to protect our interest in our NIBs, though we have no legal responsibility for these payments.


We currently estimate proceeds of approximately $79 million on the NIBs owned as of September 30, 2014, and acquired from PCH Financial and Del Mar Financial. This amount is based on the estimated proceeds from polices of approximately $217 million in face value, which includes estimated return of premiums; less the senior debt or MRI repayments outstanding of approximately $36 million, expected premium payments of approximately $65 million over the life expectancies, and estimated expenses and interest of approximately $37 million over the term of the senior loans.


We use an estimation methodology to project cash flows and returns as presented. The estimation model required many assumptions, including, but not limited to the following: (i) an assumption that the distinct number of lives in the portfolio would exhibit similar experience to a statistically diverse portfolio based upon which the mortality tables have been created; (ii) an assumption that the life expectancies (the “LE” or “LE’s”) provided by third-party LE providers represent the actuarial mean of the life expectancies of the insureds in the portfolio, (iii) the weighted average of the LE’s provided by the LE providers represents an appropriate method for adjusting for discrepancies in the LE’s; (iv) life expectancy tables and projections are accurate; (v) the minimum premiums calculated based on



13




the in-force illustrations provided by life insurance carriers are accurate and will not change over the course of the lifespan of the portfolio; and the senior lending fees, MRI fees, and insurance, servicing and custodial fees do not change materially over time. While this method of modeling cash flows is helpful in providing a theoretical expectation of potential returns that might be produced from our NIBs portfolio, actual cash flows and returns inevitably will be different (possibly materially) due to the fact that predicting the exact date of death of any individual is virtually impossible. The provision of a theoretical cash flow model is by no means any guarantee of any results. The actual performance of these NIB interests (as well as our future expectations as to what such performance might be) may differ substantially from our expectations, especially if any of the assumptions change or differ from the Company’s initial assumptions. These portfolios currently contain only 60 fractionalized policies on 32 individual insureds, though insurance rating agencies have stated that at least 1,000 lives are required to achieve actuarial stability. Many risk factors beyond these assumptions may result in our expectations being incorrect; therefore, no assurance can be given that these estimated results will occur.


We advanced payments to purchase future additional life settlement products during the three and six months ended September 30, 2014, and if these life settlement products become “Qualified NIBs” as defined in the acquisition documents, we will also utilize the estimation methodology to estimate what our proceeds from these “Qualified NIBs” may be, all subject to the same assumptions, qualifications and risks referenced above.


Results of Operations


Income and Cost Recognition


Interest income on investment in NIBs represents the excess of all cash flows attributable to the investment in net insurance benefits greater than the initial investment over the life of each pool of net insurance benefits using the effective yield method.  Changes in the estimate of expected cash flows from investments in NIBs are adjusted prospectively.    


During the period from April 1, 2013, through December 31, 2013, our investment in net insurance benefits was on non-accrual status. This decision was primarily based on the initial incremental uncertainty experienced by us during our first three quarters of the year ended March 31, 2014, after closing of the acquisition on the first pool of “Qualified NIBs.”  Management concluded these uncertainties were significantly mitigated during the quarter beginning January 1, 2014, as additional experience and information was obtained, including the observation of the proper functioning of the entire system in response to the death of an insured in the quarter beginning January 1, 2014. Non-accrual status was removed effective January 1, 2014.  Interest income on investment in NIBs totaled $592,653 for the three months ended and $1,156,151 for the six months ended September 30, 2014.


Operating and General & Administrative Expenses


Operating Expenses


During the three months ended September 30, 2014, and 2013, we engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies. General and administrative expenses were $583,006 and $310,809 during the three months ended September 30, 2014, and 2013, respectively.  A significant portion of these expenses were professional fees, payroll and travel expenses.  Most all of the professional fees were legal and accounting fees related to the preparation and filing of reports with the SEC under the Exchange Act. Payroll is made up of cash payroll costs and non-cash equity issuances to management, directors and others.  The increase in administrative expenses for the three months ended September 30, 2014, compared to the three months ended September 30, 2013, primarily relates to the concentration of projects that were performed in the three months ended September 30, 2014.  These projects were in the normal course of the Company development, but were performed during this concentrated period of time.


During the six months ended September 30, 2014, and 2013, we engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies.  General and administrative expenses were $1,199,372 and $1,344,674 during the six months ended September 30, 2014, and 2013, respectively. A significant portion of these expenses were professional fees, payroll and travel expenses. Most all of the professional fees were legal and accounting fees related to the preparation and filing of reports with the SEC under the Exchange Act. Payroll is made up of cash payroll costs and non-cash equity issuances to management, directors and others.




14




Income Taxes


During the three and six months ended September 30, 2014, and 2013, we had no taxable income.


Liquidity and Capital Resources


From our inception on January 31, 2013, through September 30, 2014, we incurred net losses of $372,059.  Management has expressed its belief that we need to raise approximately $40 million to $50 million in additional funds through equity or debt financing to continue our business model and to effectively compete in the life settlement industry during fiscal 2015 and beyond.  We raised $11,942,750 (gross) in our private placement that commenced in April 2013.  Our monthly expenses are between approximately $150,000 and $225,000, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and estimated legal and accounting expenses.  As of September 30, 2014, we had a Subscription Agreement executed on June 24, 2014, for $3.3 million to purchase 660,000 shares of our common stock.  We believe we will have adequate cash resources for our estimated monthly expenses through the end of our fiscal year of March 31, 2015, excluding any other acquisitions of additional NIBs and other life settlement products, and assuming payment of this Subscription Agreement; however, we have been advised that there will be a delay in the payment of this subscription as a result of the time and issues involved in a foreign probate of the subscriber’s estate, and no assurance can be given that this subscription will be paid.


We have cash assets at September 30, 2014, and March 31, 2014, of $119,662 and $375,212, respectively.  We have only common stock as our capital resource. We will be reliant upon stockholder loans or private placements of equity or debt to fund any future operations. We have secured no sources of loans. There is no assurance that we will be able to raise any required debt or equity financing.


For the six months ended September 30, 2014, and 2013, we recorded net cash used in operating activities of $1,595,550 and $7,145,135, respectively. We used cash of $691,557 and $6,414,063 on advance for investments in NIBs under the Del Mar ATA and accreted $1,156,151 and $0 in interest income on investment in net insurance benefits during the six months ended September 30, 2014, and 2013, respectively.  During the six months ended September 30, 2014, and 2013 no cash was used to purchase investments in NIBs. We received $550,000 from proceeds from notes receivable during the six months ended September 30, 2014.  Net cash provided by financing activities totaled $790,000 and $ 7,579,275 for the six months ended September 30, 2014 and 2013, respectively.


For the three months ended September 30, 2014, and 2013, we recorded net cash used in operating activities of $576,830 and $906,470, respectively. We used cash of $138,000 and $616,363 on advance for investments in NIBs under the Del Mar ATA and accreted $592,653 and $0 in interest income on investment in net insurance benefits during the three months ended September 30, 2014, and 2013, respectively.  During the three months ended September 30, 2014 and 2013, there were no direct cash outflows that increased investments in NIBs.  In addition, there were no transfers from advance for investments in NIBs to investments in NIBs during the three months ended September 30, 2014, and 2013. Net cash provided by financing activities totaled $690,000 and $627,500 for the three months ended September 30, 2014 and 2013, respectively.


Debt


At September 30, 2014, we had a long term notes payable balance of $1,326,876, excluding accrued interest. We may borrow money in the future to finance our operations. Any such borrowing will increase the risk of loss to the debt holder in the event we are unsuccessful in repaying such loans.


We may issue additional shares to finance our future operations. Any such issuance may result in substantial additional dilution to previous investors.


Critical Accounting Policies and Estimates


The preparation of our financial statements requires that we make estimates and judgments. We base these on historical experience and on other assumptions that we believe to be reasonable.


Item 3.  Quantitative and Qualitative Disclosures about Market Risk.


Not required.



15





Item 4.  Controls and Procedures.


Evaluation of Disclosure Controls and Procedures


Our management, with the participation of our principal executive and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report.  Based on that evaluation, our President who is also deemed to be our acting CFO, concluded that our disclosure controls and procedures as of the end of the period covered by the Quarterly Report were not effective and that the information required to be disclosed by us in reports filed under the Exchange Act is not (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our President and our acting CFO, as appropriate to allow timely decisions regarding disclosure.  A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.


We are in the process of adopting specific internal control mechanisms with our Board of Directors’ and our officers’ collaboration to ensure effectiveness as we grow our business.  We appointed a COO to assist in adopting new measures to improve upon our internal controls.  Future controls, among other things, will include more checks and balances and communication strategies between management and all members of the Board of Directors to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting and disclosure of information.  We also plan to hire additional personnel, subject to available funding.


 

Changes in Internal Control over Financial Reporting


With the exception of the matters discussed by us regarding our future controls to resolve our the present weaknesses in our controls and procedures, as discussed in the preceding section, there have been no changes in internal control over financial reporting.


PART II - OTHER INFORMATION


Item 1. Legal Proceedings.


We are not party to any material legal proceedings.


Item 1A.  Risk Factors.


Not required; however, for information about risk factors affecting us, our business and our common stock, see our 10-K and our 10-KA-1 Annual Report for the fiscal year ended March 31, 2014, as amended, as filed with the SEC on July 16, 2014, and July 21, 2014, respectively.  See Part II, Item 6.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


Sales of Unregistered Securities


30,000 shares of our common stock were subscribed and paid during the quarter ended September 30, 2014, at an offering price of $5.00 per share or a total subscription price of $150,000.  These shares were issued on July 18, 2014.  


These shares of common stock were offered and sold pursuant to exemptions from registration under Sections 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D of the SEC, and, as applicable, Regulation S of the SEC.


Purchases of Equity Securities by Us or our Affiliates


There were no purchases by us or any affiliated persons of any shares of our equity securities during the quarter ended September 30, 2014.



16





Item 3. Defaults upon Senior Securities.


None; not applicable.


Item 4. Mine Safety Disclosures.


None; not applicable.


Item 5. Other Information.


(i)

On June 7, 2013, we entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets, that are consideration and collateral for certain cash advances and expense payments made by us under the Del Mar ATA. Under the Del Mar ATA and related Exhibits, PCH Financial S.a.r.l. (“PCH”) retained a lien on certain of the DMF assets being transfer or acquired by us, and we were obligated to make our initial payments under the Del Mar ATA to PCH to obtain lien releases on these assets, which was done, and we received a Collateral Release Agreement from PCH on October 3, 2013, of its lien in any of such assets.  A total of $6,717,022 was paid to PCH under the Del Mar ATA to obtain the release of its lien on such assets.  Also effective June 7, 2013, we and Europa Settlement Advisors Ltd. (“Europa”) executed and delivered a Structuring and Consulting Agreement (the “Europa Agreement”) related to services that were rendered to us regarding the Del Mar ATA, and other services to be rendered.  The end result of the Del Mar ATA and the advances was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into “Qualified NIBs” before the original due date of December 31, 2013 (which was subsequently extended to September 30, 2014, and has tentatively been agreed to be extended to January 31, 2015, as discussed below), having a combined face amount of $400,000,000 (with “Qualified NIBs” meaning that (i) the NIBs would have premium financing secured for up to five years; (ii) that any grouping of NIBs would have not less than 10 policies; (iii) that the average age of the insureds under the life insurance policies would be approximately 81 years; and (iv) that the NIBs would have mortality re-insurance coverage. All remaining NIBs that are not converted to “Qualified NIBs” and all other assets conveyed to us as collateral under the Del Mar ATA to assure delivery of the Qualified NIBs are to be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000.  In the event Del Mar is unable to provide the Qualified NIBs by the original date of December 31, 2013 (which was subsequently extended to September 30, 2014, and has tentatively been agreed to be extended to January 31, 2015, as discussed below), we will have the option of foreclosing on and selling any of the collateral assets acquired up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, we will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have no due date, but will be paid out of death benefits received, and incur interest of 4.0% per annum. Total interest and principal amounts are due upon maturity.  To date, we have received $90,600,000 in Qualified NIBs under the Del Mar ATA.  A complete description of the Del Mar ATA and the Europa Agreement, both as amended, is contained in our 8-KA-5 Current Report date June 7, 2014, which was filed with the SEC on July 10, 2014.  See Item 6.01 below.


During the past quarter, a substantial portion of the assets held by us as collateral for performance under the Del Mar ATA and the Europa Agreement were released.  It was our management’s belief that the assets released were too highly leveraged in a manner that would require excessive amounts of additional equity, that when evaluated extensively, it was determined that reaching the targeted rate of return for us would be difficult.  Some of the key reasons for the release of collateral assets include, but are not limited to, the following:


-

NIBs portfolio debt levels were too highly leveraged, thus creating a debt level unacceptable to management.

-

Changes in life expectancies within the portfolios required additional equity on some policies to make the Senior Loans required more acceptable for the lending institution, and we were unwilling to commit the additional equity.

-

Our evaluation process exposed some of the assets as less than ideal for our desired rate of return,  thus making a total portfolio unacceptable.




17




We continue to hold assets acquired under the Del Mar ATA that are being evaluated and processed to fit our Qualified NIBs criteria.  As mentioned above, they will need to fit our processes and structure without compromising our expected rates of return.  We believe that with the assets currently held as collateral, as well as other opportunities in the open market place, Del Mar will be able to find assets and portfolios that will fit our target acquisition profile and allow Del Mar and Europa to satisfy the requirements of delivering the remaining $309,400,000 in Qualified NIBs due us under the Del Mar ATA.  Management also believes that if we are required to exercise our rights with regards to seeking the liquidated damages settlement by foreclosing on the collateral, while retaining the $90,600,000 in Qualified NIBs that have already been received by us under the Del Mar ATA, that the collateral we now hold has sufficient value to recover such damages.


We have determined that extending the Del Mar ATA and the Europa Agreement delivery requirements of Qualified NIBs through January 31, 2015, is in our best interest, and documentation regarding such extension is in the process of being prepared. We will require additional equity to have sufficient liquidity to complete the balance of the $309,400,000 Qualified NIBs. The amount of the additional equity required is being evaluated and will be disclosed when determined. We are confident in our ability as an organization to complete the acquisition of the Qualified NIBs under the Del Mar ATA, as well as acquiring other NIBs moving forward, with or without the assistance of Del Mar or Europa.    


(ii)

Certain founding shareholders of the Company owning approximately 28,727,000 shares of our common stock who executed and delivered Lock-Up/Leak-Out Agreements restricting the sale of their respective shares of common stock of the Company until on or about October 5, 2014, a date which was 18 months from the filing of our 8-K Current Report dated March 29, 2013, and filed with the SEC on April 5, 2013, regarding our acquisition by merger of ANEW LIFE, INC., a Utah corporation that became our wholly-owned subsidiary following such merger (“ANEW LIFE”), have executed and delivered Agreements that have extended the Lock-Up Period under these Lock-Up/Leak-Out Agreements for an additional year, to on or about October 5, 2015, and the Leak-Out Period in their initial Lock-Up/Leak-Out Agreements will now commence on the expiration of the new Lock-Up Period, or October 5, 2015.  These persons received their respective shares of common stock of the Company on the organization of ANEW LIFE and its subsequent merger into the Company on a share for share basis.  Certain other smaller founding shareholders or their transferees who collectively own approximately 225,000 shares of our common stock, each of whom owned less than 100,000 shares of our common stock, have also agreed to extend their respective Lock-Up Periods to October 5, 2015.  See Item 6.01.


Item 6. Exhibits.


Exhibit No.                         Identification of Exhibit


Exhibit Number

Description

 

 

10.1

Form of Lock-Up/Leak-Out Agreement*

10.2

Form of Extension Agreement to Lock-Up/Leak-Out Agreement

31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, President and Director.

31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Randall F. Pearson, acting CFO.

32

Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 proved by Randall F. Pearson, President and acting CFO.

 

 

101.INS

XBRL Instance Document

101.PRE.

XBRL Taxonomy Extension Presentation Linkbase

101.LAB

XBRL Taxonomy Extension Label Linkbase

101.DEF

XBRL Taxonomy Extension Definition Linkbase

101.CAL

XBRL Taxonomy Extension Calculation Linkbase

101.SCH

XBRL Taxonomy Extension Schema


*Filed as Exhibit 10.7 to our Current Report on Form 8-K dated March 29, 2013 and filed with the Securities and Exchange Commission on April 5, 2013.




18




Documents Incorporated by Reference


8-K Current Report dated October 21, 2013, which was filed on October 24, 2013, regarding the employment of a COO.


10-K and 10-KA-1 Annual Report for the fiscal year ended March 31, 2014, as amended, which were filed with the SEC on July 16, 2014 and July 21, 2014, respectively.


8-K Current Report dated June 7, 2013, as amended, and filed with the SEC on June 20, 2013, November 14, 2013, May 5, 2014, May 27, 2014 and July 10, 2014, regarding the Del Mar ATA.


8-K Current Report dated March 29, 2013, which was filed with the SEC on April 5, 2013, along with our 8-KA Current Reports of the same date, which were respectively filed with the SEC on May 24, 2013, July 12, 2013, September 12, 2013, and November 27, 2013, regarding the PCH Transfer Agreement.



19




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

  

Sundance Strategies, Inc.


Date:

November 14, 2014

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President and, Acting CFO




20




 

EX-10 2 formofextensionofluloagreeme.htm FORM OF EXTENSION AGREEMENT TO LOCK-UP/LEAK-OUT AGREEMENT AGREEMENT


AGREEMENT



THIS AGREEMENT is made between Sundance Strategies, Inc., a Nevada corporation (the “Company”) and ____________ (“_____” or the “Shareholder”);


RECITALS:


WHEREAS, on or about March 28, 2013, ________ executed a Lock-Up/Leak-Out Agreement with ANEW LIFE, INC., the predecessor of the Company, a copy of which is attached hereto as Exhibit A and incorporated herein by reference; and


WHEREAS, the Company and the Shareholder desire to extend the Lock-Up Period outlined in the Lock-Up/Leak-Out Agreement to October 5, 2015;


NOW, THEREFORE, for $10.00 and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Shareholder hereby agree to extend the Lock-Up Period in the Lock-Up/Leak-Out Agreement that is Exhibit A hereto until October 5, 2015, with the Leak-Out Period contained in such Lock-Up/Leak-Out Agreement to commence at the end of the new Lock-Up Period or October 5, 2015, for all purposes thereof.


SUNDANCE STRATEGIES, INC.



Dated: 10-10-2014.

By/s/ Randall Pearson




DYNAMO HOLDINGS BUSINESS, INC.



Dated: 10-10-2014.

By /s/ Douglas Hawkes





SUNDANCE STRATEGIES, INC.



Dated: 10-14-14.

By /s/ Randall Pearson




ECLIPSE FUND, LLC



Dated: 10-14-14.

By/s/ Kraig Higginson





SUNDANCE STRATEGIES, INC.



Dated: 10-6-2014.

By /s/ Randall Pearson




NOEL INVESTMENTS, LTD.



Dated: 10-6-2014.

By /s/ Kelly Trimble





SUNDANCE STRATEGIES, INC.



Dated: 10-13-2014.

By /s/ Randall Pearson




NORTH SHORE FOUNDATION, LLP



Dated: 10-13-2014.

By /s/Ty Mattingly





SUNDANCE STRATEGIES, INC.



Dated: 10-14-14.

By /s/ Randall Pearson




PEOPLES PHILANTHROPIC, LLC



Dated: 10-14-14.

By /s/ S. Blatter





SUNDANCE STRATEGIES, INC.



Dated: 10-13-2014.

By /s/ Randall Pearson




PRIMARY COLORS, LLC



Dated: 10-13-2014.

By /s/ Ty Mattingly





SUNDANCE STRATEGIES, INC.



Dated: 10-7-14.

By /s/ Randall Pearson




RADIANT LIFE, LLC



Dated:  10-7-14.

By /s/Mitchell Burton






SUNDANCE STRATEGIES, INC.



Dated: 10-7-14.

By /s/ Randall Pearson




ZOE, LLC



Dated: 10-7-14.

By /s/ Mitchell Burton



EX-31 3 ex311.htm 302 CERTIFICATION OF RANDALL F. PEARSON, CEO Exhibit 31-1

Exhibit 31-1

  

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  

I, Randall F. Pearson, certify that:

  

1.   I have reviewed this Quarterly Report on Form 10-Q of Sundance Strategies, Inc.;

  

2.   Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

  

3.   Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

  

4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Registrant and have:

  

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

  

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

  

d)

disclosed in this Quarterly Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

  

5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);

  

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

  

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

  

    

Date:

November 14, 2014

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President




EX-31 4 ex312.htm 302 CERTIFICATION OF RANDALL F. PEARSON, ACTING CFO Exhibit 31-2

Exhibit 31-2

  

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  

I, Randall F. Pearson, certify that:

  

1.   I have reviewed this Quarterly Report on Form 10-Q of Sundance Strategies, Inc.;

  

2.   Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

  

3.   Based on my knowledge, the financial statements, and other financial information included in this Quarterly Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

  

4.   The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Registrant and have:

  

a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

  

b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Quarterly Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Quarterly Report based on such evaluation; and

  

d)

disclosed in this Quarterly Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

  

5.   The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);

  

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

  

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

  

    

Date:

November 14, 2014

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, Acting CFO




EX-32 5 ex32.htm 906 CERTIFICATION Exhibit 32

Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Sundance Strategies, Inc. (the “Registrant”) on Form 10-Q for the period ending September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Randall F. Pearson, President and acting CFO of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Date:

November 14, 2014

  

By:

/s/Randall F. Pearson

  

  

  

  

Randall F. Pearson, President and acting CFO





EX-101.PRE 6 sund-20140930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.INS 7 sund-20140930.xml XBRL INSTANCE DOCUMENT 0001171838 2014-07-01 2014-09-30 0001171838 2014-09-30 0001171838 2013-10-01 2013-10-29 0001171838 2013-06-01 2013-06-07 0001171838 2013-06-07 0001171838 2013-10-29 0001171838 2014-01-13 2014-01-14 0001171838 us-gaap:NotesReceivableMember sund:DelMarMember 2014-04-28 0001171838 us-gaap:NotesReceivableMember sund:DelMarMember 2013-10-23 0001171838 us-gaap:NotesReceivableMember sund:DelMarMember 2014-04-27 2014-04-28 0001171838 2014-06-23 2014-06-24 0001171838 2014-06-24 0001171838 2013-07-01 2013-09-30 0001171838 2013-09-30 0001171838 2014-03-31 0001171838 2014-04-01 2014-09-30 0001171838 2013-04-01 2013-09-30 0001171838 2013-03-31 0001171838 2014-11-14 0001171838 2013-04-01 2014-03-31 0001171838 sund:FirstIssuanceMember 2014-07-01 2014-07-31 0001171838 sund:SecondIssuanceMember 2014-07-01 2014-07-31 0001171838 us-gaap:SubsequentEventMember 2014-11-11 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure -61270 -1405435 212242 659867 691557 6414063 280 117911 -6286 17780 1156151 -1595550 -7145135 -550000 550000 6826775 640000 790000 7579275 -255550 434140 375212 545417 119662 979557 100000 139251 20782 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>(<font>1</font>) ORGANIZATION AND BASIS OF PRESENTATION</strong></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#147;SEC&#148;). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">March 31, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company's condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on </font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">December 14</font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">, 2001, for the purpose of selling coffee and other related items to the general public from retail coffee shop locations. These endeavors ceased in </font></font><font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">2006</font></font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">, and it had </font></font><font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">no</font></font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;"> material business operations from </font></font><font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">2006</font></font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">, until its acquisition of ANEW LIFE, INC. (&#147;ANEW LIFE&#148;), a subsidiary of Sundance Strategies, Inc. On </font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">March 29, 2013</font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">, Sundance Strategies, Inc., a Nevada corporation (&#147;Sundance Strategies&#148;), its newly formed and wholly-owned subsidiary, Anew Acquisition Corp., a Utah corporation (&#147;Merger Subsidiary&#148;), and ANEW LIFE, INC., a Utah corporation (&#147;ANEW LIFE&#148;), completed an Agreement and Plan of Merger, whereby the Merger Subsidiary merged with and into ANEW LIFE, and ANEW LIFE was the surviving company under the merger and became a wholly-owned subsidiary of Sundance Strategies on the closing of the merger (the &#147;Merger&#148;). The Merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of ANEW LIFE, which was incorporated on </font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">January 31, 2013</font></font><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">.</font></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">Sundance Strategies, Inc. and subsidiary (the &#147;Company&#148; or &#147;we&#148;) is engaged in the business of&#160;directly&#160;purchasing&#160;from third parties and purchasing, acquiring and assisting third parties in assembling portfolios of high quality life insurance policies and residual interest in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations from the secondary and tertiary marketplace often referred to as the &#147;life settlements market.&#148;&#160;&#160;Currently, the Company is focused on the acquisition of Net Insurance Benefits (&#147;NIB&#148; or &#147;NIBs&#148;).&#160;&#160;&#160;NIBs are residual interests in or financial products tied to life settlement policies.&#160;&#160;The Company purchases NIBs on life settlement policies from third parties in pools of multiple policies, but does not typically take possession or control of the policies, other than the policies held as collateral for advances to third parties, of which the Company does take temporary possession until collateral is returned for NIBs.</font></p> </div> 5 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">(</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">5</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">) NOTE RECEIVABLE&#160;</font></font></strong></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">On </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">October 23, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company made a loan totaling $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">650,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in the form of a note receivable to Del Mar. The note incurred interest at </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">3</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">%, compounding annually. On </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">April 28, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company received full payment of the $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">650,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> Del Mar note receivable entered into on </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">October 23, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. Of the $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">650,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company received cash payments totaling $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">550,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">; and $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">100,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> was applied to advances for investment in NIBs.</font></font></p> </div> </div> 650000 0.03 650000 550000 100000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>(<font>8</font>) GOING CONCERN</strong></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style="font-family : Times New Roman; font-size: 10pt;">The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. At </font><font style="font-size: 10pt; font-family : Times New Roman;">September 30, 2014</font><font style="font-size: 10pt; font-family : Times New Roman;"><font style="font-family : Times New Roman; font-size: 10pt;">, the Company had accumulated losses of $</font><font>372,059</font><font style="font-family : Times New Roman; font-size: 10pt;">, working capital deficit of $</font><font>2,218,624</font><font style="font-family : Times New Roman; font-size: 10pt;">, and has yet to receive cash payments on interest income on Investment in NIBS. These factors raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty</font></font><font style="font-size: 10pt;">.</font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style="font-family : Times New Roman; font-size: 10pt;"><font style="font-family : Times New Roman; font-size: 10pt;">The Company's continued existence is dependent on its ability to generate sufficient cash flow to cover operating expenses and to invest in future operations. Management is actively pursuing opportunities to expand existing operations. The Company does not anticipate having adequate revenues from operations until </font><font>three</font><font style="font-family : Times New Roman; font-size: 10pt;"> to </font><font>four</font><font style="font-family : Times New Roman; font-size: 10pt;"> years, and until a revenue stream has been established, the Company will require debt or equity funding to fund its current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is possible</font></font><font style="font-family : Times New Roman; font-size: 10pt;">.</font></p> </div> </div> -2218624 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>(<font>7</font>) STOCK TRANSACTIONS</strong></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman; margin-right: 5pt; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-size: 10pt;/* text-indent: 5px; *//* margin-right: 5px; */">During July 2014, the Company issued </font><font>30,000</font><font style="font-size: 10pt;"> shares of common stock for $</font><font>150,000</font><font style="font-size: 10pt;"> and issued </font><font>140,000</font><font style="font-size: 10pt;"> shares of common stock for $</font><font>700,000</font><font style="font-size: 10pt;">. &#160;&#160;The $</font><font>700,000</font><font style="font-size: 10pt;"> in cash was received prior to March 31, 2014.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman; text-indent: 36pt;"><font style="font-family : Times New Roman; font-size: 10pt;">On </font><font style="font-size: 10pt;">June 24, 2014</font><font style="font-size: 10pt;"><font style="font-size: 10pt;">, the Company entered into a private stock offering subscription agreement to issue </font><font>660,000</font><font style="font-size: 10pt;"> shares at $</font><font>5</font><font style="font-size: 10pt;"> per share for a total of $</font><font>3,300,000</font><font style="font-size: 10pt;">, which subscription was due and payable on </font></font><font style="font-size: 10pt;">August 15, 2014</font><font style="font-size: 10pt;"><font style="font-size: 10pt;">. &#160;The Company has been advised that there will be a further delay in the payment of this subscription as a result of the time and issues involved in a foreign probate of the subscriber's estate, and there is </font><font>no</font><font style="font-size: 10pt;"> assurance that this subscription will be paid.</font></font></p> </div> 660000 3300000 400000000 400000000 20000000 8000000 12000000 0.040 4000000 24000000 12000000 12000000 25000 90600000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">(</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">6</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">) NOTES PAYBALE-RELATED PARTY&#160;</font></font></strong></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></font></strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">During the </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">six</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> months ended</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company borrowed $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">740,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> from related parties and paid back $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">100,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, bringing the total notes payable-related party loan balance to $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">730,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> at </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. &#160;The notes do not incur interest, are payable on demand and are not collateralized.</font></font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>(<font>9</font>) SUBSEQUENT EVENTS</strong></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman; text-indent: 36pt;"><font style="font-size: 10pt;">On or about November 11, 2014, the Company, Del Mar and Europa have tentatively agreed to extend the delivery date of the remaining $<font>309,400,000</font> in Qualified NIBs due under the Del Mar ATA until January 31, 2015, for which documentation is presently being prepared.</font></p> </div> </div> 730000 90000 2374511 142915 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">(</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">4</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS</font></font></strong></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">On </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">June 7, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company entered into an Asset Transfer Agreement (the &#147;Del Mar ATA&#148;) with Del Mar Financial, S.a.r.l. (&#147;Del Mar&#148;). The Del Mar ATA involved the purchase of certain life settlement assets consisting of </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">100</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the &#147;NIBs&#148;), among other assets, that are consideration and collateral for certain cash advances and expense payments made by the Company. The end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into &#147;Qualified NIBs&#148; before the original due date of </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">December 31, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, which was subsequently extended to </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), having a combined face amount of $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">400,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> (with &#147;Qualified NIBs&#148; meaning that the NIBs would have premium financing secured for up to </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">five</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> years; that any grouping of NIBs would have not less than </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">10</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> policies; that the average age of the insureds under the life insurance policies would be approximately </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">81</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> years; and that the NIBs would have mortality re-insurance coverage). All remaining NIBs that are not converted to &#147;Qualified NIBs&#148; and all other assets conveyed to the Company as collateral to assure delivery of the Qualified NIBs will be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">400,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. In the event Del Mar was unable to provide the Qualified NIBs by the original date of </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">December 31, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, which was subsequently extended to </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), the Company will have the option of selling any of the collateral assets acquired up to a liquidated damages settlement payment equal to </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">100</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, the Company will have paid $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">20,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> of consideration, $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">8,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> of which would be in cash and the remaining $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">no</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> due date, but will be paid out of death benefits received, and incur interest of </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">4.0</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% per annum. Total interest and principal amounts are due upon maturity. Del Mar is continuing its efforts in delivering the Qualified NIBs. The Company has received $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">90,600,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in Qualified NIBs under the Del Mar ATA.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (&#147;Europa Agreement&#148; and &#147;Europa&#148;). The Company is required to pay a structuring fee of </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">1</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">50</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% of the fee on the delivery of the NIBs; and the remaining </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">50</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. The total restructuring fee will be up to $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">4,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. In the event that any cash consideration by the Company under the Del Mar ATA exceeds the defined $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">8,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">24,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> under the Del Mar ATA, which is comprised of $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in cash consideration and $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in promissory notes.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">On </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">October 29, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up-front cash payment due from the Company under the Del Mar ATA and Europa Agreement shall not exceed $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">; that the Company would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">8,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">300,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">two</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">; and if at least $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">300,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within </font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">90</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> days.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Also on </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">October 29, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">25,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> to such consultant for services related to the purchase of Qualified NIBs associated with the $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">400,000,000</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> in life insurance policies under the Del Mar ATA.</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">On </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">January 14, 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Company completed the closing of $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">90.6</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> million of Qualified NIBs. These Qualified NIBs are part of the $</font></font><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">400</font></font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;"> million transaction of additional NIBs in portfolios from the Company's second acquisition in </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">June 7, 2013</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, related to the Del Mar ATA.</font></font></p> </div> </div> In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days. The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. 740000 1455904 2374511 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">(2) NEW ACCOUNTING PRONOUNCEMENTS</font></font></strong></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">In </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">May 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standard Update (&#147;ASU&#148;) 2014-09 &#150; Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for annual periods, and interim periods within those annual periods, beginning after </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">December 15, 2016</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. Early adoption is not permitted and companies can transition to the new standard under the full retrospective method or the modified retrospective method. The Company does not believe adoption of this ASU will have a material impact on its financial statements.</font></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements&#151;Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements.</font></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;">&#160;</p> <div> <div style=" display: inline; font-size: 13.333333015441895px; font-family : Times New Roman; font-variant: normal; font-weight: normal; font-style: normal; text-decoration: none solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;&#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160;&#160; <font style=" font-size: 10pt;">The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.</font></div> </div> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style=" display: inline; font-size: 13.333333015441895px; font-family : Times New Roman; font-variant: normal; font-weight: normal; font-style: normal; text-decoration: none solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;&#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160;&#160; <font style=" font-size: 10pt;">The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.</font></div> </div> 13767 18001028 16703040 18156915 17080252 170826 52915 146809 1326876 1598819 10000000 0.001 0 500000000 0.001 43015941 43186 43017 1500 16111277 15050705 700000 -372059 -310789 15782404 15481433 18156915 17080252 0 0 7625 2000 155887 377212 13399562 12243411 4376419 3584862 211000 861000 14047 43015941 0.001 43185941 500000000 10000000 43185941 0.001 592653 1156151 583006 310809 1199372 1344674 9647 -310809 -43221 -1344674 6303 4478 8820 21 17031 30709 33172 60782 -12553 -30709 -18049 -60761 -2906 -341518 -61270 -1405435 -2906 -341518 -0.01 -0.01 -0.01 -0.03 43163575 42261441 43090561 41781441 28600 28600 5625 150000 752500 217000000 1 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;"><strong>(<font>3</font>) INVESTMENT IN NET INSURANCE BENEFITS</strong></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. The investment in NIBs&#160;is a&#160;residual economic beneficial interest in a portfolio of life insurance policies that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (&#147;MRI&#148;).&#160;&#160;Future expected cash flows are defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments. &#160;At the time of purchase of an investment in NIBs we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our cost basis. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations.&#160; Subsequent to the purchase, and on a quarterly basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion.&#160; Any positive or adverse change in cash flows that does not result in the recognition of an &#147;other-than-temporary impairment&#148; (&#147;OTTI&#148;) results in a prospective increase or decrease in the effective interest rate used to recognize interest income.&#160; Management has concluded that there was <font>no</font> change in estimated cash flows as of September 30, 2014.</font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid. &#160;The face value of the underlying life insurance policies approximated $<font>217</font> million (includes estimated return of premiums) as of September 30, 2014.&#160;The Company holds a <font>100</font>% interest in the NIBs relating to the underlying life insurance policies as of September 30, 2014.&#160; The estimated fair value of the Company's investment in NIBs approximated carrying value at September 30, 2014, with fair value calculated using level <font>3</font> inputs.&#160; As of September 30, 2014 and March 31, 2014, investments in NIBs were as follows:</font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <div class="CursorPointer"> <div> <table cellspacing="0" cellpadding="0" style=" width: 50%; border-collapse: collapse;"> <tr> <td align="right" valign="middle" style=" vertical-align: middle; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; background-color: #ffffff;">&#160;</td> <td align="center" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family : Times New Roman; background-color: #ffffff;">&#160;</td> <td colspan="3" align="center" valign="middle" style=" vertical-align: middle; border-bottom: #000000 1pt solid; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30,&#160;<br style=" font-size: 10pt;"/> 2014</font></font></p> </td> <td align="center" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family : Times New Roman; border-bottom: #000000 1pt solid; background-color: #ffffff;">&#160;</td> <td colspan="3" align="center" valign="middle" style=" vertical-align: middle; border-bottom: #000000 1pt solid; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; background-color: #ffffff;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">March 31,&#160;<br style=" font-size: 10pt;"/> 2014</font></font></p> </td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; width: 50%; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Beginning Balance</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%; text-align: right;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff; width: 22%;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff; width: 22%;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Additional investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Accretion of interest income</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">1,156,151</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Distributions of investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Impairment of investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Total</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff; text-align: right;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">13,399,562</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> </tr> </table> </div> </div> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; font-size: 10pt;">We evaluate the carrying value of our investment in NIBs for OTTI on a regular basis and, if necessary, adjust our carrying value in the investment in NIBs using new or updated information that affects our assumptions about remaining life expectancy, credit worthiness of the policy issuer, funds needed to maintain the asset until maturity, utilization of MRI, discount rates and potential return. We recognize OTTI on investment in NIBs if the expected discounted cash flows (using the effective yield) expected to be received are less than the carrying amount of the investment.&#160; OTTI of the investment in NIBs could be generally caused by the insured significantly exceeding the estimate of the original life expectancy, which causes the original policy costs and projected future premiums to exceed the estimated maturity value, a change in credit worthiness of the policy issuer, increased or changes to applicable regulation of the investment, counter party performance risk, shortage of funds needed to maintain the asset until maturity and changes in discount rates. There are also risks associated with the policy holder's ability to repay such financing and the occurrence of events of default under such financing. We have not recognized any OTTI from January 31, 2013 (inception) to the period ended September 30, 2014.</font></p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table cellspacing="0" cellpadding="0" style=" width: 50%; border-collapse: collapse;"> <tr> <td align="right" valign="middle" style=" vertical-align: middle; font-family : Times New Roman; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; background-color: #ffffff;">&#160;</td> <td align="center" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family : Times New Roman; background-color: #ffffff;">&#160;</td> <td colspan="3" align="center" valign="middle" style=" vertical-align: middle; border-bottom: #000000 1pt solid; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">September 30,&#160;<br style=" font-size: 10pt;"/> 2014</font></font></p> </td> <td align="center" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family : Times New Roman; border-bottom: #000000 1pt solid; background-color: #ffffff;">&#160;</td> <td colspan="3" align="center" valign="middle" style=" vertical-align: middle; border-bottom: #000000 1pt solid; border-left: none; border-right: none; border-top: none; border-color: #000000; padding: 0px; background-color: #ffffff;"> <p style=" margin: 0pt; text-align: center; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">March 31,&#160;<br style=" font-size: 10pt;"/> 2014</font></font></p> </td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; width: 50%; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Beginning Balance</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%; text-align: right;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff; width: 22%;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff; width: 1%;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff; width: 22%;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; width: 1%;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Additional investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Accretion of interest income</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">1,156,151</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Distributions of investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Impairment of investments</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff; text-align: right;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 1pt solid; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">-</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-left: none; border-right: none; border-top: none; border-bottom: #000000 1pt solid; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; background-color: #ffffff;">&#160;</td> </tr> <tr> <td valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-top: none; border-bottom: none; border-color: #000000; padding: 0px; font-family : Times New Roman; background-color: #ffffff; text-align: left;"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">Total</font></font></p> </td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #ffffff;">&#160;</td> <td valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff; text-align: right;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">13,399,562</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> <td align="right" valign="middle" style=" vertical-align: middle; border-left: none; border-right: none; border-color: #000000; padding: 0px; text-align: right; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">$</font></font></td> <td align="right" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; border-bottom: #000000 2.80pt double; background-color: #ffffff;"><font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">12,243,411</font></font></font></td> <td align="left" valign="middle" style=" vertical-align: bottom; border-top: #000000 1pt solid; border-left: none; border-right: none; border-color: #000000; padding: 0px; font-family : Times New Roman; font-size: 10pt; white-space: nowrap; padding-right: 5px; border-bottom: #000000 2.80pt double; background-color: #ffffff;">&#160;</td> </tr> </table> </div> 12243411 100000 30000 150000 140000 700000 0 309400000 Sundance Strategies, Inc. 0001171838 10-Q 2014-09-30 false --03-31 Smaller Reporting Company 43185941 2015 Q2 EX-101.SCH 8 sund-20140930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 103 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS link:presentationLink link:calculationLink link:definitionLink 104 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS link:presentationLink link:calculationLink link:definitionLink 105 - Disclosure - NOTE RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 106 - Disclosure - NOTES PAYBALE-RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 107 - Disclosure - STOCK TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 108 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 109 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - NOTE RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - NOTES PAYBALE-RELATED PARTY (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - STOCK TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - GOING CONCERN (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 80000 - Disclosure - COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS link:presentationLink link:calculationLink link:definitionLink 80002 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 80003 - Disclosure - STOCK OPTIONS link:presentationLink link:calculationLink link:definitionLink 80004 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 30301 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 80006 - Disclosure - STOCK OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 80007 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 80008 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Investment in Net Insurance Benefit Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 80009 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Future Estimated Premiums Payments, Other Expenses and Interest Paid By External Parties) (Details) link:presentationLink link:calculationLink link:definitionLink 80010 - Disclosure - COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS (Details) link:presentationLink link:calculationLink link:definitionLink 80012 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 80013 - Disclosure - STOCK OPTIONS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 80014 - Disclosure - STOCK OPTIONS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 80015 - Disclosure - WARRANTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 80016 - Disclosure - WARRANTS (Schedule of Warrant Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefit Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 sund-20140930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 sund-20140930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 sund-20140930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Investment [Text Block] INVESTMENT IN NET INSURANCE BENEFITS Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Award Type [Axis] Document Period End Date Document Period End Date Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Document Type Document Type SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Receivable Type [Axis] Accounts Payable Accounts Payable, Current Accounts, Notes, Loans and Financing Receivable [Line Items] Accrued Expenses Accrued Liabilities, Current Additional Paid In Capital- Stock to be Issued Additional Paid in Capital, Common Stock Additional Paid in Capital Additional Paid In Capital Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile to cash from operating activities: Assets Total Assets Assets, Current [Abstract] Current Assets ASSETS Assets [Abstract] Assets, Noncurrent Total Other Long-term Assets Assets, Current Total Current Assets Assets, Noncurrent [Abstract] Other Assets Counterparty Name [Axis] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Period Increase (Decrease) Net Change in Cash Cash and Cash Equivalents Cash and Cash Equivalents, at Carrying Value Cash at Beginning of Period Cash at End of Period Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Exercise price of warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Shares of common stock issuable under warrants Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Table] COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS [Abstract] Commitments and Contingencies Disclosure [Text Block] COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS Common Stock, Par or Stated Value Per Share Common Stock, par value per share Common Stock, authorized 500,000,000 shares, par value $0.001; 43,185,941 and 43,015,941 shares issued and outstanding, respectively Common Stock, Value, Issued Common Stock, shares issued Common Stock, Shares, Issued Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares Subscribed but Unissued Subscriptions receivable, shares Common stock to be issued, shares Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Common Stock, shares outstanding Common Stock, Shares, Outstanding Common stock to be issued, value Common Stock, Value, Subscriptions Subscriptions receivable Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk and Major Customers Consolidation, Policy [Policy Text Block] Principles of Consolidation Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Debt Instrument, Face Amount Note payable, face amount Debt Disclosure [Text Block] NOTES PAYABLE Debt Instrument, Term Note term Collateral Debt Instrument, Collateral Debt Instrument, Interest Rate, Stated Percentage Interest rate Debt Instrument, Maturity Date Maturity date Derivative, Maturity Date Maturity Description of New Accounting Pronouncements Not yet Adopted [Text Block] NEW ACCOUNTING PRONOUNCEMENTS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTIONS STOCK OPTIONS [Abstract] Basic and Diluted: Earnings Per Share, Basic and Diluted [Abstract] Earnings Per Share, Basic and Diluted Loss Per Share Earnings Per Share, Policy [Policy Text Block] Income (Loss) Per Common Share Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost related to stock options, weighted average service period Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation cost related to stock options Common stock issued, price per share Development Stage Entities, Equity Issuance, Per Share Amount Fair Value Assumptions, Expected Volatility Rate Volatility Fair Value Assumptions, Risk Free Interest Rate Risk free rate Expected Term Fair Value Assumptions, Expected Term Gain on Extinguishment of Debt Gain on Extinguishment of Debt Gains (Losses) on Extinguishment of Debt General and Administrative Expense General and Administrative Expenses Condensed Consolidated Statements of Operations [Abstract] Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Loss Before Income Taxes Income Tax Expense (Benefit) Income Tax Provision Income taxes Income Taxes Paid Income Tax, Policy [Policy Text Block] Income Taxes Accounts Payable Increase (Decrease) in Accounts Payable Accrued Expenses Increase (Decrease) in Accrued Liabilities Advance for Investments in Net Insurance Benefits Increase (Decrease) in Other Noncurrent Assets Accrued Interest Income Increase (Decrease) in Accrued Interest Receivable, Net Accrued Interest Increase (Decrease) in Interest Payable, Net Increase (Decrease) in Other Operating Assets Investment in Net Insurance Benefits Interest Income Interest Income, Other Interest Payable Interest Expense Interest Expense Interest Income on Investment in Net Insurance Benefits Interest Income, Operating Interest Interest Paid Accrued interest income Accrued interest receivable Interest Receivable INVESTMENT IN NET INSURANCE BENEFITS [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Operating Leases, Rent Expense Rent expense Lease Arrangement, Type [Domain] Lease Agreements [Member] Verbal Lease Agreement [Member] Lease Arrangement, Type [Axis] Liabilities, Current Total Current Liabilities Liabilities and Equity Total Liabilities and Stockholders' Equity Liabilities Assumed Liabilities assumed through the merger Liabilities, Noncurrent Total Long-Term Liabilities Current Liabilities Liabilities, Current [Abstract] Liabilities Total Liabilities Liabilities, Noncurrent [Abstract] Long Term Liabilities Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Life settlement contracts Life Settlement Contracts, Policy [Policy Text Block] Life Settlement Contracts, Investment Method, Number of Contracts, Maturing in Year Two Number of interests in life settlement contracts, year two Life Settlement Contracts, Investment Method, Premiums to be Paid after Year Five Premiums to be paid, thereafter Life Settlement Contracts, Investment Method, Number of Contracts, Maturing in Year Three Number of interests in life settlement contracts, year three Life Settlement Contracts, Investment Method, Number of Contracts, Maturing in Year Five Number of interests in life settlement contracts, year five Life Settlement Contracts, Investment Method, Premiums to be Paid in Year Two Premiums to be paid, year two Life Settlement Contracts, Investment Method, Premiums to be Paid in Year Four Premiums to be paid, year four Life Settlement Contracts, Investment Method, Number of Contracts, Maturing in Next Twelve Months Number of interests in life settlement contracts, next twelve months Life Settlement Contracts, Investment Method, Number of Contracts, Fiscal Year Maturity [Abstract] Number of Interests in Life Settlement Contracts: Face value of underlying policies, total Life Settlement Contracts, Investment Method, Face Value Life settlement policies, face value Face value of underlying policies, thereafter Life Settlement Contracts, Investment Method, Face Value, Maturing after Year Five Investment in Net Insurance Benefits Life Settlement Contracts, Investment Method, Carrying Amount Life Settlement Contracts, Investment Method, Premiums to be Paid in Year Three Premiums to be paid, year three Life Settlement Contracts, Investment Method, Premiums to be Paid in Next Twelve Months Premiums to be paid, year one Life Settlement Contracts, Investment Method, Number of Contracts, Maturing in Year Four Number of interests in life settlement contracts, year four Face value of underlying policies, year four Life Settlement Contracts, Investment Method, Face Value, Maturing in Year Four Face value of underlying policies, year five Life Settlement Contracts, Investment Method, Face Value, Maturing in Year Five Face value of underlying policies, year three Life Settlement Contracts, Investment Method, Face Value, Maturing in Year Three Life Settlement Contracts, Investment Method, Premiums to be Paid Premiums to be paid, total Face value of underlying policies, year two Life Settlement Contracts, Investment Method, Face Value, Maturing in Year Two Life Settlement Contracts, Investment Method, Number of Contracts, Maturing after Year Five Number of interests in life settlement contracts, thereafter Face Value of Underlying Policies: Life Settlement Contracts, Investment Method, Face Value, Fiscal Year Maturity [Abstract] Life Settlement Contracts, Investment Method, Premiums to be Paid, Fiscal Year Maturity [Abstract] Premiums: Life Settlement Contracts, Investment Method, Number of Contracts Number of interests in life settlement contracts, total Face value of underlying policies, next twelve months Life Settlement Contracts, Investment Method, Face Value, Maturing in Next Twelve Months Life Settlement Contracts, Investment Method, Premiums to be Paid in Year Five Premiums to be paid, year five Loans, Notes, Trade and Other Receivables Disclosure [Text Block] NOTE RECEIVABLE NOTE RECEIVABLE [Abstract] Notes Payable, including accrued interest Notes Payable, Noncurrent Maximum [Member] Minimum [Member] Net Income (Loss) Attributable to Parent Net Loss Net Loss Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Net Cash from Operating Activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash from Financing Activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Operating Activities Net Cash from Investing Activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations NEW ACCOUNTING PRONOUNCEMENTS [Abstract] NEW ACCOUNTING PRONOUNCEMENTS New Accounting Pronouncements, Policy [Policy Text Block] Non Cash Financing Activities Noncash Investing and Financing Items [Abstract] Nonoperating Income (Expense) Total Other Expense Nonoperating Income (Expense) [Abstract] Other Income (Expense) Amended and Restated Promissory Note [Member] Notes Payable, Other Payables [Member] Notes Payable, Related Parties, Current Notes Payable-Related Party Total notes payable-related party loan balance Notes Receivables Exchanged for Advance for Investment in Net Insurance Benefits Notes Reduction Notes Receivable [Member] NOTES PAYABLE [Abstract] Financing Receivable, Net Note Receivable Face value of loan Notes, Loans and Financing Receivable, Gross, Current Notes Payable Notes Payable, Current OPERATING EXPENSES Operating Expenses [Abstract] Operating Expenses Total Operating Expenses Income (Loss) from Operations Operating Income (Loss) Lease Agreement [Line Items] Operating Leased Assets [Line Items] ORGANIZATION AND BASIS OF PRESENTATION [Abstract] ORGANIZATION AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Advance for Investment in Net Insurance Benefits Other Assets, Noncurrent Other assets Other Assets, Miscellaneous, Noncurrent Other Nonoperating Income (Expense) Other, net Advances Other Liabilities, Current Maximum purchase price payable by promissory notes Other Notes Payable Payments for (Proceeds from) Loans Receivable Proceeds from Notes Receivables Payments to Acquire Businesses, Gross Total purchase price Payment of introduction fees Payments of Stock Issuance Costs Advances for investment in NIBs Payments to Acquire Other Investments Preferred Stock, Par or Stated Value Per Share Preferred Stock, par value per share Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding Preferred Stock, Value, Issued Preferred Stock, Shares Issued Preferred Stock, shares issued Preferred Stock, Shares Authorized Preferred Stock, shares authorized Preferred Stock, Shares Outstanding Preferred Stock, shares outstanding Prepaid Expense, Current Prepaid Expenses Amount borrowed from related parties Proceeds from Collection of Long-term Loans to Related Parties Proceeds from Issuance of Notes Payable-Related Party Related party loan received Collection note receivable Proceeds from Collection of Notes Receivable Common Stock to be Issued Proceeds from Other Equity Proceeds from issuance of common share issued through private placement Proceeds from Issuance of Private Placement Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Common Stock Issued for Cash Professional Fees Professional Fees Range [Axis] Range [Domain] Receivable from Shareholders or Affiliates for Issuance of Capital Stock Subscription Receivable Receivable [Domain] NOTES PAYBALE-RELATED PARTY Related Party Transactions Disclosure [Text Block] Related Party Transaction [Domain] Related Party Transaction [Axis] NOTES PAYBALE-RELATED PARTY [Abstract] Counterparty Name [Domain] Restructuring and Related Cost, Incurred Cost Restructuring charges accrued Accumulated Deficit Accumulated losses Retained Earnings (Accumulated Deficit) Revenue Recognition Revenue Recognition, Policy [Policy Text Block] INCOME Revenues Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting rate after six months Expected life Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Stock option term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Remaining contractual term, outstanding shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Sale of Stock, Name of Transaction [Domain] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Stock Option Activity Schedule of Operating Leased Assets [Table] Schedule of Investments in Net Insurance Benefit Contracts Schedule of Life Settlement Contracts, Investment Method [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Warrant Activity Secured Debt [Member] Secured Note [Member] Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Number of Options Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-based Compensation Stock-based compensation expense Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract] Remaining vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share price Stock Price Remaining contractual term, outstanding shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Cancelled/Expired Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Cancelled/Expired Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cancelled/Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility Risk free rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Cancelled/Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Cancelled/Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Remaining options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Number of Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Equity Award [Domain] Condensed Consolidated Statements of Cash Flows [Abstract] Condensed Consolidated Balance Sheets [Abstract] Common Stock issued for cash Development Stage Entities, Stock Issued, Value, Issued for Cash Issued restricted stock, shares Stock Issued During Period, Shares, Restricted Stock Award, Gross Common stock issued for subscription receivable Stock Issued Share Based Compensation - Options Stock or Unit Option Plan Expense Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Issued restricted stock Stock Issued During Period, Value, Restricted Stock Award, Gross Shares issued through private stock offering Shares of common stock issued Stock Issued During Period, Shares, New Issues Common Stock issued for cash, shares Development Stage Entities, Stock Issued, Shares, Issued for Cash Stock Issued During Period, Value, New Issues Value of shares issued through private stock offering Value of shares of common stock issued Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity Attributable to Parent Total Stockholders' Equity STOCK TRANSACTIONS [Abstract] STOCK TRANSACTIONS Stockholders' Equity Note Disclosure [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS [Abstract] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event [Member] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Subsidiary, Sale of Stock [Axis] Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Estimates Use of Estimates, Policy [Policy Text Block] Warrant [Member] Warrants [Member] WARRANTS [Abstract] Weighted Average Number of Shares Outstanding Weighted Average Number of Shares Outstanding, Basic and Diluted Advance For Investment In Net Insurance Benefits [Abstract] ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract] ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS The entire disclosure for advances for investments in net insurance benefits. Advance For Investment In Net Insurance Benefits [Text Block] Advance to consultant for services The amount advanced to consultant for services under exclusivity agreement. Advance To Consultant For Services Amount Of Payments Advanced Under Ata Agreement Advanced payments under the Del Mar ATA The amount advanced in payments under the Del Mar ATA. Buyback option The amount of buyback option per loan agreement. Buyback Option Amount Buyback amount, added monthly percentage The percentage amount of additional cost added to buyback amount for everymonth past the twelve month period. Buyback Option Amount Additional Percentage Minimum buyback price The minimim price threshold for buyback option. Buyback Option Minimum Price Buyback period The time period from assigment of ammended note to buyback. Buyback Option Period The capitalized cost of fee paid to the consultant for arranging purchase of net insurance benefits through pledge agreement. Capitalized consultant fee Capitalized Consultant Fee Number of warrants authorized for issuance Number of warrants authorized for issuance. Class Of Warrant Or Right Number Of Warrants Authorized For Issuance Ammendment terms Description of the ammendment terms of the debt instrument. Debt Instrument Ammendment Terms Disclosure of accounting policy for a development stage company. Development Stage Company Development Stage Company [Policy Text Block] Document and Entity Information [Abstract] Document And Entity Information [Abstract] Employee Stock Option Group Four [Member] Employee Stock Option Group Four [Member] Employee Stock Option Group One [Member] Employee Stock Option Group One [Member] Employee Stock Option Group Three [Member] Employee Stock Option Group Three [Member] Employee Stock Option Group Two [Member] Employee Stock Option Group Two [Member] The face value of net insurance benefits purchased under asset transfer agreement. The face value of net insurance benefits purchased under asset transfer agreement Face Value Of Net Insurance Benefits Purchased Under Asset Transfer Agreement Fair Value of Warrants Issued as Stock Issuance Costs A non cash financing activity incurred directly from the issuance of warrants. Fair Value Of Warrants Issued Stock Issuance Costs Former Director Member Former Director [Member] GOING CONCERN [Abstract] The entire disclosure relating to going concern issues. GOING CONCERN Going Concern [Text Block] Lease Agreement Two [Member] November 2013 Lease Agreement [Member] Lease Agreements Two [Member] Lease And Rental Monthly Payment Monthly rental payment Amount of the required periodic rental payment. Life Insurance Policies Purchased With Debt Life insurance policies purchased with debt Life insurance policies purchased with debt. Life Settlement Contracts Investment Method Expenses Plus Interest In Next Twelve Months Expense + Interest to be paid, year one Amount of life insurance expense and interest anticipated to be paid in the next fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid After Year Five Expense + Interst to be paid, thereafter Amount of life insurance expense and interest anticipated to be paid after the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Fiscal Year Maturity [Abstract] Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Fiscal Year Maturity [Abstract] Expenses + Interest: Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Five Expense + Interest to be paid, year five Amount of life insurance expense and interest anticipated to be paid in the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Four Expense + Interest to be paid, year four Amount of life insurance expense and interest anticipated to be paid in the fourth fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Three Expense + Interest to be paid, year three Amount of life insurance expense and interest anticipated to be paid in the third fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid In Year Two Expense + Interest to be paid, year two Amount of life insurance expense and interest anticipated to be paid in the second fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Expenses Plus Interest To Be Paid Total Expense + Interest, total Total amount of life insurance expense and interest anticipated to be paid to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Paid And Other Expenses Total amount the policy holders have paid on policy premiums and other expenses on the insurance contracts. Total amount policy holders have paid on policy premiums and other expenses on insurance contracts Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid Premiums, interest and expenses, total Amount of life insurance premiums, expense and interest anticipated to be paid to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid [Abstract] Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid [Abstract] Total Premiums, Interest and Expenses: Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid After Year Five Total to be paid, thereafter Amount of life insurance premiums, expense and interest anticipated to be paid after the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Next Twelve Months Total to be paid, year one Amount of life insurance premiums, expense, and interest anticipated to be paid in the next fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Five Total to be paid, year five Amount of life insurance premiums, expense, and interest anticipated to be paid in the fifth fiscal year following the latest fiscal year to keep the life settlement accounted for under the investment method contracts in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Four Total to be paid, year four Amount of life insurance premiums, expense, and interest anticipated to be paid in the fourth fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Three Total to be paid, year three Amount of life insurance premiums, expense, and interest anticipated to be paid in the third fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Investment Method Premiums Plus Expenses Plus Interest To Be Paid In Year Two Total to be paid, year two Amount of life insurance premiums, expense, and interest anticipated to be paid in the second fiscal year following the latest fiscal year to keep the life settlement contracts accounted for under the investment method in force. Life Settlement Contracts Portion Of Pledge Agreement Paid In Cash Amount of cash paid for the net insurance benefits purchased through pledge agreement. Amount of cash paid for the net insurance benefits purchased through pledge agreement Life Settlement Contracts Purchased Through Pledge Agreement Face value of net insurance benefits purchased through pledge agreement Face value of net insurance benefits purchased through pledge agreement. Maximum Number Of Common Shares Offered Through Private Placement Maximum number of shares offered through private placement. Maximum number of common shares of restricted stock offered through private placement Nonemployee Stock Options [Member] Nonemployee Stock Options [Member] Number Of Shares Of Restricted Stock Sold Through Private Placement Number of shares of restricted stock sold through private placement. Number of shares of restricted stock sold through private placement Number Of Subscriptions Receivable Number of subscriptions receivable The number of subscriptions receivable. Private Placement Investment Amount Private placement investment amount The amount of investment in a private offering of common stock. Return Of Premium Provisions On Life Settlement Contracts Return of premium provisions on investments in net insurance benefits. Return of premium provisions on investments in net insurance benefits Schedule Of Future Estimated Premiums Paymenst And Other Expenses Expected To Be Paid On Insurance Benefit Contracts [Table Text Block] Tabular disclosure of the future estimated premiums payments, other expenses and interest paid by external parties expected to be paid on the policies through the estimated death date, future cash flows to investors, as well as future estimated proceeds from policy maturities for insurance benefit contracts. Schedule of Future Estimated Premiums, Payments and Other Expenses Expected to be Paid on Insurance Benefit Contracts Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights On Anniversary Date Amount Vest rate at anniversary date The vest rate at each anniversary date following the grant date. Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights On Grant Date Amount The vest rate of options on grant date. Vest rate of options on grant date Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Or Expired In Period Intrinsic Value Cancelled/Expired The intrinsic value of equity instruments other than options cancelled or expired during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms Exercisable Weighted average remaining contractual term for equity-based awards excluding options exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Remaining Contractual Terms Cancelled/Expired Weighted average remaining contractual term for equity-based awards excluding options forfeited, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Weighted Average Remaining Contractual Terms Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value Extended Granted The grant-date intrinsic value of equity instruments other than options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Exercise Price Outstanding as of March 31, 2013 Outstanding as of December 31, 2013 Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options outstanding. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Cancelled/Expired Weighted average price under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price Forfeitures Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price Granted Granted Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Exercise Price Exercisable Exercised The weighted average grant-date fair value of options exercised during the reporting period as calculated by applying the disclosed option pricing methodology. Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term 2 Exercised Weighted average remaining contractual term for option awards exercised, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures Weighted Average Grant Date Fair Value Cancelled/Expired The weighted average grant-date fair value of options forfeited during the reporting period as calculated by applying the disclosed option pricing methodology. Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term 2 Granted Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value [Abstract] Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options outstanding during the reporting period as calculated by applying the disclosed option pricing methodology. Outstanding as of December 31, 2013 Outstanding as of March 31, 2013 Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value [Abstract] Share Based Compensation Expense Recognized Over Service Period Stock-based compensation recognized ratably over the requisite service period The amount of share based compensation expense to be recognized ratably over the requisite service period. Stock Issuance Costs Payable Total amount of stock issuance costs payable. Total introduction fees payable Structuring And Consulting Agreement Terms Structuring and Consulting Agreement, terms The terms of Structuring and Consulting Agreement. Total Cash Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement The total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. The total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement. Total Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement Total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. The total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement. Total Notes Payable That Would Be Issued By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement Face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l. The face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement. Del Mar ATA note Value Of Classa Notes Purchased Value of Class A notes purchased. Value of Class A notes purchased, issued by Hyperion Life Assets Limited Value Of Classb Notes Purchased Value of Class B notes purchased. Value of Class B notes purchased, issued by Hyperion Life Assets Limited Required amount of qualified NIBs under the Del Mar ATA Value Of Net Insurance Benefits Required To Be Delivered Per Asset Transfer Agreement Face amount of net insurance benefits required to be delivered to the company per the asset transfer agreement. Face amount of net insurance benefits required to be delivered to the company per the asset transfer agreement Valueof Qualified Net Insurance Benefits Qualified net insurance benefits received The value of qualified net insurance benefits required to be delivered to the company per the asset transfer agreement. Warrants And Rights Note Disclosure Text Block WARRANTS Warrants and rights note disclosure text block Warrant Term Warrant Term Working Capital Working capital defined as current assets less current liabilities. Working capital deficit Del Mar [Member]. Del Mar [Member] First Issuance [Member] First issuance [Member] Represents the first issuance of shares of common stock during the period. Second Issuance [Member] Second issuance [Member] Represents the second issuance of shares of common stock during the period. Life Settlement Contracts Investment, Ownership Percentage Percentage of interest in the Net Insurance Benefits The percentage of ownership of Net Insurance Benefits relating to the underlying life insurance policies which is categorized as investments by the reporting entity. Other Assets, Current Increase (Decrease) in Other Current Assets Increase (Decrease) in Prepaid Expense Other Current Assets Prepaid Expenses Proceeds from Issuance of Common Stock Net of Issuance Costs Proceeds from Issuance of Common Stock - net of issuance costs The cash inflow from the additional capital contribution to the entity, net of issuance costs. Other Current Assets Summary of Life Settlement Contracts [Table Text Block] Schedule of Investments in NIBs Tabular disclosure of investments in net insurance benefits. Payments to Acquire Investments Distribution of Life Settlement Contract Investments Distributions of investments Distributions of life settlement contract investments. Other than Temporary Impairment Losses, Investments Beginning Balance Additional investments Accretion of interest income Impairment of investments Total Payments to Fund Long-term Loans to Related Parties Amount paid to related parties Stockholders Equity [Table] Stockholders Equity [Line Items] Value of Remaining Net Insurance Benefits Required to Be Delivered As Per Asset Transfer Agreement Face amount of remaining net insurance benefits required to be delivered to the company under the Del Mar ATA Face amount of remaining net insurance benefits required to be delivered to the entity as per the asset transfer agreement. Disclosure of information pertaining to changes in stockholders' equity during the period. Proceeds from (Repayments of) Related Party Debt Proceeds from Issuance of Notes Payable-Related Party Proceeds from Related Party Debt Repayments of Related Party Debt Borrowings from related parties Repayments to related parties EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#ZP-;3N@$``-<0```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/@S`4AN]-_`^DMP9* M4>#T;*N M@@486RJ9$A;%)`"9*5'*:4H^)B]AGP36<2EXI22D9`66C(:7%X/)2H,-?+6T M*2FFYL[?FBG5/)OQ*=`DCGLT4]*!=*%K>I#AX`ER M/J]<\+STC]2KA1B'QEN\86I;97'H/0 M3H5FYG>!3=V;WQI3"@C&W+A77GL,NJSHES*S3Z5FT>$F'90JS\L,A,KFM=^! MR&H#7-@"P-55U(Y1S4NYY3Z@WRZVM!W8F4&:]VL;G\B1(.&X1L)Q@X3C%@E' M#PG''1*./A*.>R0<+,8"@L51&19+95@\E6$Q58;%51D66V58?)5A,5:&Q5D3 M+,Z:8''6!(NS)EB<-?DO9W4^-@)MKW__.MHV1W*+=:L*[)G_-=9-CRD7W(!X M=\8'[+,#_.Q]B,/'S[%1VOH@;N#T7=@F[:8ZU+X1&%?"+FMW9=:=H@_QIPON MA69HC@D$B`YMVAY+#+\!``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P" M```+``@"7W)E;',O+G)E;',@H@0"**```@`````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````````C)+/ M3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?/ M/UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBD ME)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\ MU<%J"`=[!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5 M\YS3$$ MX4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`$ MM^X'F$1-0E,[V-Y'__U,UZ4M=-HEZ!*P0^271Z\4>;'ZVC?)!SI?6Y,)&*0B M09/;HC9E)MXVSP\SD?B@3:$;:S`3!_1BM;R_6[Q@HT/\R%=UZY,8Q?A,5"&T MCU+ZO,*]]@/;HHEOMM;M=8A+5\I6YSM=HE1I.I'N,H987L5,UD4FW+J(YV\. M;3SY_]AVNZUS?++Y^QY-N'&$_+1NYRO$$(-J5V+(1+?EY?'-;!`5"WE;#`R9 MU<"0E,,-!T@Z:M(G'1\.331;EZB?-86#.SED;A3T":-SZ9E'MW4RK@**S919 MS902`XI9#2A2#C<<(.FH<9]T0FS%>';-<2F/3](OW!FB$]1K8^D*YTREVSK5 M$DPHOZCXDV3])ZF4DL/=:$C?<&>*3!2PHR'9J!&W;T:4;WIM,UT%_5U48TH, M<*L!4H[BGB44.4P`=\?D-``#__P,`4$L#!!0`!@`(````(0!/ MI"GB]P(``$0(```/````>&PO=V]R:V)O;VLN>&ULE)9?4Z,P%,7?=V:_`\/[ MRC]UU;%U*$U=9A52D&NG5DZAH3\S+CXG&@3Y/)MS-=JV4JLC0O!1OH+ZS6KX9?OUQN MRNKI3UD^:0`0]4!?2KFZ,(QZOF1%6A^5*R9@9%%612JAK!Z->E6Q-*N7C,DB M-VS3/#6*E`M]2[BH/L(H%PL^9^-ROBZ8D%M(Q?)4@OQZR5>U/KQ<\)S-MAUI MZ6H5I`7H?LYU+4]K23(N63;03Z`L-VSO0;5>C=8\A]%SQW1T8]@V>5=I&5ND MZUPFT-Z.#G[9Q[9]JGZIK)AQMJG?)JE2>[[G(BLWZJ=@[4M;.2!@TPS=\TPN M8=PTS?;9#\8?EW+W$/`&XC<.PCK-51-->SM'*.P4)4)R^4)]L76?E["%RG4? M.K-TK;K@<%/YF:6$8XI7BHR)FF44[NHRYUD*9M%1FJ=BSA#%1A3[NYX73(/&#:Y@;!G#OD5L2)'N44R3F>U>,'\Q( MG*@YU`]H0-0EGD8N@.B(8#'?$>:LBW''LV;*)(P`T$5B#)P!K37G74P0)H1& MQ"/^S!W=["U_CN99YJ&),;US'T;N#8G(C9N0,911\H#6=N"M:=>V>HF-D]#[ M21/H/78]M3G816375+E/9IU]WP>! M#V^O*DZD]N_\62CIE,>5XC)0Y^.^!T[BA1 MN3X<3\5"'!O'#(H.IQ_10UJP*_;[43TPW<:Y@Z(KH1O90P@<.;N)KM%L&GQI MYFD^AT^@NJAO2&.5L?L#,/P'``#__P,`4$L#!!0`!@`(````(0`^:6$,S`0` M`'D2```8````>&PO=V]R:W-H965T&ULE)A=CZLV$(;O*_4_ M(.X3,-]$28Z6P+9':J6JZLO_;K&=MC MMM\^\TSYH&65LF*GDK6N*K1(V"DM+COU[[]>5YZJ5'5M.I6TOC4 M-,HSS=!U1\OCM%"YPJ9JLZM3Q9(I?' MY=O[;96P_`82QS1+ZZ]&5%7R9//]4K`R/F;@^Y-8<=)I-U]&\GF:E*QBYWH- MRB8BK:OMM,T'_I/1>#?Y7JBN[_U*F MI]_2@L)L0YPP`D?&WA#]?L)'T%@;M7YM(O!'J9SH.7[/ZC_9_5>:7JXUA-L& M1VAL<_H*:97`C(+,VK!1*6$9#``^E3S%U(`9B3^;O_?T5%]WJNFL;5#* MD5;U:XJ2JI*\5S7+_^40::6XB-&*0(M6A!AKP[.)[8@V8!RYXR/H_?Z?U;!(XJ\H,I.=54%7%00GX^]XVRU#YC2I$6" M)X@K(H<.P0E$V;![\)`E8I.H(S!ZX*BW!9,UM/4\4-WH$<;1=_T&_`%H]W8, ML=_#F'`\$0G'B"02C8F!B&#'%.U@E$S(XFE;V`BX@0O'%\<8<,0:(+9('&:) M<):(I@C!)@QD&+5E-K'13H6Y[(/EZJ*)@"->DYBV;SBV*0('#L!GKV%)F18. M-0BL.6)+1#0I(OB$A3;T.1U&A"5_4L\!1QSNSS/A<)#\#0&3Z)XN)4(X!`CQ M?=.5DU4@3,MR7*OO1##G_(@YA"5S4L&>2>OOUDBG"6B*4(('=8K@\-@.B\1ED+WR(AF M_PXX,K0G+ZO#/!)RA">`8^K2'$:3"H(]_T?L(2S9DV(3<(0/S+)Q%(CI6&(EL-PBKQL@6GUIY3W6`3\F M\"H%TP!#Z)E''K4[SBP2SJM$DX@81ZP)EIOD%<0P80>[66N2,WY3I*WTM2[- MPH',`.$<$(V`QU$IFL."8&!N69T-%^Q1LCXZ:$URAF\\EDD!*7G`=G`]73\/,0W#_AX57/!0NOOH:X#-C=?<%.^A?&NW_`P``__\# M`%!+`P04``8`"````"$`T8#I,1X#```K"0``&0```'AL+W=O;CQ_6)\:?1$F(M("A$0DJI6Q7CB.RDM18V*PE M#>P4C-=8PI0?'-%R@G/]4%TYONM&3HUI@PS#BL_A8$5!,Y*R[%B31AH23BHL M0;\H:2LZMCJ;0U=C_G1L;S)6MT"QIQ65KYH4676V>CPTC.-]!;Y?O`7..FX] MN:"O:<:98(6T@L2<%?4B`P""C2V'RJFC%4@`*Y6355E0$#PBQY/-)=E@H+(#F,W M\`!N[8F0#U11(BL["LGJWP;DG:D,B7\F@?%,XH7VP@_CY?^P!&<6&,\LOF\O MPW`1+>/Y6A9G%A@[EG"N(<<$1\-[X;K9UG2&]VQFP-!JX]QHO#,69WR>/%$YZT MPZC:`1.]$TC1T,G[9=()5F`E6)6-^NQQCTNN8D6"H MAOF"%7@D>+JP,PMC=;<3=>]@/+?'C-1!,SVLB;#!P[?,_ MS?X_$>DUQ$@]O%7SU2MP@B!SO3+?\R?J#2;2M1U%+OS&@-T0$%SNI\-];S$" MC)1'8^7JA0S@[+Q>SNJAJ8-@+'!K,$OM(-`*IQ:&""\<2=0I3(>`6.V_,8P\ MP$$P/_H*/-6^F&@W&*-]6C5F[TI=09-2__`^PN@V3<@&ULE)7);MLP%$7W!?H/!/?1Y"DQ+`>)#;:+R\/N\^DEK<'T6%]DQI+NL4QT&$$:NIS'A=I/C7S\W- M+4;:D#HCE:Q9BE^9QO?+SY\6!ZE>=,F80>!0ZQ27QC3S,-2T9(+H0#:LAC>Y M5((8N%5%J!O%2.8&B2I,HF@:"L)K[!WFZAH/F>>M#+FN_"NQ"+Z:XG"Y]=(E_+P M1?'L&Z\9A`UML@W82OEBI4^9?02#PXO1&]>`[PIE+">[ROR0AZ^,%Z6!;D^@ M(%O7/'M=,TTA4+`)DHEUHK("`#@BP>W,@$#(T9T//#-EBD?38#*+1C'(T99I ML^'6$B.ZTT:*/UX4GZR\27(R@?/)))X$XV0RN_T?E]')!<^O:.AM'\!L*5EX`Q\[D#7Z`!BOF>C0K/D<;#__YT6NF M#BVV9.=H7G`%VG2(=EUG[:!SQ+?2?6>]YI3>Z!W$ON!N\-YGY[Z&^, M;-R6L)4&]C)W6<*GB\$ZB@(0YU*:]L:NTNYCN/P+``#__P,`4$L#!!0`!@`( M````(0`LOFCT!@,``&T)```9````>&PO=V]R:W-H965T!MAW_$PHFW&<]:6$?[YX^%F@Y%4I,U) MS5L:X5!2E M*SM!2=Y/:FIWX7DKMR&LQ48A%',T>%&PC*8\.S:T549$T)HH\"\KULDWM2:; M(]<0\73L;C+>="!Q8#53K[TH1DT6/I8M%^100]PO_BW)WK3[AW?R#!ZH7-K,^DU9CTP+M@?8H`4SH]!PSH&76$=5#P>2,R`[6XY_'(_*9UF+'=0 MMOGN-&RY&P\D9L!VMQJYFV8L=U#S2W=Z5P2PMZ;7@9X$G%6_48UCP\!UJ/$H MA\D_B72*L**`'7@9Q;1[#4<8*C@X\[=;.X.Q8:;<&V+3[X+5TH./+9%.`);W MU?]XU_#(^V:TFN=XH_>)>3\16SI6^+O'+>=P$,S/NH9MY]#_[)3% MAIEPEAABU8>VO);U*0G+O&[KLP\^#8_-^R/SAIDR;PBS9'R]8D;Q0_O3/W-= MPI@W[0+?K2$F_ M$E&R5J*:%B#I.6M8R,+T2_.@>-?WC0-7T.?ZVPK^UE`X3#T'X()S]?:@._+P M1VG_!P``__\#`%!+`P04``8`"````"$`+]%N._4#``"(#@``&0```'AL+W=O M,V]D+JJ- MSX+(]WB5BBRO3AO_G[\?/R]\3ZJDRI)"5'SCOW+I?]G^]FE]%*2)I>)$HT"_/>2UO;&5Z#UV9-$^7^G,JRAHH#GF1J]>6 MU/?*=/7M5(DF.13@^X5-DO3&W;Z\HR_SM!%2'%4`="$)?>]Y&2Y#8-JNLQP< M8-B]AA\W_@-;Q6SBA]MU&Z!_$/HM MPR;H'+[K_=AFX,_&R_@QN13J+W']RO/364&ZI^`(C:VRUYC+%"(*-,%HBDRI M*$``?'MECE,#(I*\M+_7/%/GC3^>!=-Y-&8`]PYPG\4+`H4D#\BR\>>^!Z&0D.3G+9M/UN$S)";5F-T09FIB]C<, MY@&)8VJ`[Q[QK.L4@HG."02W[V0XP3?!"$;!MX%VU&`.-.\&:L7LAS`+$Q,/ M898=QA`,^>P+QM"/87Z[A6,GP/4#,K:BN",,9+,+FH78?XB(70C#!0QCNYC\ M='W=PH^=-C[$JE/(%E$7I3;:.\*X7!!BTG.Q_8 MR7;"3`T[PKB<$&+6.H$"T7Y,DMA%8MB8_1\;V,FV,3(5[`CCLD$(LK$8=-%' M,.VT&\:P`9O)KV<#.]DVQAT_S2O"N&P0@FR\$TG[DHO$L('GB-[^ZIY,"+;E MV]LH85SR"3&>M[,I"B*+(78Q&-J7OZ(=P;9V:]O9$<:EG1`4>KVDS?3%+@Y# M/8.]M!]ZW%]'6+3=.6B[V4;>2@[-(0UR.1F`L(554>)!T%M),?U@+;Q[*C&J MG.86^U:(M`T".6T01&]-PRG18PW3F!ZP//8\W%?S&!55P\O2+A<:-"RBM;O7 M$.?"=M*87K!$]KQ\,*VHH)H>[$+!7%57>_@0$FL6G;(I[,/=$C(-0*SZ!NY, M!O:RUL?2+A5PHD<0E>9E-!LH:'N-<20,+P9(,PPA+W3PIR-MR9L3W_.BD%XJ M+GBH'\$>V+5V%XZ'$9[[K/8=6\'Q$]K#[@^X!]3)B?^1-*>\DE[!CT`9!7@H M:.@F02]*U.U!^B`4W`#:QS/<^#@<8*,`P$5^A\0^S'&B?.PXHPF&4T[4BM551]K@G&,8HP% MY/7O>S&99#P3M>G&F.3P<>Z!Z]G]0=5H)XR5NLDQC6*,1,-U(9MUCG_^>+J; M8&0=:PI6ZT;D^"@LOI]__##;:[.QE1`.`:&Q.:Z<:S-"+*^$8C;2K6C@GU(; MQ1Q,S9K8U@A6=(M439(X'A'%9(,#(3.W,'192BX>-=\JT;@`,:)F#OS;2K;V MA:;X+3C%S&;;WG&M6D"L9"W=L8-BI'CVO&ZT8:L:ZC[0(>,O[&[R#J\D-]KJ MTD6`(\'H^YJG9$J`-)\5$BKPL2,CRAP_T&PYQ&0^Z_+Y)<7>OGI'MM+[3T86 M7V0C(&PX)G\`*ZTW7OI<^)]@,7FW^JD[@&\&%:)DV]I]U_O/0JXK!Z>=0D&^ MKJPX/@K+(5#`1$GJ25S78`">2$E_,R`0=NC&O2Q-!$M%A/`(U6@GKGJ0G M8L2WUFGU.VCHB108R8D!XXE!DRB9I#3]'\K@1('Q0DG'\8#^VPH)574A/3+' MYC.C]P@N'ABW+?/7F&8`OIX*Q.&U#U[<+8&*+9SD;I[0=$9V$#\_:197-'W% M\HKB`B'@ZVP.\KK=G!?#X6!T-@?Q]K=>!,WPE>:R3BZ#G#,J[W9D7OW4V[F^\")K@+$GH M9)0,^PKH7T^!Y[F^2Z[!6^C/?X'``#__P,`4$L#!!0`!@`(```` M(0`I,?[`.P(``",%```9````>&PO=V]R:W-H965T`DW^^F7]F0OITE`TZ<&V$:C,_?-@\+C(RE;4$;U?(, MG[C!3_G[=VFO],[4G%L$A-9DN+:V2P@QK.:2FD!UO(5?2J4EM7#4%3&=YK08 M@F1#XC"<$TE%BSTAT?*[25OK8=HWE`+]9M:=.9"D^P>G*1ZM^\> MF)(=(+:B$?8T0#&2+'FI6J7IM@'?QVA*V84]'&[P4C"MC"IM`#CB"[WUO"1+ M`J0\+00X<&U'FI<9?HZ2U123/!WZ\T/PWEP](U.K_H,6Q2?1V.5_.E%T1GE M(?$9`O[[G?@XY6_#/5E6@-:G@)=83!(RRE]EON#U9UP[RWRL)V M#H\UO(PX+$,8@+A4REX.[G\TOM[R7P```/__`P!02P,$%``&``@````A`/MB MI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@ M=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/ ME(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R M^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9 M=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z M`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\ M*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7[ M'IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@! MQRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF M%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E M\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV M&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E; MS8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO8 M9=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;` M?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_ M6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T M8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI) M6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2 MI*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9 MDRD*0Y/L(&,<8[Z4%3]F\=%]?JNICON`[<#-.!X^BK^KJNO'O?SV7AV;\KA;N?_\_?00NT[;9<=-=JB/Q=%I[7YONBRMI9?2J.<&5;-U76P==FY[6GIL@V_4W5P:.^'WI55AY= MC+!HQL2HM]LR+Q[K_+4JCAT&:8I#UH'^=E^>VL]H53XF7)4U+Z^GA[RN3A#B MN3R4W4 MW(-(Z^6FA!6(M#M-L5VYW\DB#7S76R_[!/U;%N=6^]MI]_7YMZ;<_%$>"\@V MU$E4X+FN7P3Z8R/^"V[V!G<_]17XLW$VQ39[/71_U>??BW*W[Z#<'%8D%K;8 M?#P6;0X9A3`SRD6DO#Z``/C7J4K1&I"1[+W_/)>;;K]R@W#&(S\@@#O/1=L] ME2*DZ^2O;5=7_R%$9"@,0F40^)1!")W1F!,>3H@2R"CPJ:*,E.+ALOHL/69= MMEXV]=F!U@/A[2D3C4P6$%BD!\IQ(SV0%W'/=W%3?RO0+=3T;4W9TGN#,N02 M2:X@)I%>(?@%\4#>12.D3==XO72?V@0,:W`=I2V\A.WE)X@P#5$/[HGT'F%( M@^>,ER;@E0NQE;3(DH9(W.>4D'D84A-(=2"(."4*,(3!ZL8+$[`E+#:?FR`2 M]L(BZ%KS%(8+"".=Q;-4YU8$@BFZ6,9HB3,!FZP?$RA@BUS.".;M' M&#D3#JE-CON[4L!6SE3C8LX0D3D+@ODNW`^$Z/L0 MBRNC(!&'!F&*LWSA?G4)SG)]L@5JIV%Y)2/KRWQF;PD3@-PJP)0FAO/HQB,X MR@UIMA](1DJ+?9_XU)I_JY0^93(+PVS(F5 MWU3&D4SDQS[E:O^8`L6T'I]!G.T@X3)%`RL["4'FWERYBYCR)MF$>)FS=ZVU M)Q/)J-Q0JP52@^!43Z^I;9)3D*%5:$TC:ZM;`6%A[%OJ4QE%3RZ[,?;()+_H M:7.F,-4R4A[Z@4Q=0,,X&N1N:!DW]4TR#3)T#68/9,F@OBB`D:=V9;^"U"#F M!F"6UO*,+T;>T"S88![K7D"#B''-KJ0X'2'L=N-1RRW&.5I_EU5A:W`DDKG1 M7BA3,K(+&.=S7RW6R"*=9!P];>FSVBN1##[[>A8-A/!Y'&NV;,J;9!X4S4,? M?;9M)9+1TV=E.+V+F/+$H-T)+196J;5%89X]Q@ M3*$`V4+#+W\W4G&756YKVB62P7*S@,16/Z06X!/EEJ;$238B?H=;TK@U21+) MW,B/S"'&0?D/A&OCR%0WR4CHT$BXLH#^R8EDY!X-"2$T4JF1Z@RSX3[W(U]U MJRG0LI*1`P>]0&]%[2U$"KWK%U(H,KB82`QM50Q3YB1'H4-'X;:C2$96,(BH MSZT>32V$^%&L$%/>)%.A0U/A:L[*[!F.P:.8PKNT^2LEE7%D*W`6$Q:H91H" MQ6&/O9&_/@#J[S(W,E=]A$(E(\\RXJLOK29S_:45C_;PT.J4[8J?6;,KCZUS M*+8P'?U9!#NNP8,]_-+5I_YPZKGNX$"N_W,/![`%G%SY,X"W==U]?A%'AY<"``!W"0``&````'AL+W=O MVN6Z5- MFJ8=KHF-8U3;6$":]M_OPS@'2!HEO8CC\O#ZX0-#%O=O=85>J9",-S$.O0`C MVF0\9\TZQG]^/]U-,9**-#FI>$-C_$XEOE]^_K38=ZLH?!,'8KPEKL$F8BVLR>%&PC#[R M;%/31ID002NBP%^6K)6[M#J[)JXFXF73WF6\;B%BQ2JFWKM0C.IL_KQNN""K M"L;]%HY(MLON;D[B:Y8)+GFA/(CSC>CIF&?^S(>DY2)G,`)==B1H$>.'<)Z& M`?:7BZY`?QG=RJ/O2)9\^U6P_#MK*%0;YDG/P(KS%XT^Y_I?T-D_Z?W4SF#S_/V1R@PJ"C'>(-))&:]``#Y1S?32@(J0 MM^ZZ9;DJ8SP<>]$D&(:`HQ65ZHGI2(RRC52\_F>@L(\R(8,^!*Y]2#CP!M,H MC,8WI`S[%+@>4JY4\B,N6Z(4ZH.\%8,#HX M3O;QW3`2@XR.$9M(+Q&6(CSG6/%R^30<8\@^J$WM!R<&&7>U#0/S9R/I1<22 M@Q%>+Z=A1VYF/SDQR,S(?;D;VLWIA\V6%+P]UTMIV)8:!_93$X.,.BFG+3W? M9NF,;]'1L*,3.CH&.:]SOLW2F=RBHV%'QWG9$H.8]13UZ\FMTF7&TM.GX]&N M<7FY:]C187,TNU?/7/1SF+."YN@TAT)+UO0'$6O62%31`O:GP)O`VR/, MP6EN%&^[S7_%%1QXW=<2?N!0.!D"#^""<[6[T4?S_B?3\C\```#__P,`4$L# M!!0`!@`(````(0`/I(F[S24``/=R```4````>&PO3+^]M[^[=R_)IL-BE$^OO[WWX>)HY\6]I)JGTU$Z+J;9M_=N ML^K>OW_W/_[M557-$^9.JV_OWE0-;[))6NT6LVS*DZNBG*1S/I;7 MCZI9F:6CZB;+YI/QH\=[>\\?3=)\>B\9%HOI_-M[3U^^O)S;][4PP7DVPZ3P`C.9S.\_EM::@/?YZ\ M*Z;SFXJAHVS4?7J>S7:3)WO;R>.]_:?=AR?%Q]UD_^GJAS48@Y5@)'\=7%;S M,AW._U=WV?O=+^JE+FYG6??A_?V]G1^Z7PY`P,B0<#1.K[M/[U^EXZJW4+W+ M^ZS,"Z%NE+Q)Y[UQ`:5GV76N`X#HDW32&W7_?`$73(=9[ MT(3U#B!9F8X9,LI^3?XCN^V.N[^WM[>__\W^BR"?W]G9^_)SI/][AKU\<,B`0M'<%/5'7O_A\?=K[K3#8;5DV&E9]WI`0E' M^3@KDP/AJRC[&#B?I&,-.,MF13E'Z)*#8C)+I[V1$:?%9%),H4`Q_&4[.;]) MRZQ*3A=S$U&F=Z$X*$#^M,I&K#NMBG$^`I)1\CH=.R4ED57RX,/YFV3K87?R MN[1$5/972T.DT*"J6*([]2"M;DQ<[9?#ORWRC^D8@O8&OB^S69K#F[^B-:JL M]_QT?B/\!798O=E%,8='-H_Q=5;//YY^S*JY"5<^34ZR.2Q;+1`$>/UU-LVN M\C[<@]%'>XX68O1OGW]2S#.H/LQ`S.6X)VP.;KH2MWY<'_&VF%[OS+-RDJP^ MFH]=_2PB[&V>7N;C?(X\=\DX&)J"KI+WZ>TJ,'E>+N"G==2[_^7SE\_=177T MM2LN/=PYR\;&K^_33PIAB/,*#W$[%Y'TPX_"I#FXVBU*:+^4U1YG_GF_V];72@_B65R?)V,D/3 M(2N++-G:VT4__BG9V=L)3Y.\JH1NV<%BD]"WE41KNV>^UU?V>_ID>__%L^V7 M3_=M(SZBWNRCP[@&BNT$%,ZRX3S_F(U[Q#I?7%;#,I_-,=@;^'XP&L&(Q11Y M?B^U<#Q%=\YRY+M+F_4C=QS1R;Q(+K/DV%#6FSW$I5@X<[U!P(?Y&N+?A<(] M-C&\W67F'=4S[(_NO,GF.<;PX3IU?;?%UGLI/48-Y&X8J(O%WHR&>6=H;9O_ MU3E+3'77T7?F_J^>`7O;LJAW.,#RA(W0KQRZ$?25UOI\CA*4>:J2XBHY!;6I M9&2MW7YR9P?X21??:WAH+03KN>DXZ%1$>%A,L@2Q_SUV\GOLKYQ(J;S!:))/ MS465CEEK=,*&#]X65?4PN2J+20MGW0.[&8U3@AWK>4(V:CN99CTMT3EF=_GZ M<5BY^]Q5AP.Q9HB.@1N"HX$RI+_V;77S+'E?%A]S173=[>3;:+WN]Z_3 M*A\:CM_DXP4>XA^[(PP*/&CW.;M/?\KRZQLYE@-"R?0Z2TX6DTL&PZ[GO]=' M7>8Y\R./QL6GM5P?Y`*S/I`-6NW/C'Y>N*=7R3R4V;"8#O'0]6$HE]6XA0!6 M$F8.0ERIAQ`[%XZT^]83>:\FEQPA^YJ\\9W)6:J9SDW7U$ M9$-7F_4WHL4%4P=>CSIX:IAEH\I1=&(^7.._]CAJ&8B[;'"43_&H?PL0,NWF MA,-F;54+"9!4,9_\)1LQ+*J^#[]\I/9J?KS@]&[V0I`9!2#29@1Z<8:@2!FL'G:#1 MC0P-W9-A:+1MW%XVC-"^3'\UM!N"?TE)IC"HX?TE:!9>PIO'! M*GXX/?M^<'+\/P<7QZ#D3?)Z<'Y\GIP>)>_/#L\/3R[L21=9=YNU(3OT M8/]AY'-]8),CDH]$5SL_&!BC0I.$JGG*(?,F=\CO"@:9Q/<+I:156^^FQQD96\I/;XJBKG@2T8DKL8%601P-54F=#R^7=ILY?%JI`,- MP6E1>L+M4SY'=#T6E^#.2L#.9Z+#M?M'+,[S;.8$MY-\F!KYS8R:XT@*L22` M:-&XX1T45A&PUZ9WM1C>K";X=I*."6,7US=MM,$ZXSPC&\*7J!HAM(T(T2P= M97];P']BITGZ"S\9U*9(0U31;))78U+'G'HW.9ZCT)-J<7U-K`[)XA[56BE8 MB62"0F6C17$0\/-BBKL`RQB2!0QI+TX=\UX<-`C2DGRM7%D;.$ MTKD$8)).<0HMP1:I#@5SR@,\%-)(="TF[C4Y5=.K*^!W9$Y4$:B@F5*DJR2U M8>.[D:A/GETY/I+VB$727N,1O`L8)>"+(";!YE+!][!;#3Q2BR3 M'1KKJ"R/;-3N:3M-Y?H#V-"M2#YYJV9<\NDF']YHM"&KF!$APT6Y7\.?V8*H@#E,H+"0^33WQ/P2B=6GJ,@@/H%W#C%,<_VAB9+WTX MR3ZFHU3J_@UGLX##:S=[Y*QKH!?E3.1B?)6-QT+?L("L2"FG+"278';,DF@$ MS*(%!MHR:%;LW^68X,@HCPBG^3@N4-T4LV1<2`Z1W\@&&4"G'XNR2H:910>0 M1A4OJ,"&^1S]*QM6XY>6[W]"=6%=O4?K M!MQCHI!*UR-FV/MS'!+!/\T^07]C!,]A?B)U.K[=@1]`?@/I=C)@*"+9'/>` M?7:U[X=Y>@/^EW=]EY77D%$Y1C]K.#WXKA'B2%J[1#W.ITI_CS/Q1#I-!M=E MYMI+%'Q/Z42X]$VW$4`T^Z7+4`^0!)Z_9A6WX*+_%.FK-P.<-HS&_N(]_(:/ MA+#&JV9(*(Y&4;`52YMXF0TIU(&5-8A<0W))C':1@Z(].(P^AH4?Z'=\-#^+ MT.$FPS_#O94[B'.,J"$(QD2"5$.6Y6MHIJ/IR=`3N/G?:W.31J$*9E+J5\X. MP(QOMPV8&_(\),F1NU5N:X`X.&NFW@3U5R>U$&]ZTQ".+Q7X"4*!FC^G.'[( M2_``GOP&+:O+YV""\A+7G+((51OCA68(3"4JN*40#?"[L;80>G[3GB7[ M3H%I@GKCF8SK%07"PO3L#?F% M&=A$?M$A&[+-RF*T&"+^@(I[5*Q;;MGBX1EL)Z,RO9KS$X.-:ZO-^8"=`6QA&98<'U><*1KU\JNMX7:2LF>D0@K*F'1YZ85)VGY2S:?C=.A;,2MZ M#;#"[$$<#`F4.N?CD(KUB;L04D6N`Z]01O:-G`F%KU1O=L[24FT)@8T5M_>K MC:;+3XY?-QS#ATH\LZO-OGS61V/['OXMGW0'`C1'@?1.4%O[`A@C](&GX##; M#]GH8*&>&M'Y+O!GG('4J_9!@O? M`I65KMR1LG7B\0TZ@P>_0&8.WFE!YH:YM0?$QD%8E+)FVD](ZRD/&>W!P<'I MAY.+XY/OR2R$[\@OGKSJM+!L';THI/'Z8;)S;W>A8YO_6>F)<_Q[5 M:E>J64=%1Q!+2H)&Y*,+?AB7'@W.Q:929E:;7#$\^3!3VX$[*.C6L):IGQHL6W`2:/_6Q50EW[ MHJ4(YM0*,XALS1TQ-HCX:(C5M@]5#F6IVBHM]?-B M=.W%,5O/DHJF!)(YTRZ>+PI!$GC@=#'W%B,GN8'0P5$?$DSUA,LZ,8O50Z\U05.G]\30'VK^-K?( M1`+<'YJ.()4XL/X:"[REWG*I)\Q3FBSMXSA<(D^M[*X7=&ZQ"S8?93QJ!?JL@'W MVM#"=X86,1L\%6`$BK'%`ZM2H"N.UI.?*V_U4XX*9?]5Z5D>_KMDIY8;!Z\6 MJ\BDM90$.:N3:IQZ/=]*QH(@@,L[<;#[=%\^)_Y+^,'GBV8M"[S0G'GV"1E4 MMBCF+H:H>+2"VU_WJR1[MWB6=J1L!#H;(QY/%1Q%3(FH."+818M,+1]++<5U M&X3(KZ`%05F02'BMG[HDVU*["SA((4.!XU;GD'9#I50F2YEA/XB[&E%K+.>. MI[0;N_%%8L5D4QB?+`^'E6O0J(ZV+7"H(ZP-4)PY5#SZVN/DQ\/S"WE?9%%P MFO3C_,/9`)7UX88?6(X>62V"*Q84/QL+(*B/I`=6N(@N_VWR,4]1O^."(>8&X$QF)$[+A"95 M282K'R)>5O*Q$X#Q*^ED5J^5LTCI!U)F!C_FEJ1GB`!866%9<>2U8J%XDA\ M!";DP.^-&S9OR1(MK;ZLGXA/A]8R"*+IQ"`53.,NI)&TQ.B$M>1AEB.G7[U: MD"DIT;ZJW%*_73,<)(3-_E%`:(.$CKJJ34JFPD7 M<2(7MJ,'4<_::(V*Q(="\6!JP3VJ$G\>YB=98!E-1P@KM:R9G[].7KA-U!"A M)$08%G>Z+"#^)DH[RE30K1US"?)U[<(+'F.Y,12S]AX^O8APDP"K*BY>!>G?]=4Z-3BE=.GA?&3<%* M$V26+:5RT:!DM;A9QH=[-IQ436#QLDW/]%ZTO!L(+J<%H-R51;)DE'1+2.&8 MW/%9F4WR!06:6C5)@^K2`-/<]^20[1DBAR7.Q[=:H&-"Y-M:IL%,%D$V@;]+ M?,,V0JWEOB[#C8G`=L'8X>#%!W:YJ4EHU72R1,`&T%6:TPT(J50AY$J)2+?/ M@8G7GZ!.>*4S>.37H/FV'N]_0]V<6A?`/@`0T9%HM58`GJ22EHEP/92QX?,* MHCE4X;R)>MU1?[16[/VAS47&^88H(X6P#2TVX[^!?OW>Y@$WD*M-JM6AMT])"*M/!1*27QLD3#C^C`]\TQQKPS8GH M-A,T4)K_;2C[)-F"`*3?56_MMQJV1:E_GZ+>HO^HZ?5Z[?S[JI-@W.I^T6JK M;X':';73_6(05:FXJ*-=NF.)G>=E3OI755,?'[5TKXWPN%:17QEXH3M`W9U^ M:JR;\6*'!0!5;D%S3GYU:9?JD2Z6E5$)2WU.I9M54=6BHKJ>C@FV>KS[&,M< M%FS"BBV)$!@<%@<%:@AY)3F MJ/WCN+B,>QU1)@\<@S:R3L29]_"PF]`O^P'D8T%[:8J==J@GL7G@H#B M)WV:Q$0]TGH>W';PE'`]--#6LXM4])&6,:Z$/JR$YQ""CJPTJ5#Z2['7 M-A=+%(S1Z@JN?C,#&W-&J)#/R%W.NL$7L$#,\]_L"$-754&$*DS6?6(!VW[] M:SEM9L$5N3;ZR$(2`LLA@AAEN7LDIY7C`+^J%81N_$;%L9V2]=F_K$>Z).'T2![OIFZ@"2^;P)[7MK@S8^6##DZ M/?M=68O?.G]3XN3IP^2W+M>U":<4^!>DEKZ);2XB271O(`6V6'I8[$I>646# MY"+4<%J-(+&R_P9?`/N;#"X&5M8RYHA?'L6D&+TTN^ENN3OV)IWPW/(!YN#$ M":PBS5.,E5817#'*$WN$$HKK@U;UUI2T.>RQS,]@\\_XJ47&V35J1-RG5$(K MVZ*^F[*ZR6!I+(PB)T&NL[-`;4'QI.$DC^H*\,*,0'U MD)0-'/;:%(PH,8R4(&&CNI`4.UIBMD+==BH(>&J!T#K[%9NM4P-\7S5X/XN4 MLLH(FEY8?LTBI,=M;3UNW6Q^8(*[$UB2CNY"58ESK:/]D M=5P[4["1+G@F735\%SJ%J%NG4"Z9OAA;2B'A#Y8C_"Z?R//-:\ MUH)O3>IR6#A,](`-2+DW#J>=KY9NG(F`EQ^"^M$*RQB^+@U<&0$*9[1A`8>4HB0NR"SRS%+;(5#-3 M9YF:V]I,AIBX7+=9C4R9>Y)FR&N1EVC1^:L,(;!'-;$"X*#'&L'][R2T;8(V M-1M]&RK8D"!VY-@I75%?9WCO:X!(7/U+WO"LFO,QBE$Z0W9P5 M34524RS:0VUB%B9FLMV8$`2AM[1U9!1,<9T#M=)XS/,`8H=72%W5U@)JAA4\ MDQ2YN3F\E@H*`\>"<.?[N[]04T./)XN M)NQN[_NH1VA2TZ_C!@&.`6!!8A(?HYK=2!U+,'MM6PI;O09D3_%[+"L3=(Q; MB:Z*\=-'PBI7&N%/ME[N;3\/[W.``AT^6-[QH1@12$5B$S`,@7MII$3PV56NXAYOX?XM':JI4'8N9UMLU0 MYTE<&9#H#UGE#:4@T**&T!LT[%TE8N*844N>P4%A#X/#57:@,3QNBZ-Z`["6NQUL3"352D8,Z0#/*$186YK(E,[\!O@4\#HO!N%7A5RMDC:/:6T?J":(-0?)` M0D)CZW&-HY;;U,)W=']59%+KH%6@X(Z.`K43+R-2C-89U56#O?CY=)J<#N>% M*B'-W0IQ0"2'%G6$A?2S'J;UG0,`"[`KQ,K9W9%K,=T@86LW`W.)A$TYJ636@#V="VA4@3E1XP?IMOUE\H`Y<)&&S`EEV!>@[_)62 M'[W0NKM1F_`F;RF5!G9H`I1Z^#IK.WW=#6VKA$A,O-EG]DHI5C.5W=I`W!5: M2Y:JM%JG5N.P2!?W*]*M[:!+7O!&7Z&K"%=IY9B9B.][7/:O9!G\!I@Q?'-5 M"B=O]WE=7^W!;H:JZLFZ4[SQZW2:>A%K$J?M-2:&FD[KX.DT*3E\&K4MM^A` MYMFOMK@+%+KO0-!RFK-5(M?DMJ+JNJ`GIQ>'R=GAP>'QCX/7;P^_\GA3OO89 MUQ"6%^O7*-OV\L,'V[AW'E=9LWE;*N'%R)PU3 MSQQ3K@"WB(1-6)6@L((,&E)>0KP;(XEMJE\2-/%@3WY$UO/D_>`OKP=O#W?. M#M\.+@[?\/GLXB^K^&7-T$V\\]QY9\W,+A^5O"A6[Z/]8S6C@>+;>S-E$LN/ MV;WO8G-M_V?BD#)5_[WG?]7?5??B/;A[]QY]]XHTA)OU"0ONZYOR2-Z2#;F@ M[XU[4=1OSPJN6NOI54K7!;V%MH*^>&2+\@);C\O$IU7^*YUX]GK:;$T%9IF\ MET59%FKYW?KFJ5/.%$`49\6*\2Z>691+_#U\U.!!))>*",4&VMR]/O&?@DR+ MDG;:"^$4J",RICI@BZUOZ-[1ZPD1CWY"./:L^(HC?\O&JW.3:A"IO;^9+GSYUKPO%@GJUGEL&Q M+SS`"]P(QK:>;$>/-V2[EM;7*>6$"WV!:^43A3L?O)K2CA%Y,885]3UE-)L% M>#'V@>EB2-V4+/`J25@$6[*DP`D2EZ"1V@3I[2*3M<#6Q%4&*93P6(\MJ,W0 M_ZA\W&7+A0Z+$A9BP`GZ>>3Y+P05$-F63CO+>=N]CP!]%YIX$HE^C]+?G^J& MX<$IK>QG)UWF7GJX251>/$R6QG87ND"Q!*1SDE#N)D]>M[.&4E%\JY`*/*@S M*"B5Y!&_G8YV%8Z78J"SO5V%TK,$RO$H9Q4 M$3-%=TJ!3GB_;:1P>*,&?0:ZM`X+QGO7E#E6*;IER=<+'.@AK5\@BF^H)D3C MY&_(P3Y["=1%^8L=(U0#E5'A):,VZ/'VX_T7V\\E@.(:<:HN:R`],0I>-N6@ MJDYVHEW5G,]7QW5OJTZ%D3Z/KJ?.KG1>F<+XQKVK;OP(^PW=[G;GQSVHE31N MM+_:#3D844[]FA)(C0Z8Z"6!479J-Y:]G*E^6V/HY=Y33RA MRTDJ$=-39AT5+-!T_`MQBCJ;BU'>H2.%UB[8$L-=T7DG"EC!*W9?PX9U#D&4 MDGXSK`OCH:.FU:C=[J$5)\.!>A6N`IUJ(68H9BJM\YY[,]FLQNI:U\#W`>%B M)]GZUEF;ME*"-MAH)CT22U3Q?4KA5F4($!JP0*CZMY2ZLUK4E7K)6K>L_+&_ MP@%D(K>(UL2XTD16NHG[]/2WCI;%P'1/R/F"=&X;8'_(&RCL5%>.#L09]:N1 MP3QNW"?3E$BSN3^-X-%PWKRR1II@09C*Q?^JPJL6PF%8V#FDZ4/+F3&`*4BD MKW5FINNF=D[4W6.B\P^OSP]_^'!X#L[_H%7OGQ]^?'!\= M'PP@2_M^_.G;XX-C0HT'[U4PO^V]FO7\PYV7V/"RVCO7"AV^7&>YR\RMY<*)7&(K@KY[1*1P>H8+^MWYQ\ M.SFM&XO>U^F\[DIW0\/Y8C+1:Q=6H!:+>5Q?PGIM=\CF*GLY/'=`V_[CY!W# MU_VAD-_::/9U.NUMW&]_XU/D;_U?)L&?WTWV0D=;%]'D#G?KRD/WH8Q,0VVA M>?FZ67VU+";K=)E?M7+SM^JW&S3EBMX&5M7"4K?*4>8,U.TJ'K7Z'4(<`0PB MCCB)''+':V"QB#+V9SDXTG7K0/+,9\R^K&C*Z\',8AXJFQ_V_Q?P1Y+=4)B# MG)WR%)8"1ZS&?8A&0Q+^_PWL'\?*OUK)NZ0Y6RJ/#@FZU?D1+G1U!]^E)H[U MY=YS[][!?0E&\([EB_RKM/T[2]M=FMS'6$E8O5M*OW4=D:;D0AC\KZ(8_3C_ M*HI]U\X%7IA)B09)*:IA3T^\2[D-MY@T-28;5:>/4'@=Q=C3`(/P!WXL)JP+ M9LKGQ7I6E[4;1EYCMV*JKCOQ9+E$\G5'@EH$)CV4(GJK67KW3#V.]J>%DK^^ MLX"C]U?)HD5<]]P=AU"$Z.["A2]=TL#A/-%^V_Q9`5YT9+%=L+!$?VT@WNK= M$L?D<*H>(&:RO+Z-Q5(*NKO;`1EB[K&H/C95^<8Q*7>\.S*03:T_J^H8W>%" M_9H*P]?)\-I2\X2Y(>9NI]+)R7?W.HMW\567TX_BN_77\Q+O!>0'?'<8I<^ZW:O@; M?IY/^.L&]CE?G7IWWZ9[D!_C.^)#:AJ&P^UI$O:K9]D6JS7-4F[TZUA&;CIY MPRZ$/ZW.'':']9(.[;W/ZZ;^Y%#WBVH=L)VL#B']#Q^N^5-O:U?KP=3;=@/9 M.HYJDZE8JSWM1626]KBLTQU($,(D/R)ZKTU`$!46QE99UYV=G>6Y.3;K>ZKN[$C]]NZWOYE$\ MZ?AJ@G#K62(@GAF^;M975N"MS=A9.*X3[QB6JGC6[8=G/PC-A0M4MSW=M#)L M=G``[SE6&$3!*KX&N$ZP6CF6?+('$'W[>!/$WOTO^O/OCNW?=?WW]S3]^L)?__/&KP]]^_%KM M9&(()OC@..9U]R@L_)P@=U(-[B:KP">*:&`FM-;MJQ]\\0W\#8(!U,/+[B;1 M+\IGTX4S/:1G!6X0*C%X&?1C9WS3LY,KYJ;K+$('+UN9GN/NDM,:GF"!D5[G M.>`F/-E))%Q6S@+99#J-D`:G4Q_/4)T\4,G$D\=U,G\JT8F3-:B7=8K].%E, MB^-ZM2;K,"X.;'B*K-Q71$[XO)BJA@$YI-?MHEFIP\XD;#SO@KR+";L97$RS MOM$WAJUJQL7BH=]08-]HTY0U`HWWP_N+F;-]857:I6GX4CT`.UR[5G2@ZQ[I MWT,#/Y>(DPL/:&?W6+D^3XYG1\JC_47Y(?!,'PU+!S764A\U#@,XP;TF8$BL)SCNOELL*_C?`G.W$U@8AK;H6_`@9)^ M?]JM8;;DPQP:3=Y)KJNY^CDT=SV-S1G$&D2!ZRR1Q?./M/Y>-PVJ&;`IV70]P/\M`QJP'_SUFR:9A6]+9(Y MGA([N*;J7@_'X_&H=S,:C<9ZOZ?KS,B+-*(=?VEO;5QFM6:F0P8#8##NC\8W M&A#IZB,FZJ(,^D!@.!B,!KVQIL/_+-.>GT';-AVHLKU*&$CR*F$@R:ML6M]I M(?.G/04J')+[*F$@R:N$@22O#EO.P$/I7B4,)'F5,)#D55:,:K&O0N50']9MR;F[B6NO8E@EAL[S"_Z-@S7\NPCBI[B9+QWP.?-.% MKYVL1?;W2$O8QH$=FZD:OSC6*PCCEO()WT3$N23DF4C'&;X^U+M#?:#=)(NH MED1[]M+9>(?:Y;)+8P7,B+:M5YS8T,^%I.%05*HZZ(74?8(MF*N9IP4;0$QD M(2'8H@T=BZJMJ(ZDA9B.I(&@CJ2%J([0=2>E>.-V5JUL+ M7Z]U6Y0.5-^S;C,YZ6@*@[-EN^XG'"[_OLI':"A$W4VV*[(M#_=*X+XU[OKC M5ZCVIE^3T3@Y`(I5C6#7O:*18J[7[NYQXRWLT&`W4#`1[*P!?9]VQ62E,3F._#(+:MF-W@P4KA57SZ%7QZ*9`(GU/DZQ7RP4["]CA%/I1J M2OT!=I$J'X)+6'Z;\8"WLJ1!#2Z@07V,3YL,8$&>,0`GR&"`M]ZD-H#PE,$` M%CH9`PC0@@'0.1(5I_2#'LEF$`.%2)!_+I&08S(M.9%GU+(J_8+\(UH:7/H] MRE4Y7YI!2-(% M#H5%(`T0@)"DQ%LBD`'2D4B"-ZDL;?'N4@:02F MT2!I"*84N#'X@GV">H(;(25Q`#Y2>D4Q3^AQ(\8%S4`HR,J0)!HT62F2U4>0E"YQ=89.)#3Q844^U0Q8?D8L>B9[Z$YOK)WL)2--D5 MVJZJ:[W`)*MO[`Y'!%[=K M(Z26!!9W9'-`6Z<<6@^!EKH(]ES99H)!4CH'XBJ@QAHU1RUZ8W$:X_XHK^_ M!#H6'@8K6C8*7[Q[X-2A^))\V;T+)81A5[AS;+IP>8ZEC,@@UH!1^5#*IX8W M^#ZQ92E/F='X=D)8W!;O'[.TPMZHOYQJLPM09%WZ?\"(APN`$TB#$^5Y7JA7 MP[L>]B@V[]9R0O:`^+',\R:*IX8LK,,OXOTWA"R9Z9U[+*\:&YLM;2](N+(2 M\/9$T&@$J)PYMK06$QI%+S`B5-JYI6. M3GS!.[^&Q2_)>:TPJ@T9[#$K"64:5E&&&C*Y(Y>_'S>O."OX'@IX)5?W]\J5 M\M["%)+/`]"#BXWCPI-P6$K&W0`+RB"!-TM.IO7;8UCYB*WA`I=@P79;4RQ` M2$9_#7>("!:XM2D6B$^P^J`MP8*;E1MCP:Y=BH7[=P4O'6IT37E!DQ2+M_U` MT/9ZF1_93G?!"U46X46Q"C_B/BG!`I6;8A5^!,=1+%"Y*5;A1V!(L'00TA2K M\"-X@6)!N#7%ROVH8Z(I[#40M/U-J1_Y6,5M*1%>%*OP(Q^K?<%8I5B%'_E8 M196;\BK\"*C$7CK\T!2K\".?)W3!/$%U+/S(VWX@:/O]C,I'O"88\0E*X3OX M1FR$ZPT1&R4HA=?X*.\+1GF"4OB+CV]=,+X3E,)3@$`K.=FV*U8!B$)XDXT0THMMO2IS>(HF M!^+[`PZC(D`/V[5K^F808-#$4+?P0M,X=VH M"M@EL1`?P[C-U@0F[PN\>?"^RR8PT#IAP\WL`8D19`>[4TT(O M7P^`H9;VRMRX\5/^XU0MOO^9/1H.P91>];WS.8@9Q%0MOG_$9^ZA%\,Z'=+- MQPB>XX:_RB9TINJ_'V;#\?V#H5V-NK/1E=ZW!U?CP>S^:J#/9_?WQKBK=>?_ M`9/A^Y!OX86Z)[QOF+T7&6XGZ>FWD0MO)0Y395/RGXIS4Y4<)/39@[9`&S:9 M,B4Z4?Z^YKO_`@``__\#`%!+`P04``8`"````"$`Q^A$XG0#``"Z"P``&``` M`'AL+W=O3WK\>;6^)IP_*$I3+G(7GEFMRM/GY8'J5ZTGO.C0<. MN0[)WIABX?LZWO.,Z8$L>`YOME)ES,"MVOFZ4)PEY:`L]8/A<.IG3.3$.BQ4 M'P^YW8J8/\CXD/'<6!/%4V:`7^]%H4]N6=S'+F/JZ5#2U/B M9?'BRRZ7BFU2F/<+';/XY%W>=.PS$2NIY=8,P,ZWH-TYS_VY#TZK92)@!IAV M3_%M2.[I(J(CXJ^698+^"'[4C6M/[^7QDQ+)5Y%SR#:LDV&;GSSEL>$)K!SQ M<$4V4C[AT"_P:`A!="G`(/K?*F&&KI9)'#[8K<.N"X>:G"S"^G!5(!VKO41R2&:Q;2#0LS?-JN/2?(?EQ MI5A;!?S6"MI61"<%KA\PU""0FOX@*$807"XD6]L'S;B!$[>K&-6*%@ADH0F" M^V4$6_7MS.`@T#7F/:[=+:%5C!N*25L1O:5H$8))D_!M,A2'!&9?K\BT'7=M M%4VR65L1=15G]A895$1_,A2WR6[;<==6T22;MQ515W&%;/H>,A2WR:B[T:UD M4A;!F,ZIN]WL^R;Z%3"HIOXI0[$#YM37VDJ:@3ML7PH=AA.]M:-BMIL3F%$G4E9Y-6&5`X+_HGKE0[=$X% MKBM-"\^IENB"YAH?'L*]%Y;:([MYA%"G#M>5ILD7."437=!RK&PO=V]R M:W-H965TOS[G/;8YK#Z_5J7S@ADGM%Z[ M@3=Q'5SGM"#U:>W^^)Y]FKL.%Z@N4$EKO';?,'<_;_[\8W6E[)F?,18.*-1\ M[9Z%:):^S_,SKA#W:(-K^.9(684$/+*3SQN&4=%.JDH_G$P2OT*D=I7"DCVB M08]'DN.4YI<*UT*),%PB`?'S,VEXIU;EC\A5B#U?FD\YK1J0.)"2B+=6U'6J M?/GE5%.&#B7D_1I,4=YIMP^6?$5R1CD]"@_D?!6HG?/"7_B@M%D5!#*0MCL, M']?N4[#,%JZ_6;7^_"3XRK7/#C_3ZU^,%%])C<%L*),LP('29XE^*>003/:M MV5E;@'^84^`CNI3B7WK]&Y/364"U8TA(YK4LWE+,'4J M(G<&&()>V_J23>-(QG\P=B\55>K4TI$FBS8O3JP-:#R'F#Y$8. MEJ`L_9E"G"J;WK&/#`.GI,B35%F[,]>!Z1R*_+()9N'*?X'*Y#=F:S/);(CL M.D360>JFW8"F.YRR[XAN2J8&X%4+)>HG^9!VGSO41<_]UWNB2U'",L5NH:T: MT!6\5,->8]@I;8C1+I*+$?);)[Q,`)"/7QVDMX[8+-[WM**L8"*`WRMP&HT1J$U/3 M!!LQELEL0A,9>`"7WN,>2-CTP#P*BDG:(L:+,(G?;Q]U$A2@FZ3%UB*IKA'` MST00FQ:,BV1WD8$'<'$_[H&$#0^BR7"7;A6CIV@4:#=*I#9AVK2W$6.9S"8T MD8$'LN'3?@CO7XD2-CTP*K15S#T/1HG4)K3PVZVRMQ'3`YO01`8>+'['`PF; M'A@_7EO%W"ZT*%HLH.,9;I6=0N[8E(Z+[$=%H,>4T7YPM2H35!.INJ,*LQ/> MX;+D3DXOLD&,X$#WHWWO^A3*AL`8WP9+:&7L\3180K\"XWX_`7K-!IWP-\1. MI.9.B8^PU,2;P?W%5+>J'@1MVE[M0`5TF>W',_RIP-`D33R`CY2*[D$NT/]- MV?P/``#__P,`4$L#!!0`!@`(````(0#[UA!J/@4``($3```9````>&PO=V]R M:W-H965TB.BWLO_^*OTQMJVFSZI!=<(46]C?4V%^7O_XRO^'ZM3DCU%K@ M4#4+^]RVU\AQFOR,RJP9X2NJX)LA?MOSL6UX6YE_AF[,JM?WZY?P>*E MN!3MM\[4MLH\2D\5KK.7"_3[PYUD.??N3@S[LLAKW.!C.P([A]ZHV>>9,W/` M:3D_%-`#$KM5H^/"?G:CO>O9SG+>!?1/@6Z-]+_5G/%M5Q>'WXH*0=HP3F0$ M7C!^)=+T0!`T=HS6<3<"?]36`1VSMTO[)[XEJ#B=6QCN`'I$.A8=OFU0DT.B M8#/R`N*4XPO<`/RURH*4!B22?73'6W%HSPO;#T?!T]AW06Z]H*:-"V)I6_E; MT^+R7RIRF14U\9@)')F)YX_-2-3\3AM M&(%9L8_0\]4(MT+$K6.#[`SK1&ADZXEJG0H1M][+1(DCU.*@L^V(+"3MNAB!@]1,6[JV M3#2E*YOG3?R)ZZIE$#/-3%CO&.DOE@C-G8NEG[C87AA!KDJ*9`LNK^<#E03[ M)UY*1*VFR(B:HC8?K9FH[]B&D?XYW0HB=W6J9<9$4F:&=6)HTL]8[^5F2D(P M3SR0$%&K"3&B)J2M:VLFDA)B1$J($594;A"Z@5Y33"+E8Q@GAB9E!&I$*FDM M^KW<3,F'[`(?"*B3JPEQI$3DC]6Q7W.5E!%'4D@]NM.9F*NDH#CJ[1..>E7* MT?VLN*IKJ(9%]H[R\_9#,[I+=Z"P"^#3Y(HC-4.M/M9%U"\:V M1W\"I#LPR8NE@;[GT]>^$M4GM$:72V/E^(V\PT-BR[G`X@/# M!"\/`]R/8`=M\N=)]`PW:OZPFD2PF1S@0;3J\M(NO`ZB M]1#?!!%L\$R?31C!OL;DNR""W8W)DR""W=P`#R/8R0!WQ`W!!Y!K=D*_9_6I MJ!KK@HX0[KC;V]7T$PH]:?$50H?/(+B%3Q_=OV?XU(6@-,8C*(`CQBT_(1<0 M'\^6WP$``/__`P!02P,$%``&``@````A`*AUJ%;>!@``!QT``!@```!X;"]W M;W)K(\Q8/ML9+N*S6^U M4E6E[3.'\1F=,19PN>2_[RR["SL[Q(FCOL2Y#S.SS'>'W5G8_/:EO$P^YW53 M5->M84UGQB2_9M6QN+YLC;\_!1]6QJ1IT^LQO537?&M\S1OCM]VOOVS>J_JU M.>=Y.X$(UV9KG-OVYIIFDYWS,FVFU2V_PI5359=I"W_6+V9SJ_/TV#F5%].> MS99FF197@T=PZQ^)49U.199[5?96YM>6!ZGS2]K"_3?GXM;(:&7V(^'*M'Y] MNWW(JO(&(9Z+2]%^[8(:DS)SXY=K5:?/%\C[BS5/,QF[^X.$+XNLKIKJU$XA MG,EOE.:\-M&>9NTPGT3Y&_-\K_)\VY>@_K MXOA[<Q11#X'0ERQ]$1CO`K'&THS#L.<^$` MO\)A,=SM'3_(I4L3?N5`R^F3-5L[3X#N."Z%X]/@>/\.X6HW$OP^=(=KX0>_ MC]VA!37#IY`5#Y^><15-/O==*7EIF^XV=?4^@><39K>YI>QIMUP63A81UZ4O MJV]5%903B_*1A=D:H!043`./PN>=9:TVYF.!W)DUSIT39]XO'`="/$)\0@)"0D(B0F)"$I6@1&'91XFR/62U M9DW'HT\#BX1%X,2!4,/S85M:`?1&?0$0XA,2$!(2$A$2$Y*H!.D"?0#2Y7[Q M,VN<.R=J`1#B$>(3$A`2$A(1$A.2J`0E"HT+2I05@+/ZF0)@D;`(G&@%H.^7 MO5%?`(3XA`2$A(1$A,2$)"I!NK"&"@ESOP(Z/!RL9/D$(*\/:*U49WFM/V3&D/1?9Z[Z"3"#Y$<4V[/+"T9?S"0R004A1+Q8R#KTB.)OA4Y'@QD MY`0A+!-KN5291N2`K:77@W=H2`^!\*:A]Y6LYV)KS5*I*8%@15=J:HDGW9>. M*W[.L>VY,[>T+2F01NL^>BC1,&`D$:XR;`JU\(FT M&A$+2"/^II;MJZ%$PX"1 M1.A.;6W`6%J)`4=WJ$0:=0-BG5E#>T_G3]7M6XV*NC.S,%JQ%`MED[7M#WXJJ<+A?40")]N'*V)/0Q6V%<'6!]VFQ[S M3R+[M0NG)0B@D9N6*##]P5O0(?7CYV*Q$9!4*-V.]M"#3& M'1?>_XW$GT/\L8'WA5&'_<*%UT0C?.G"6Y41_N3"6X41OG+A$#["+`FW'HL'I`*YT/F8_ M'_`9ZI:^Y'^D]4MQ;2:7_`0%,^L>JII_R.)_M&*A>:Y:^`#5K3EG^."8P^HX MF\(:>*JJ5OX!-V7VGS!W_P$``/__`P!02P,$%``&``@````A`.R7&R+1`@`` M_0<``!@```!X;"]W;W)K;CQ_6!R&? M5,F81L#0J`276K)0%4:UD-+.'ZHJ$OK\@->4- M=@RQG,(A\IRG[%ZD^YHUVI%(5E$-^:N2M^K(5J=3Z&HJG_;M32KJ%BAVO.+Z MU9)B5*?Q8]$(27<5^'X)9C0]L]4"A4%&B^<&Z945)`` M7%'-S6A`1>A+@D,0YIDN$QPMO/G2CP*`HQU3^H$;2HS2O=*B_NM`UA%Q7#:U M>ZKI9BW%`4&_`:U::J8GB('X[5P@"8/=&G""EQB!C(("/F^"(%R39S"==I@[ MAX'K"=,C"(CVRJ`V7=F`C;*IBDGES@6&,J=$1C+16,84/8+6O6_4'`+G<1J-RIK\'L;<.+L>K[I3;@L507<7,[G!@8O',WT=+WKKHQY\82702&:.#F M/^TSZW?R%V+`8ZDN:UO8GLIW^E.>;@6*.+C.TLWFY.`"V<[L>BQV+' MT*4C6)XC:KO@_-!;7NV0/7DFTRV2X90'P?+,E%NV;J/53!;L,ZLJA5*Q-XLT MA!W51_LEOPW-&CF/S^*M6_ZD?P/+MZ4%^TYEP1N%*I8#IV_M2+>^W8,6+>0. M*UAH6+OVMH3?+(,]9:&PO=V]R:W-H965T&ULC%5= M;YLP%'V?M/]@^;T8R%>#0JIT5;=)FS1-^WAVC`&K&"/;:=I_OVM,*"19FI<( M7X[/N>?>F\OJ[D56Z)EK(U2=XB@(,>(U4YFHBQ3__O5XS`W1Y.Z*5@6AF5VP#HB$_TU/.2 M+`DPK5>9``>N[$CS/,6;*+F/(DS6J[9`?P3?F\$S,J7:?]8B^R9J#M6&/KD. M;)5Z#(/9HMP$@$<;;FQC\)18L1VQBKY MUX-:1\1SM:D]4$O7*ZWV"/H-:--0-SU1`L2'G#Q#G^7_DH3L',G&L:1X@1'H M&ZCL\SH*YROR#-5@'>;>8^#W#=,C"&33IP1I#%,Z7YZ#L@,[95868\8&07(]48=&)HTECZNL0== M(0T#,Y1VYN.Y&[MW_+M[;19]O;L(5.ZMK^'M>KE4COP6*J+^($>3@P, MWK&;:;@,`']9PMT;2W01&**!F^5Y-VXO#_XZEZ4<>"S514[=+,>\[6`NPN#= MWKA[8XDN,G(3A>?=1-#!Z^VTZ+'8(71J");JB+IU%"W?=]1>/%+IULC84W3D MR>]@O^@DUP7_Q*O*(*9V;K_&L*'Z:+_[-[%;(L?Q:;+QWP32OX&=W-""?Z>Z M$+5!%<^!,PP6T"#MM[H_6-5`[K"9E85MW#Z6\/7EL*7:;N9*V<,!E$G_/5__ M`P``__\#`%!+`P04``8`"````"$`=%RW(UP%``![%0``&````'AL+W=OMKM"*=$ZY(JK?W\R+EQ1E"O&9YUGRU M04VC2%??CR6ODM<\S M6(%(NU&QP\9\(JN81J:U7;<)^IFQ2SWXWZA/_/);E>W_R$H&V88ZB0J\69U"1B', MDGHB4LIS`(#?1I&)UH",))_MWTNV;TX;T_&77F`[!.3&*ZN;ETR$-(WTO6YX M\2^*B`R%0:@,X@"]_)PN:>@1S___*!82M0M\3IIDNZ[XQ8"N@7O6YT3T(%E! MY.O*D*-;Z]1288TBR).(LC$#TX!5U%"?CVWHKJT/2&DJ);NQA*B*^*H0E0"Z M#A$6/D2\G?0KB1`+$E$$@;;#-R!VAT:U^XX5?MA)%!)(T'P2(89"#VX<>EU8 M9$.).Y!HBOB>0D&#(//1A'ACPKJ[G(2VAH:2L*WEPB@#,G:IPH<*^ MTZU2810N-Q@A]Y,GQ"H;C;JPR(82R49#W]9;#P6W"Z^018^0";%*%NID*'%Q M4U!]S\37C_N&=/L9IX`1Z/_Y.6O5*AK5"RHU,FO"$M2LQE(PS-HDG9C$LRM* M<&X/IXFC)TYJD(Z0(")]8K#=%,7"A[)W_&KFQ+2>SX:S?CX:CO8AFM,'QIU`4".+2L#IB3=*W-@B)NLJ9O9\0*%6 MNRX:Y0XU5T`O\CQ/T\1$T03$]J2\9P0R??2 M'U(_"/HP"B?5K&,>9WN5MIG["8O5EAK)X-YH1JF86(F*^9"'T+&'1-H#R4YJ M$(_0BXCOSB,\W4:D"/$DB:V;B!1!]3I1/]KDOAB[2"]1LZ>9 MB)A^+E3POM=1=('A!B&V[B92)+,H-DC?7Q)S;"937@RG4/C9A//.O"HZ""54<6LSROC92_BW,L"E]QNG>[ M,[8G*HY5M/=W#8QEZ"^,!Y&ULC%1=;]HP%'V?M/]@^;UQ'`H!1*C**K9*JS1-^W@VCI-8C>/(-M#^^UW; MQ:+MM/%"<'SN.??3B3O.]$H.+)$;TS$'^MI.C/;$I?@F= M8N9Q/UYQK4:@V,E>NN=`BI'BR_MVT(;M>O#]1*\9/W&'PSMZ);G15C4$6!)C6JUJ"`U]V9$13X5NZW$PQ6:]"?7Y)<;1G_Y'M]/&SD?57.0@H M-K3)-V"G]:.'WM?^%023=]';T(!O!M6B8?O>?=?'+T*VG8-N3\&0][6LG^^$ MY5!0H,F*D`;7/20`OTA)/QE0$/84GD=9NZ["DUDV+?,)!3C:">NVTE-BQ/?6 M:?4[@JA/*I$4+R3P?"&A15;,IW0Z^S\+B1D%@W?,L?7*Z"."H0%-.S(_@G0) MS-[9!.KS=V>0C8^Y]4$A%-`6NG%8T]E\10Y00OZ"V41,B5'"%`E!0#QE`*KG M&?Q;V8/?*B\2;\AN$S%EZ.BYT.2UT&56?1"4Y,P&I6\%(^;Z##--*;VR"I#+ MK7IPA<%,*B`M\\0;K4;,/+2@H&6Z?:4*(W:N>IEO'_16G2;^J!XQDS).0+J, MXG&9XJPI85KQ2?2]15SO_:)0B$EOXPYO8(>+T+1T`3LTLE8\,-/*P:)>-!": M9R4(F[B%\>#T&(9BIQUL3_C;P<=2P*SF&8`;K=WIX/<\?7[7?P```/__`P!0 M2P,$%``&``@````A`'\:LX0J`P``N0D``!@```!X;"]W;W)KL3A]6IR'B]3YY*"U91Y8J&U?!+ M+F1%-7S*K:<:R6AF%E6E%_K^S*LHKXEEB.4U'"+/>1+JK6*TMB60EU9"_ M*GBC#FQ5>@U=1>7SKKE)1=4`Q8:77+\94N)4:?RTK86DFQ)\OP83FAZXS<<1 M?<53*93(M0MTGDWTV//"6WC`M%IF'!Q@V1W)\H2L@_@^F!)OM30%^LO97O7> M'56(_5?)L^^\9E!MZ!-V8"/$,T*?,@S!8N]H]:/IP$_I9"RGNU+_$OMOC&\+ M#>V>@B,T%F=O#TRE4%&@<4.31BI*2`">3L5Q:T!%Z&M"0A#FF2X2$LWI')O`WV9\+1,-)1!YQ'T]+P<+@)$0.C M`+G>*(*A24/I<8TMZ`IIV#!]:30?SG#;7?"/ZTP67;W;"%3NO:_1K"O)P/!L MJ'J^U`@>2K41NZ'[.P8VWMC-Q%^X@#\O@>N&$FT$-E'/S?RT&[R7>T?GO!2" MAU)MY-C-8LAK>K.`GIX7P%5#@38R]')[VDL`_;O>C$$/Q0ZA8SL!'OQ>G(#S! M8YDV-#`U\3\PA6>\IWS!E+T10+0[L$$;.F$*SW*/&DTM+EZ).,+&AMK0T%`P M,F0'I9U&%9-;]H65I7)2L<,A&,(8Z:+=@%Z':&0NV'%@UT#L:GT#`RS6L!?Y$83#7?!1NY$/KP`]Z=K M]1\``/__`P!02P,$%``&``@````A`-=`5@5_`@``308``!D```!X;"]W;W)K M&ULE%7+;MLP$+P7Z#\0O$>4Y%SL,YL2E]`I;AZWW970JD.*C6RD._2DE"B1W5>M-GS3H.]],N;B MF;L_O*%74AAM=>DBI&,AT;>>;]@-0Z;%O)#HP)>=&"ASNDRRU8RRQ;ROSQ\) M.WOR3&RM=U^-++[+%K#8V";?@(W6CQYZ7_@07F9O;M_U#?AA2`$EWS;NI]Y] M`UG5#KL]04/>5U8.+N=$[@NU&M.VX'YXD0^+W M<\$D/';IP3F=48(R%NOWM$C&TSE[0M/BB%D%#/Z^8`8$0]%!&=4N5_9@K^RK MXE-9A<"I3/J^S.A(TFF%N'_?07SS7.$;.[=R\LA/6-^R(`E/!%V@:2X3>^M5,<>J'Z/#5 M6*9^,%_'Q]FR'U@VO,!M[G@%#]Q4LK6D@1(IX]Z+"=^#<'"ZP\QQI[7#/>X? M:_QL`PY^'*'Q4FOW?$!A-OP1+/X!``#__P,`4$L#!!0`!@`(````(0`W!V,P M:P(``*,%```9````>&PO=V]R:W-H965T#.RM0;CQ_6 M!VWN;`O@"#+TMJ2MX-`VS@P%>A4.J8WF:+IGB MLJ>1H3"G<.BZE@*NM-@KZ%TD,=!QA_YM*P=[9%/B%#K%S=U^.!-:#4BQDYUT MCX&4$B6*FZ;7AN\ZS/V0S;DX>A-Y;?P M,'MU^CHTX+LA%=1\W[D?^O`59-,Z[/8"`_E<1?5X!59@09$FR8,-H3LT@$^B MI)\,+`A_*&F.PK)R;4EGRV2Q2F<9PLD.K+N6GI(2L;=.JS\1E`53D2M8N^*. M;]9&'PBV&]%VX'YXL@*)CYXBP^CR/9/HSI-L/4M)5Y2@OL7"WF^RY7S-[K$: MX@ES&3'X?,:,"(9N1DMH8VKI[?(#C;'@3SM3T2Q;C36)B>.EB).GP#3P&;K.$J'W?N!S')EQ=[R+ MV]QW]=_]>;$-EX.-'_".#+R!6VX:V5O208V4:',.\[[?!VA-<6 M?X:``YPFF*+6VAT7_AZ/O]?-7P```/__`P!02P,$%``&``@````A`.*ZTC6, M`@``AP8``!D```!X;"]W;W)K&ULE%5;;YLP%'Z? MM/]@^;T8R*U!(56ZJENE59JF79X=/Z[-S2JSC;<$;W4).'\'2B_7'#ZN] M-G>V!G`$&5J;T]JY+F/,BAH4MY'NH,4OI3:*.]R:BMG.`"_Z0ZIA:1S/F>*R MI8$A,Z=PZ+*4`JZTV"EH72`QT'"'_MM:=O:)38E3Z!0W=[ON3&C5(<56-M(] M]J24*)'=5*TV?-M@W`_)E(LG[G[SBEY)8;35I8N0C@5'7\>\9$N&3.M5(3$" MGW9BH,SI)LDN%Y2M5WU^?DG8VX-W8FN]_VQD\56V@,G&,OD";+6^\]";PIOP M,'MU^KHOP#=#"BCYKG'?]?X+R*IV6.T9!N3CRHK'*[`"$XHT43KS3$(WZ`"N M1$G?&9@0_M`_][)P=4[3970^FTWGYPNDV8)UU])S4B)VUFGU.Z"2@2NPI`,+ M/@>6R3R:+>))@J+_(6'!HS[`*^[X>F7TGF#3H*3MN&_!)$/BMR/"4#QVX\$Y M75""OEJLPOTZF<8V8@X"A`AIP?HP5B#8^F7N0V@$Z2Q'TZ7 M]N!>>DSN8,$Y..^0<+ MMLM!*),7!0N#'^9"@:G@$S2-)4+O_%"GV.FC=;QO-JEOQI?V:;;IFY2-'_`> MZ'@%M]Q4LK6D@1(IX\C/O0DW2=@XW:'G.,?:X070O]9XX0,V>QPAN-3:/6U0 MF(V_D/4?````__\#`%!+`P04``8`"````"$`\ES@[(X"``"+!@``&0```'AL M+W=O?/RP/FAS;VL`1Y"AM3FM MG>LRQJRH07$;Z0Y:_%)JH[C#I:F8[0SPHM^D&I;,9DNFN&QI8,C,%`Y=EE+` MK19[!:T+)`8:[C!_6\O./K,I,85.<7._[RZ$5AU2[&0CW5-/2HD2V=>JU8;O M&O3]&*=_":VUH?/1A;?9`M8;&R3;\!.ZWL/_5KX$&YFKW;?]0WX84@! M)=\W[J<^?`%9U0Z[O4!#WE=6/-V"%5A0I(F2A6<2NL$$\$F4]).!!>&/_?L@ M"U?G-%E&:;)87<:()SNP[DYZ3DK$WCJM_@94/'`%EF1@P??`,E]&B]5L/H&$ MA8QZ@[?<\N_7@G*XHP5PM=N%A$Z?)FCU@ MZ<2`N0D8?!XQ(X*AZ*B,:M.5/=@K^]KZ5&Y"X%3FF,B9S/P],AZ<4WP>DT_G M8_I!.6#2$\QB1)PI(V2Z00_&'IQ+'RT%Z0":((U#-5W:@WOIL;A#!,_)21W2 MMUTNWR/EP>=20Z2?]+/JX92=6NB/7'+IS]=_AM1O/-<8(C@R)W9>-BT<_G`V M%)@*/D'36"+TWA_L!*=]C(YWSC;Q`_DRGF;;?E#9^`'O@HY7\)V;2K:6-%`B MY2Q:H1<3;I.P<+K#S/%"T`XO@?YGC9<^X,#/(@276KOG!0JS\6]D\P\``/__ M`P!02P,$%``&``@````A`$5=C&ULE%5=;YLP%'V?M/]@^;T82$(:%%*EJ[I5VJ1IVL>S8PQ8 MQ1C93M/^^UUC2D)3*?2%C\OQ.?=<^U[6-\^R1D]<&Z&:#$=!B!%OF,I%4V;X MS^_[JVN,C*5-3FO5\`R_<(-O-I\_K0]*/YJ**[25OK"?1O*86 M\C>5:,TKFV13Z"35C_OVBBG9`L5.U,*^=*08298^E(W2=%>#[^=H3MDK=_=R M1B\%T\JHP@9`1WRBYYY79$6`:;/.!3AP94>:%QG>1NGM"I/-NJO/7\$/YN09 MF4H=OFJ1?Q<-AV+#-KD-V"GUZ*`/N0O!8G*V^K[;@)\:Y;R@^]K^4H=O7)25 MA=U>@"'G*\U?[KAA4%"@">*%8V*JA@3@BJ1P)P,*0I^[^T'DMLIPG`31/$P` MC7;V.5_.*>`^X]QRP)%LMP%ETF(3Z?SMX=M72SUNJ` MX,B`I&FI.X!1"L3O^P$C#KMUX`PO,8)<#>S!TR9:+-;D"0K'>LRMQ\#UB!D0 M!$0'95";KNS`3ME5UJ5RZP.G,O'[,K./R#APAN%Z3'Z1#+Q>V6/F)YAC"48& M`3+=H`/#'HREC\1>VH,F2,.AFB[MP)WT4-P^`EUR4H?E4(>1R^0C4@X\ENHC MW4D?\<(I.[70-=SJX@EUJ\8"?016GGBY?M^+&]:3F\&!QU)]Y-S+:LS;>4F@ M=R_UFULWEN@C8S>K-V[\%/-M+KDN^1=>UP8QM7<3*H;&':+#\-S&KK?>QN?I MMANJ9/@`0ZVE)?]!=2D:@VI>`&48+,&+]F/1OUC50N8PVY2%>=8]5O#WXM"[ MH3->*&5?7T"8#/_#S7\```#__P,`4$L#!!0`!@`(````(0"NW3&"L`(``%0' M```9````>&PO=V]R:W-H965TO2%R"7XW/NN??Z9G7] M*"OTP+41JDYQ%(08\9JI3-1%BG_]O+WZA)&QM,YHI6J>XB=N\/7ZXX?54>F] M*3FW"!AJD^+2VB8AQ+"22VH"U?`:_LF5EM3"HRZ(:32G67M(5F02AG,BJ:BQ M9TCT&`Z5YX+Q&\4.DM?6DVA>40OYFU(TYL0FV1@Z2?7^T%PQ)1N@V(E*V*>6 M%"/)DKNB5IKN*O#]&,TH.W&W#Q?T4C"MC,IM`'3$)WKI>4F6!)C6JTR``U=V MI'F>XDV4;)>8K%=M?7X+?C1GOY$IU?&+%MDW47,H-K3)-6"GU-Y![S(7@L/D MXO1MVX#O&F4\IX?*_E#'KUP4I85NQV#(^4JRIQMN&!04:())[)B8JB`!^$12 MN,F`@M#']OLH,ENF>!H&BRA<3A?`LN/&W@I'B1$[&*OD'P^*.BI/,NE(X/M$ M,@_B13B-0/,_),0GU/J[H9:N5UH=$(>,3`(D/$&'1AZ,)1^65L/&B$-\S!>VH%;Z;ZX M702NR7,3XW_4=_X>*0<>2G61=M('U8,I.[?@;MQ\%D!F;X^H.S94Z"(P,&=F MIJ^WS*WKT;?!@8=27>32S'+(VZZ/&0SOVU[8O^62ZX)_ MYE5E$%,'MZ$F<&_[:+\\-Q-WM5[&9\FF7:JD_P.66D,+?D]U(6J#*IX#):PR MZ(OV:]$_6-5`YK"5E(5UUOXLX>W%X>J&KHFY4O;T`,*D?Q^N_P(``/__`P!0 M2P,$%``&``@````A`&6EX'NH`@``7`<``!``"`%D;V-0&UL M(*($`2B@``$````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````G%7!;N(P M$+VOM/^`O9<5JS9GJ0`FA!LY:Z^K*=56^9ANJSB$M(+.2]89J6-;WKERM M>,Y&,G_<,*'=7K?[PV5/FHF"%6?5:T&GJ7BUU5\M6LC>VDQZHPRQ_K+E^]KN>VUYZ.**]_;ZJLMR[6L.XK_`]MZ3N<"H-G(IR9/(EB$B/S@Q=I`"0R1-8F MP6BY2X^3%,#'="LE3C)$4A2B:!D,I_:R!H/)/+@;!E.4HFF0H1$LT^S.6A)G M2?B+9*`4!Z&QR'Z^26*,"!,X3QK;"RV&&/U>&`?0\D.?\&(V"]([XSZ.)G$T MCL(`&"]F6PN_]Z9MK7WFISF]+_2YM').S]"N[6B(9,0TY:6RUO]XF(9FI;P? MZ,D.!X,]B<3'`[:A#ZZQHXMKRL6#6E29',$??'\S'VYZ>$UK5L"=M<^_;7@W M<"G7I2D2KJFX9\4>\SYAWI%E\UCZ%_WS[F47GHC6GN>^/8O^?P```/__`P!0 M2P,$%``&``@````A`(N!ZY4R`0``0`(``!$`"`%D;V-0 M]#<9[%A8KAMG.8A'MT.6R[>^0[P),]O ML(;`)0\<=\#4CD0T(*48D?;#U3U`"@PU:##!8Y(1_-T-X+3_\T*?7#2U"D<; M9QIT+]E2G,*Q??!J++9MF[737B/Z$[Q9/SSUHZ;*=+L2@%BWGYK[L(ZKW"J0 MMT=V>'-UXOV^P+^S0HK>C@H'/(!,XGOT9'=.7J9W]]4*L4E.9BDA*9E59$'G M.27SUP*?6\-]-@+U(/!OXAG`>N^??\Z^````__\#`%!+`0(M`!0`!@`(```` M(0#ZP-;3N@$``-<0```3``````````````````````!;0V]N=&5N=%]4>7!E M&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L````````````` M````\P,``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`$+W`@``1`@```\`````````````````]@D` M`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"R^:/0&`P``;0D``!D````````````````` M9A@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`"DQ_L`[`@``(P4``!D`````````````````:"(``'AL+W=O&UL4$L!`BT`%``&``@````A`(7!+AZ:"@``]5D` M``T`````````````````7EH``'AL+W-T>6QE&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`!-3@HBG`P``ZPP``!D````` M````````````S6@``'AL+W=O&PO=V]R M:W-H965T0`` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$%Q]AS: M`@``%`@``!@`````````````````.WP``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`.*ZTC6,`@``AP8``!D`````````````````/I```'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`*[=,8*P`@``5`<``!D`````````````````J9@``'AL+W=OZ@"``!N5,@$``$`"```1`````````````````&Z?``!D;V-0 XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS
6 Months Ended
Sep. 30, 2014
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]  
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS

(4) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS

 

On June 7, 2013, the Company entered into an Asset Transfer Agreement (the “Del Mar ATA”) with Del Mar Financial, S.a.r.l. (“Del Mar”). The Del Mar ATA involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the “NIBs”), among other assets, that are consideration and collateral for certain cash advances and expense payments made by the Company. The end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into “Qualified NIBs” before the original due date of December 31, 2013, which was subsequently extended to September 30, 2014 (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), having a combined face amount of $400,000,000 (with “Qualified NIBs” meaning that the NIBs would have premium financing secured for up to five years; that any grouping of NIBs would have not less than 10 policies; that the average age of the insureds under the life insurance policies would be approximately 81 years; and that the NIBs would have mortality re-insurance coverage). All remaining NIBs that are not converted to “Qualified NIBs” and all other assets conveyed to the Company as collateral to assure delivery of the Qualified NIBs will be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000. In the event Del Mar was unable to provide the Qualified NIBs by the original date of December 31, 2013, which was subsequently extended to September 30, 2014 (the parties have negotiated a further extension to January 31, 2015, for which documentation is presently being prepared), the Company will have the option of selling any of the collateral assets acquired up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, the Company will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have no due date, but will be paid out of death benefits received, and incur interest of 4.0% per annum. Total interest and principal amounts are due upon maturity. Del Mar is continuing its efforts in delivering the Qualified NIBs. The Company has received $90,600,000 in Qualified NIBs under the Del Mar ATA.

 

As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. (“Europa Agreement” and “Europa”). The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. The total restructuring fee will be up to $4,000,000. In the event that any cash consideration by the Company under the Del Mar ATA exceeds the defined $8,000,000 cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $24,000,000 under the Del Mar ATA, which is comprised of $12,000,000 in cash consideration and $12,000,000 in promissory notes.

 

On October 29, 2013, the Company and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up-front cash payment due from the Company under the Del Mar ATA and Europa Agreement shall not exceed $12,000,000; that the Company would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $8,000,000, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.

 

Also on October 29, 2013, the Company entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $25,000 to such consultant for services related to the purchase of Qualified NIBs associated with the $400,000,000 in life insurance policies under the Del Mar ATA.

 

On January 14, 2014, the Company completed the closing of $90.6 million of Qualified NIBs. These Qualified NIBs are part of the $400 million transaction of additional NIBs in portfolios from the Company's second acquisition in June 7, 2013, related to the Del Mar ATA.

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W.3DY8F,X.%]B8S1B7S1C,S-?.&0R9E\R8V0V M-68W8F0X9CDB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE. M5D535$U%3E1?24Y?3D547TE.4U5204Y#15]"13PO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D%$5D%.0T5?1D]27TE.5D535$U%3E1? M24Y?3D547SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DY/5$5?4D5#14E604),13PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$537U!!64)!3$5214Q!5$5$7U!!4E19/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-50E-%455%3E1?159%3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DE.5D535$U%3E1?24Y?3D547TE.4U5204Y# M15]"13(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DY/5$5?4D5#14E604),15]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z M5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O M#I7 M;W)K#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0 M#I%>&-E;%=O7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^4V5P(#,P+`T* M"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)U-U;F1A;F-E(%-T"!+97D\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^)RTM M,#,M,S$\'0^)S(P M,34\'0^)SQS<&%N M/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4M M4F5L871E9"!087)T>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4L(&EN8VQU9&EN9R!A8V-R=65D(&EN=&5R97-T/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB3PO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO MF5D(#4P,"PP,#`L,#`P('-H87)E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS<&%N M/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,BPU-3,I/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#DP-BD\'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W.3DY8F,X.%]B8S1B7S1C,S-?.&0R9E\R M8V0V-68W8F0X9CD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-SDY M.6)C.#A?8F,T8E\T8S,S7SAD,F9?,F-D-C5F-V)D.&8Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4M4F5L871E M9"!087)T>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQD:78@:60] M,T1%9&=A2`Z M("=4:6UE'0M86QI9VXZ(&IUF4Z(#$P<'0[)SX\'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT M('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE2!I;F-L=61E9"!I;B!F:6YA;F-I86P@2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D M(%-T871E6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/DUA M6EN9R!N;W1E'!E8W1E9"!F;W(@=&AE(&9U;&P@>65A M2!A8V-E<'1E9"!A8V-O M=6YT:6YG('!R:6YC:7!L97,@2`Z(%1I M;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/'`@F5D('5N9&5R('1H92!L87=S(&]F('1H92!3=&%T M92!O9B!.979A9&$@;VX@/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SXL(#(P,#$L M(&9O6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P M<'0[)SXL('5N=&EL(&ET2!O9B!3 M=6YD86YC92!3=')A=&5G:65S+"!);F,N($]N(#PO9F]N=#X\+V9O;G0^/&9O M;G0@2!F;W)M960@86YD('=H;VQL>2UO=VYE9"!S=6)S:61I M87)Y+"!!;F5W($%C<75I2!T:&4@365R9V5R(%-U8G-I9&EAF%T M:6]N(&]F(&$@<'5B;&EC(&-O;7!A;GDN($%C8V]R9&EN9VQY+"!T:&4@:&ES M=&]R:6,@9FEN86YC:6%L('-T871E;65N=',@;V8@=&AE($-O;7!A;GD@87)E M('1H92!H:7-T;W)I8R!F:6YA;F-I86P@2`S M,2P@,C`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`Z(%1I;65S($YE=R!2;VUA;CLG M/B8C,38P.SPO<#X-"@T*/'`@6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL M93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/D1E8V5M8F5R(#$U+"`R,#$V/"]F;VYT/CPO M9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="US:7IE.B`Q,'!T.R<^/&9O;G0@ M2!A9&]P=&EO;B!I6QE/3-$ M)R!M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R<^/&9O M;G0@6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/DEN($%U9W5S="`R M,#$T+"!T:&4@1D%30B!I2=S($%B:6QI='D@=&\@0V]N=&EN=64@87,@82!' M;VEN9R!#;VYC97)N+B!4:&4@;F5W('-T86YD87)D('!R;W9I9&5S(&=U:61A M;F-E(&%R;W5N9"!M86YA9V5M96YT)W,@65A2=S(&9I;F%N8VEA;"!S=&%T M96UE;G1S+CPO9F]N=#X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"<@;6%R M9VEN.B`P<'0[('1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO M<#X-"@T*/&1I=CX-"CQD:78@6QE.B!N;W)M86P[('1E>'0M9&5C M;W)A=&EO;CH@;F]N92!S;VQI9"!R9V(H,"P@,"P@,"D[(&-O;&]R.B!R9V(H M,"P@,"P@,"D[)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@)B,Q-C`[)B,Q M-C`[)B,Q-C`[("8C,38P.R8C,38P.R8C,38P.R8C,38P.R`\9F]N="!S='EL M93TS1"<@9F]N="US:7IE.B`Q,'!T.R<^5&AE($-O;7!A;GD@:&%S(')E=FEE M=V5D(&%L;"!O=&AE2!I65T(&%D M;W!T960L(&%C8V]U;G1I;F<@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD M:78@:60],T1%9&=A2`Z("=4:6UE2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<^ M/'-T6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@9F]N M="UF86UI;'D@.B!4:6UE6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O M;6%N.R<^/&9O;G0@F4Z(#$P<'0[)SY4:&4@0V]M<&%N>2!A8V-O=6YT M2!A;B!I;F1E<&5N9&5N="!T:&ER9"!P M87)T>2!V:6$@82!L;V%N(&9R;VT@82!S96YI;W(@;&5N9&5R(&%N9"!I;G-U M2!R:7-K(&EN2!R92UI;G-U2!C86QC=6QA=&5S(&%C8W)E=&%B;&4@:6YC;VUE+"!W:&EC:"!I2!B87-I M2!B87-E9"!O M;B!T:&4@8W5R'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF M;VYT('-T>6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R<^5&AE($-O;7!A;GD@:7,@;F]T(')E'!E;G-E M&EM M871E9"`D/&9O;G0^,C$W/"]F;VYT/B!M:6QL:6]N("AI;F-L=61E6EN9R!L:69E(&EN2=S(&EN=F5S=&UE;G0@:6X@3DE"'0M86QI9VXZ(&IU6QE/3-$)R!W:61T:#H@-3`E.R!B;W)D M97(M8V]L;&%P#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#L@9F]N M="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/E-E<'1E;6)E6QE/3-$)R!V M97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I M;F#L@=VAI=&4M#L@9F]N="UF86UI;'D@.B!4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/DUA2`Z(%1I M;65S($YE=R!2;VUA;CL@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF M;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[('=H:71E+7-P86-E M.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F M=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE M.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X M="UA;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I M;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A8VMGF4Z(#$P<'0[ M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B0\+V9O;G0^/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/C$R+#(T,RPT,3$\+V9O;G0^/"]F M;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1M M:61D;&4@2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED M9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE'0M86QI9VXZ(&QE9G0[)SX-"CQP('-T>6QE/3-$)R!M87)G:6XZ(#!P=#L@ M9F]N="UF86UI;'D@.B!4:6UE'0M86QI M9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W'0M M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&UI9&1L92!S='EL93TS1"<@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E M.B!N;W=R87`[(&)A8VMGF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[ M('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I M;F#L@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/D%C M8W)E=&EO;B!O9B!I;G1E#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF M86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CLG/C$L,34V+#$U,3PO9F]N=#X\+V9O;G0^/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&UI9&1L92!S='EL M93TS1"<@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQOF4Z M(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET M92US<&%C93H@;F]W6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/D1I#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US M<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A8VMG2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@ M;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N M;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA M;CL@8F%C:V=R;W5N9"UC;VQO2`Z M(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#$P M<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@ M<&%D9&EN9RUL969T.B`U<'@[(&)A8VMG2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&UI9&1L92!S='EL93TS1"<@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1M:61D;&4@#L@9F]N="UF86UI;'D@.B!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@ M;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#%P="!S;VQI9#L@8F]R9&5R+6-O;&]R.B`C,#`P,#`P.R!P M861D:6YG.B`P<'@[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[(&)A8VMG2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CLG/E1O=&%L/"]F;VYT/CPO9F]N=#X\+W`^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R M87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A M8VMG2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W#L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`R+C@P<'0@9&]U8FQE.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$;6ED9&QE('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M=&]P.B`C,#`P,#`P(#%P="!S;VQI9#L@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R M87`[('!A9&1I;F#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`R+C@P<'0@9&]U8FQE.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&9O;G0@6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B0\+V9O;G0^ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1M:61D M;&4@#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I M;65S($YE=R!2;VUA;B<[)SX-"CQD:78^#0H\<"!S='EL93TS1"<@;6%R9VEN M.B`P<'0[('1E>'0M86QI9VXZ(&IU2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/'`@2!E;G1E6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/F9I M=F4\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="US M:7IE.B`Q,'!T.R<^/&9O;G0@2!G6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE2`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`Z(%1I;65S($YE=R!2;VUA;CLG/C$P,#PO9F]N M=#X\+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE2!C87-H('!A>6UE;G1S(&UA9&4@=6YD97(@=&AE M($1E;"!-87(@051!+B!)9B!T:&4@9G5L;"!B86QA;F-E(&]F(%%U86QI9FEE M9"!.24)S(&ES('!R;W9I9&5D(&)Y($1E;"!-87(L('1H92!#;VUP86YY('=I M;&P@:&%V92!P86ED("0\+V9O;G0^/"]F;VYT/CQF;VYT/CQF;VYT('-T>6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/B!O9B!C;VYS:61E6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CLG/B!O9B!W:&EC:"!W;W5L9"!B92!I;B!C87-H(&%N9"!T M:&4@6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/B!I;B!P2!B92!I6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CLG/C0N,#PO9F]N=#X\+V9O;G0^/"]F;VYT M/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL M93TS1"<@9F]N="UF86UI;'D@.B!4:6UE2X@1&5L($UA2!H87,@6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/CDP+#8P,"PP M,#`\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="US M:7IE.B`Q,'!T.R<^/&9O;G0@2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/'`@2!A('-T6QE/3-$)R!F;VYT+7-I M>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B4@;V8@=&AE(&9A8V4@86UO M=6YT(&]F('1H92!L:69E(&EN6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CLG/C4P/"]F;VYT/CPO9F]N=#X\+V9O;G0^ M/&9O;G0@6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B4@;V8@=&AE M(&9E92!O;B!T:&4@9&5L:79E6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/C4P/"]F;VYT/CPO9F]N=#X\+V9O;G0^/&9O M;G0@6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B4@8F5I;F<@<&%Y M86)L92!O;B!T:&4@8V]N=F5R6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/C0L,#`P+#`P,#PO9F]N=#X\+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE2!C87-H(&-O;G-I9&5R871I;VX@8GD@=&AE($-O;7!A;GD@=6YD97(@ M=&AE($1E;"!-87(@051!(&5X8V5E9',@=&AE(&1E9FEN960@)#PO9F]N=#X\ M+V9O;G0^/&9O;G0^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/C@L,#`P+#`P,#PO9F]N=#X\+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE M/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF M86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CLG/C$R+#`P,"PP,#`\+V9O;G0^/"]F;VYT M/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="US:7IE.B`Q,'!T.R<^/&9O M;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/C$R+#`P M,"PP,#`\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N M="US:7IE.B`Q,'!T.R<^/&9O;G0@'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$ M)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE2!A;F0@175R;W!A+"!W:71H('1H92!A M9W)E96UE;G0@;V8@1&5L($UA2!U;F1E6QE/3-$)R!F;VYT+7-I M>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/BP@86=A:6YS="!A;&P@9F5E2!T:&4@<')O(')A=&$@<&5R8V5N=&%G92!O9B!T:&4@475A M;&EF:65D($Y)0G,@9&5L:79E2!T:&4@0V]M M<&%N>2P@;75L=&EP;&EE9"!B>2`\+V9O;G0^/"]F;VYT/CQF;VYT/CQF;VYT M('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/C,P,"PP,#`L,#`P M/"]F;VYT/CPO9F]N=#X\+V9O;G0^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CLG/B!I;B!1=6%L:69I960@3DE"6QE/3-$)R!F;VYT M+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4 M:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA M;CLG/B8C,38P.SPO<#X-"@T*/'`@6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE2!E;G1E6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N M="UF86UI;'D@.B!4:6UE2`Z(%1I M;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X-"@T*/'`@2`Q-"P@,C`Q-#PO9F]N=#X\+V9O;G0^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CLG/BP@=&AE($-O;7!A;GD@8V]M<&QE=&5D('1H92!C M;&]S:6YG(&]F("0\+V9O;G0^/"]F;VYT/CQF;VYT/CQF;VYT('-T>6QE/3-$ M)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI M;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B!M:6QL M:6]N(&]F(%%U86QI9FEE9"!.24)S+B!4:&5S92!1=6%L:69I960@3DE"6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CLG/DIU;F4@-RP@,C`Q,SPO9F]N=#X\+V9O;G0^/&9O;G0@6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/BP@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE M=R!2;VUA;B<[)SX-"CQD:78^#0H\<"!S='EL93TS1"<@;6%R9VEN.B`P<'0[ M('1E>'0M86QI9VXZ(&IU2`Z(%1I;65S($YE=R!2;VUA;CLG/B8C,38P.SPO<#X- M"@T*/'`@6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/BP@=&AE($-O;7!A M;GD@;6%D92!A(&QO86X@=&]T86QI;F<@)#PO9F]N=#X\+V9O;G0^/&9O;G0^ M/&9O;G0@6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/C8U,"PP,#`\ M+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"<@9F]N="US:7IE M.B`Q,'!T.R<^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CLG/C,\+V9O;G0^/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS M1"<@9F]N="US:7IE.B`Q,'!T.R<^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CLG/D%P2!R96-E:79E9"!F=6QL('!A>6UE;G0@;V8@=&AE("0\+V9O;G0^/"]F;VYT M/CQF;VYT/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/B!$96P@36%R(&YO=&4@6QE/3-$)R!F M;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@ M.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`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`Z(%1I;65S M($YE=R!2;VUA;CLG/D1U6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S M($YE=R!2;VUA;CLG/B`\+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE/3-$)R!F M;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@ M.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CLG/B!F6QE/3-$)R!F;VYT+7-I M>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/BP@8G)I;F=I;F<@ M=&AE('1O=&%L(&YO=&5S('!A>6%B;&4M2!L;V%N(&)A M;&%N8V4@=&\@)#PO9F]N=#X\+V9O;G0^/&9O;G0^/&9O;G0@6QE/3-$)R!F;VYT+69A;6EL M>2`Z(%1I;65S($YE=R!2;VUA;CLG/C6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/E-E<'1E;6)E6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/BX@)B,Q-C`[5&AE(&YO M=&5S(&1O(&YO="!I;F-U6%B;&4@;VX@9&5M M86YD(&%N9"!AF5D+CPO9F]N=#X\+V9O;G0^ M/"]P/@T*/"]D:78^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@:60],T1%9&=A2`Z("=4:6UE'0M86QI9VXZ(&IUF4Z(#$P M<'0[)SX\2`Z(%1I;65S M($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@/'`@2`Z(%1I;65S M($YE=R!2;VUA;CL@;6%R9VEN+7)I9VAT.B`U<'0[('1E>'0M:6YD96YT.B`S M-G!T.R<^/&9O;G0@2`R,#$T M+"!T:&4@0V]M<&%N>2!IF4Z(#$P<'0[)SX@6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M2`Z(%1I;65S M($YE=R!2;VUA;CLG/B8C,38P.SPO<#X@/'`@2`Z(%1I;65S M($YE=R!2;VUA;CL@=&5X="UI;F1E;G0Z(#,V<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R<^3VX@/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M2!E;G1EF4Z(#$P<'0[)SXL('=H:6-H('-U8G-C6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S M($YE=R!2;VUA;B<[)SX-"CQD:78^#0H\<"!S='EL93TS1"<@;6%R9VEN.B`P M<'0[('1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[)SX\6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF M>3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W M(%)O;6%N.R<^)B,Q-C`[/"]P/B`\<"!S='EL93TS1"<@;6%R9VEN.B`P<'0[ M('1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:&4@0V]M<&%N>2=S(&9I;F%N8VEA;"!S=&%T96UE;G1S(&AA=F4@8F5E M;B!PF%T:6]N(&]F M(&%S2`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`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W.3DY8F,X.%]B8S1B7S1C M,S-?.&0R9E\R8V0V-68W8F0X9CD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-SDY.6)C.#A?8F,T8E\T8S,S7SAD,F9?,F-D-C5F-V)D.&8Y+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@9F]N="UF86UI;'D@.B!4:6UE3L@9F]N M="UF86UI;'D@.B!4:6UE6QE/3-$)R!M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@9F]N M="UF86UI;'D@.B!4:6UE'0M:6YD96YT.B`S-G!T M.R<^/&9O;G0@2!A9W)E960@=&\@97AT96YD('1H M92!D96QI=F5R>2!D871E(&]F('1H92!R96UA:6YI;F<@)#QF;VYT/C,P.2PT M,#`L,#`P/"]F;VYT/B!I;B!1=6%L:69I960@3DE"2!B96EN9R!P'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O;G0M9F%M:6QY M(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQD:78@6QE.B!N;W)M M86P[('1E>'0M9&5C;W)A=&EO;CH@;F]N92!S;VQI9"!R9V(H,"P@,"P@,"D[ M(&-O;&]R.B!R9V(H,"P@,"P@,"D[)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#L@)B,Q-C`[)B,Q-C`[)B,Q-C`[("8C,38P.R8C,38P.R8C,38P.R8C,38P M.R`\9F]N="!S='EL93TS1"<@9F]N="US:7IE.B`Q,'!T.R<^5&AE($-O;7!A M;GD@:&%S(')E=FEE=V5D(&%L;"!O=&AE2!I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W.3DY8F,X.%]B8S1B M7S1C,S-?.&0R9E\R8V0V-68W8F0X9CD-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-SDY.6)C.#A?8F,T8E\T8S,S7SAD,F9?,F-D-C5F-V)D.&8Y M+U=O'0O M:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY M(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQT86)L92!C96QL6QE/3-$)R!W:61T:#H@-3`E.R!B;W)D M97(M8V]L;&%P#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=VAI=&4M#L@9F]N M="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/E-E<'1E;6)E6QE/3-$)R!V M97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R M9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I M;F#L@=VAI=&4M#L@9F]N="UF86UI;'D@.B!4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/DUA2`Z(%1I M;65S($YE=R!2;VUA;CL@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CLG/CQF M;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[('=H:71E+7-P86-E M.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F M=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE M.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[ M('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!V97)T:6-A;"UA;&EG M;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N M;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X M="UA;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I M;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A8VMGF4Z(#$P<'0[ M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)R!F;VYT M+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B0\+V9O;G0^/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A M;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/C$R+#(T,RPT,3$\+V9O;G0^/"]F M;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1M M:61D;&4@2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED M9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B M;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4 M:6UE'0M86QI9VXZ(&QE9G0[)SX-"CQP('-T>6QE/3-$)R!M87)G:6XZ(#!P=#L@ M9F]N="UF86UI;'D@.B!4:6UE'0M86QI M9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W'0M M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&UI9&1L92!S='EL93TS1"<@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F]R9&5R+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E M.B!N;W=R87`[(&)A8VMGF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[ M('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I M;F#L@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CL@ M9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z M(%1I;65S($YE=R!2;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/D%C M8W)E=&EO;B!O9B!I;G1E#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF M86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CLG/C$L,34V+#$U,3PO9F]N=#X\+V9O;G0^/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&UI9&1L92!S='EL M93TS1"<@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6QE9G0Z(&YO M;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQOF4Z M(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET M92US<&%C93H@;F]W6QE/3-$)R!F M;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/D1I#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA M;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1M:61D;&4@2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US M<&%C93H@;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE M.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A8VMG2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@ M;F]W6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE M6QE/3-$)R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"<@ M9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N M;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P M,#`[('!A9&1I;F#L@9F]N="UF86UI;'D@.B!4:6UE2`Z(%1I;65S($YE=R!2;VUA M;CL@8F%C:V=R;W5N9"UC;VQO2`Z M(%1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"<@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L M;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#$P M<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F#L@ M<&%D9&EN9RUL969T.B`U<'@[(&)A8VMG2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&UI9&1L92!S='EL93TS1"<@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/BT\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1M:61D;&4@#L@9F]N="UF86UI;'D@.B!4:6UE'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>2`Z(%1I M;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@ M;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.B`Q M,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#%P="!S;VQI9#L@8F]R9&5R+6-O;&]R.B`C,#`P,#`P.R!P M861D:6YG.B`P<'@[(&9O;G0M9F%M:6QY(#H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R87`[(&)A8VMG2`Z(%1I;65S($YE=R!2;VUA M;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE M=R!2;VUA;CLG/E1O=&%L/"]F;VYT/CPO9F]N=#X\+W`^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$6QE/3-$)R!V97)T M:6-A;"UA;&EG;CH@;6ED9&QE.R!B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R M+7)I9VAT.B!N;VYE.R!B;W)D97(M8V]L;W(Z(",P,#`P,#`[('!A9&1I;F#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R M87`[('!A9&1I;F#L@<&%D9&EN9RUL969T.B`U<'@[(&)A M8VMG2`Z(%1I;65S($YE=R!2 M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE M=R!2;VUA;CL@9F]N="US:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W2`Z(%1I;65S($YE=R!2;VUA;CL@9F]N="US M:7IE.B`Q,'!T.R!W:&ET92US<&%C93H@;F]W#L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`R+C@P<'0@9&]U8FQE.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$;6ED9&QE('-T>6QE/3-$)R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M=&]P.B`C,#`P,#`P(#%P="!S;VQI9#L@8F]R9&5R M+6QE9G0Z(&YO;F4[(&)OF4Z(#$P<'0[('=H:71E+7-P86-E.B!N;W=R M87`[('!A9&1I;F#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`R+C@P<'0@9&]U8FQE.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&9O;G0@6QE M/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2;VUA;CLG/B0\+V9O;G0^ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1M:61D M;&4@#L@9F]N="UF86UI;'D@.B!4:6UE6QE/3-$)R!F;VYT+69A;6EL>2`Z(%1I;65S($YE=R!2 M;VUA;CLG/C$R+#(T,RPT,3$\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1M:61D;&4@#L@9F]N="UF M86UI;'D@.B!4:6UE'1087)T M7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2!T:&4@8V]M<&%N>2!I9B!A;&P@;F5T(&EN'0^)SQS<&%N/CPO2!T M:&4@8V]M<&%N>2!I9B!A;&P@;F5T(&EN'0^)SQS<&%N/CPO2!T:&4@8V]M<&%N>2!I9B!A;&P@;F5T(&EN'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@ M6UE;G0@86YD(&%L;"!C;W-T M7,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`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`@("`\=&%B;&4@ M8VQA2!;3&EN92!)=&5M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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` end XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVESTMENT IN NET INSURANCE BENEFITS
6 Months Ended
Sep. 30, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]  
INVESTMENT IN NET INSURANCE BENEFITS

(3) INVESTMENT IN NET INSURANCE BENEFITS

 

The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance policies that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance (“MRI”).  Future expected cash flows are defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments.  At the time of purchase of an investment in NIBs we estimate the future expected cash flows and determine the effective interest rate based on these estimated cash flows and our cost basis. Based on this effective interest rate, the Company calculates accretable income, which is recorded as interest income on investment in NIBs in the statement of operations.  Subsequent to the purchase, and on a quarterly basis, these future estimated cash flows are evaluated for changes. If the determination is made that the future estimated cash flows should be significantly adjusted, a revised effective yield is calculated prospectively based on the current amortized cost of the investment, including accrued accretion.  Any positive or adverse change in cash flows that does not result in the recognition of an “other-than-temporary impairment” (“OTTI”) results in a prospective increase or decrease in the effective interest rate used to recognize interest income.  Management has concluded that there was no change in estimated cash flows as of September 30, 2014.

 

The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid.  The face value of the underlying life insurance policies approximated $217 million (includes estimated return of premiums) as of September 30, 2014. The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of September 30, 2014.  The estimated fair value of the Company's investment in NIBs approximated carrying value at September 30, 2014, with fair value calculated using level 3 inputs.  As of September 30, 2014 and March 31, 2014, investments in NIBs were as follows:

 

   

September 30, 
2014

 

March 31, 
2014

Beginning Balance

  $ 12,243,411     $ 12,243,411  

Additional investments

    -       -  

Accretion of interest income

    1,156,151       -  

Distributions of investments

    -       -  

Impairment of investments

    -       -  

Total

  $ 13,399,562     $ 12,243,411  

 

We evaluate the carrying value of our investment in NIBs for OTTI on a regular basis and, if necessary, adjust our carrying value in the investment in NIBs using new or updated information that affects our assumptions about remaining life expectancy, credit worthiness of the policy issuer, funds needed to maintain the asset until maturity, utilization of MRI, discount rates and potential return. We recognize OTTI on investment in NIBs if the expected discounted cash flows (using the effective yield) expected to be received are less than the carrying amount of the investment.  OTTI of the investment in NIBs could be generally caused by the insured significantly exceeding the estimate of the original life expectancy, which causes the original policy costs and projected future premiums to exceed the estimated maturity value, a change in credit worthiness of the policy issuer, increased or changes to applicable regulation of the investment, counter party performance risk, shortage of funds needed to maintain the asset until maturity and changes in discount rates. There are also risks associated with the policy holder's ability to repay such financing and the occurrence of events of default under such financing. We have not recognized any OTTI from January 31, 2013 (inception) to the period ended September 30, 2014.

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Mar. 31, 2014
Current Assets    
Cash and Cash Equivalents $ 119,662 $ 375,212
Prepaid Expenses 7,625 2,000
Other Current Assets 28,600  
Total Current Assets 155,887 377,212
Other Assets    
Investment in Net Insurance Benefits 13,399,562 12,243,411
Advance for Investment in Net Insurance Benefits 4,376,419 3,584,862
Note Receivable 211,000 861,000
Other assets 14,047 13,767
Total Other Long-term Assets 18,001,028 16,703,040
Total Assets 18,156,915 17,080,252
Current Liabilities    
Accounts Payable 170,826 52,915
Accrued Expenses 146,809   
Notes Payable 1,326,876   
Notes Payable-Related Party 730,000 90,000
Total Current Liabilities 2,374,511 142,915
Notes Payable, including accrued interest    1,455,904
Total Liabilities 2,374,511 1,598,819
Stockholders' Equity    
Preferred Stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding      
Common Stock, authorized 500,000,000 shares, par value $0.001; 43,185,941 and 43,015,941 shares issued and outstanding, respectively 43,186 43,017
Subscription Receivable    (1,500)
Additional Paid In Capital 16,111,277 15,050,705
Additional Paid In Capital- Stock to be Issued    700,000
Accumulated Deficit (372,059) (310,789)
Total Stockholders' Equity 15,782,404 15,481,433
Total Liabilities and Stockholders' Equity $ 18,156,915 $ 17,080,252
XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND BASIS OF PRESENTATION
6 Months Ended
Sep. 30, 2014
ORGANIZATION AND BASIS OF PRESENTATION [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

(1) ORGANIZATION AND BASIS OF PRESENTATION

 

The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the March 31, 2014, audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company's condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented.

 

Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, for the purpose of selling coffee and other related items to the general public from retail coffee shop locations. These endeavors ceased in 2006, and it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. On March 29, 2013, Sundance Strategies, Inc., a Nevada corporation (“Sundance Strategies”), its newly formed and wholly-owned subsidiary, Anew Acquisition Corp., a Utah corporation (“Merger Subsidiary”), and ANEW LIFE, INC., a Utah corporation (“ANEW LIFE”), completed an Agreement and Plan of Merger, whereby the Merger Subsidiary merged with and into ANEW LIFE, and ANEW LIFE was the surviving company under the merger and became a wholly-owned subsidiary of Sundance Strategies on the closing of the merger (the “Merger”). The Merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of ANEW LIFE, which was incorporated on January 31, 2013.

 

Sundance Strategies, Inc. and subsidiary (the “Company” or “we”) is engaged in the business of directly purchasing from third parties and purchasing, acquiring and assisting third parties in assembling portfolios of high quality life insurance policies and residual interest in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations from the secondary and tertiary marketplace often referred to as the “life settlements market.”  Currently, the Company is focused on the acquisition of Net Insurance Benefits (“NIB” or “NIBs”).   NIBs are residual interests in or financial products tied to life settlement policies.  The Company purchases NIBs on life settlement policies from third parties in pools of multiple policies, but does not typically take possession or control of the policies, other than the policies held as collateral for advances to third parties, of which the Company does take temporary possession until collateral is returned for NIBs.

ZIP 19 0001010412-14-000185-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001010412-14-000185-xbrl.zip M4$L#!!0````(``1N;D7E.O>ZD#D``!P9`@`1`!P`OJ>[N8/_WR<6^2>>3YW[+='VDG]B##;<$QN3]\>A7Z-^@;G1\0/ MJ&U2R['9VZ,%\X_^^>ZO?_GA?VJUOL=HP$PR7I!;G5S2@)+AP@_8W"<#VS@F MM\X#\^3SP=U@2/K4&SMVK8:?/XX]BY_C?PD`8?OGW'>:#:WS]F@6!.[YZ>G# MP\,)/CYQO.EIHU[73]4;1^H#B]N?U[R-C\?49]'K8>"M?+M["D^C%_&!R>-W MT^^U3^7#]*M\'<0VHLZ(87A<@OE!%V]KW6[W5#R-7_5YT8LPK';Z[X\?AL:, MS6DM/P&W[YD?9&'WF7$R=>Y/Y3,80=-K=:VF:]%')N/%7\`#?+V9?1WH8DJI M&W\RH?Y8P*8>%'SBA[:960W>0+C]P`,*FG+FGQC.7'Q9[^KU(Z`00GY`?)S[ M8J5W;$($?LZ#A0MDZ/.Y:^&RQ;V9QR9P#P:M14.F_:1]?!#HR]*37M'I%>A*? M-+J[IJ<(A[]I>OKHQ'_*2S#[[4Z^UZYT4@,<6;.7SLBC<%/K1ZXV40 M508?&3[;I:QJODA9)6P*3:^H^^"3YEYT7[W9./OMV@F8?\<,QN_IV&(?V7S, MO-\NF?61>O+B`'A.T,>F78L;/)`P$I/#>]()4$;<><\PG-`. M?+'"#PZU_9YMON-]-;J:1!\G8IZ.BTK=^E3"'IMO4AKIYUBX9)8A$_V8^W\K+T(%&;U;QH; MN_7U&R^0HO3JL2-]?[$C_;<7Z)'M)7K4?XFLI==T;>>(:+P(1"PKNR\B(-O7 M7Q[V].K8VY-(ZK^X6+:^)R9\&9HM(XVT=)!G9XAHOPA$/)6?SUV=>Z MUT,&ZS2_;79ZLP]AMN]LL]GO(7Q^=0__68[:Y%XX8.08%=I.-'MH<[EMGX:7 MN7V;,^J''GNGLFK.X8UHH.A1>G`<:=7(M\P;SJC'Z-V!-X\U=LS2:0 M-HY^&RYM2G9L%_XL-W('B3C@R!'\4EP@ MY1&3&7Q.+?_M4?WH7:VM-3I@P1<.66*V1FXV??UL6K/>:NJM4O,)!7#C!B`X M;BUJ7SVZ($58-+%>:9D-K=%H-I)IB\>N,G^STL+;K>Y9NU-M?L"+!V3`+IG\ M_\"^"6;,NW9L(_0\D&8]WV=!O!.M2@AI=[56*P50R!&&[&LJ:0"QM?><@ M]@S#"YDYP)@]\X/D9`!(,8*T4XVXSNKKH%PW80E@Q1'(+5W@%Q%\9Y7@`XW> M1156>IHMH>I6DP7MQEE[MT`AFC]P.N86#SA+)&*]&KHZG5(;FIJI%%O>@=C0O%I]\)-#D&R,`O8DKZP-D MW`[AGGKHV`GD>>&_0=5HK6ZKU`L9MF1GWDSZ3OSN6,+A0TSW4RB)WW'3S%Q1=UVUFAW.D`VV\Z; M(Y34`'?,51MY,[EC%M8$W.+)]"4;Q^I-JZ;?VLTK%>%`/=O$_UW]'@+#6[BQM\*[S:N9V`&H MIEQKC596!U29FPW=31"]P=L#_;.\Q:P);]0*TR@S"M6;2V4>J<% M_LTF*'-S/06\O))LKI?7S593ZSPC>#E%**LCUMM4W7;[.1'86H80S^#7P=CM M=#,.VQ8PJDPH,S20]V-@\JIK@_U9STG4S*`I;?J>.S6]VT!+N.ITN_`0&WD]M`3JH\_/;6Z]/0I@L+CZ:1O_I5%- M133JG;/&\_DO>EX!5,1$-2M7WRC`U\^V&XM5WQCV*H;BJ6:FOC'JM0'7%0U% M?6.4:P.V"R6.GK?WJV!O"[&B;Y1PZU=QXTVIS?\0)`!4X3L6-\4%R-];D!"` M0W%Y,U%6%[6&<(<)Y%YRW[`<#.:.8/X+"X",X5HVP]]]9P5O3'Z/K[RZ,J?4 M&_9Z6D-OMCIGPI1]1?Q@8;&W1Q/XL#:A)S$!C7[('<.7-JOWIS M]-TT>//7O^!X;O0-F5-ORNUS4G>#-P3GK5&+3^'&?T.@_LGB#DUN[G[L70_^KS<: MW%R3WO4EN>@-!T-R\Y[D.*,%YAV\0WHQE#"C4Q.&WB7XKVX2*T:6AR_(NCGN1S M,HF('VO4%?7#0\,*0=`24"",VV1&[QD9,V83UP,!A!7I;N@ATP8D<`CH&>*% M%D!";9-X;!I:2O(Z$_%PR(S0D]H1W[AZ-&;4GC*"XI/[>,A(OE>[T>R\&5[U MHXNS-Z]/R)KU%$*/4]@HPPA`BA`CK\/+U">@$^8\P`N8$G37'%!=^UE\83KX MD6!M"DOF]@0>4RD!(W3`?5P.@.U2>_$*I[+#%9.?D#[SEH;"QQ/'"?`58L92 MQH=OX!4+-C4]6>'RXBV`%ZAA.)ZH`R@Y&XB[LR93;H0AP< MGC,W2%;RR1;$(`2?V*W>'*C"H*D=3S#O>,11V$OOOA\:L^+M/R;4"F9..)VE MT0;#6IR!YH:;-!!/THC`/:,F^ST$D'#X.?W,Q$MI-":;BGL&-&0QBCT73L@` MU*`/,$VG8!K`\V@.OQH-C8&B84C$$[S\W]"6NE`@&8%9EE3IB_WP]4?J`:9U M[9B@;W0("&!#E?@HQX6(*21)L>](E)(MT2YE@2,Y&W8RM`)!?$YBLL%6JTV7 M8DH>UDOJP"VWP<;T?>IQP3$FD"Q8@"R2-]&80#ZPD>S198:`4PTZ"2V++!CU M)`22H21AP0`K).(2KWTZ&9X4L58Q#WI`T1SI&Y!)IV+4F+K1B)T+#D2D4;"& MYJY$@Z!>.ID`_!*9TX(F-,HU2(LPG(LD(\

()V*,PN^.G5B`PNIK7$OU3")#')A8N%88'&8`*5MP_5D)1@HAR$M[$ MXT.\D7J//,RX,3N.D.*XW%9[FB#]6)*0(I\%[H$2)F0"1BHL2WX:4R(BR0#G M@TPLYR$AS(@@8TETLIXA_W26S"ZLGZ%J<@(**NIRX[TA$0U&"!O,'PA1-MF M1.P7*=BP:`-;/\?.(,9Y`#:9>7",V,[!\1&K(#(.?6X#MV<,!Z2W0V/I"Z$; MM$(LH!Q08@98'SZ/3)S>]=6OY,/@_17(R>O^2=KYBA^E7#"@0+"HHT1?'&"U M8+XYC/24MG&C*VQC_3#H7HD4Q)]2+F!"@N4F;T"C"_6> M*43"P\P!,ZP&Z@]N)/MS3'KP*AAQR9;W858!Q:>`SE;!\)%Y4Q#J249WE@)@ MPAS9;!JPF)30W+28,)1MTIMZ3-K".#XFU2%U24B.88'@)XRE1;8$'9GC'5/Y MO;:(:#AI$#,0"TL`QP$G\Y[?2W4FW='$*IC+.?##,3/H''3=*B2O8`(T'G`D M]&9Q#F5BJ(&_%YYC#N%+H0ZUTAGUI0,>J!Z!<$U!DV*S099A:&'&HT5,71Z` M2?='[,K02`NKM:)ICTX,@&8!G2`X,^X'CH>*NL@@5_!'GCN:SJ4^2FV#L,D% M^L&(5X0BXR^'X-*?J!WB]BDO^B"28F^>PI;F^TMR'JKZ"<@;*:[-<:"BZX0% M,<:5/'Y@*>;$L!*SIW2:>-V)_3%)D&B"EV\$UB*Y`Z:T`=P,3)?<4[XS]TR" M+2BBR&CRZK%D<>GBRJ@`%V==N:\P,.'[X#D($QVC`A/PMAW!A3,^G9'?P97G MP8)8?(+A%)!_`E.N@[48<GIS@LH")A;]=S\#P(9"C'H)JS:KBL MJQ[@#=.C$_3A98!$]*P\1HO-CB(EZ/?')X:)=^'`DJ9IJTZ(;U%/A%LIXDL, MD"!T`?4^L\"UJ($>2P!C>VS"/$_"JD1_LK$">)\%@:5$EOS^)-GN%%/$?_5E MPG(D.2.AR#$H8(2^%&HRY)6QMO``>A!CZ@+\HPGJ\Y2FO!Y)0V!4Z* M`$O^PK>%E%[:4;_DEB98B?>T<,Y1"@.*:I%1<7Y8]:JA2`'=`URNXUB"8N>A M%6"\+$5/XS`@IB,BY`$)%BXW1/`IP,`9>*@PJS@_@*5AZ-YSK$AI)4-(>@IF MU,X\(#-F";5J@(I'GP*0@NXO->\%E4J/-@7J,0XM]5F:``1T`A[0@*C?@"!3 MD$DK/#4'1X(/0L]6(4E$6H%.B`6Q%,6G)K_'.TF.P*Y/.'.%%%@TZ`.'L>>=1DL`B1P)!D$ZP]EABZ M@=7TOX?FSG:K?@S2\>`\&EG9&/&0SJPX-$_9BJ"?+YE%/D8'>>(YEX5E9F++ MTN!)`<%=K&4#L3T#-O\N(R]@;YO2I<#$!6NQ5`X.#JT^I>!#A%`IJYKJ5A%[*.C`RU_ET4(;+`95KC3F0LW M<>).,R[=LI>]E5M:D%`-'^:RXW_T'-]70:6X04&]P,#M9BVC!D5H,>/;U MDWJJQ4!YR+;?EL9.EK*';4D7!_0="].G1,@G!U>\D%PM0I6&U%7*>TN"55Q4 M,G+$X:7'!*<-8NZ.:P.:S?VL(E\FM1&@5(G#CP[HK[X#0LFSE\)3S>5BZ1<9 MGJH@MBM7$)QEQ/1K\N/-X/I'TK^Y[E_=E2P4(,\4&BD(S#S7U+E-V&8/4J'[ M5W[Q$6XFX5]E6JO#C3'UN4I,Y2+7FI*I(\_3!>U')[Z"W.>N157&+^939\ZF M93V:.*"#F_Z$&M$C*UU-)V=5:9^&$WHR*2TZ>SLAO0+W?@E%*1R40?,04WE% M-IY>7^&A/G6*7>QDUK;&_#!J&.$\E&EYECB#0&0MFY'1WWJG<5QO=3>OKC)D M#X[W69"%S$H`03O!YF_KP6D<-[2SXW:C!+HK`X24ADD5"R8RKY4GDG-$1+5' M?`:*+:[PUB!O8`ZCK$6D6LQ9]"CWF3AIQDYSR$VF$XX#0L=.&.2+1@1QB]1C M9!)NATPF=V3X2(:T"KE3E:JH2A$B,C/B+&C)FG,^G04J@SLY/058Y)+01P76 M#7$FK%$)%N6-^D+TKCJ_JBP6OW[QNWL1'E&12=@C]P.&Q\RPNR9SF5B@H.H@ M0W@R2S=`DIT@7^);<9:[I,Q[/(./JH=%$87MJWP!>"Y]+E&D%`9@H:=R,$_( MQZ3&`14$5N0S43%D6!G^ M*4A+-7.+$O&0[LR4CAZD2S"(D#Q^:&`-QB2TE([''/`)N/.8*X(%89*H1O-;I7.1G]+)^2G#T4W_7V1TU[L>]OI8 MU#S&U="9)]9E%:&Z`L!;R,[88AR MM'9.ML2X627RHO5V'=V6^?5RT@'8P,N!J_FNWG\A_X,NMYH#E1*K-X[K84![' MEKF.\NAM0Y#@6-^6U:)H4`:!R'9F*'-]7=6-MM*9<>%4O7`*5$^TUEZI)RVH M1IG@BS*IJ7G/_53C`8])8WJ,J3Z3T!.YJ":SZ"**;662#43S@C2QR:H/X<>K M;(2`SUDB_#%$=N]8]ZHA!.XJ`QF`Z;UC5=@JZU[$H&/F@CZ[L)[G=Y(U0$F$?.3>5JCX!S?\7F#Q?L M%KCT8J&$W6#2LZRB&7N8V"U[M)5!0M&AZL8];F1Q\&Q0+V$*#,AGQ9:^#;;. M"I#U3(`?'&$%'44W\YC6.#3&MD^X:!5U*,V12#Z;0A?9%.EVN=NF4]PQ_,8( MA*;HV:9J3XA-_08J)Q?_CH%M+RLI'964II>2@@G`)2?>D&MPH8*5S!?)%C&8 MG2W!;"S!N6G*/,.(9`;U.PHIBI,*>>?<4E# M5?=IJUHY06JO>C(5;>2@B``SG=K!>\<;,N^>&XE-UJX7T]%Z&FHEN%T_30H> M81$XDY^Q[G/"F5F$Y!@JK=A27`U5K77TKEMOIW>]S(1Y49%T+A5;*\_^UQ5X MM9=_MN)%9M#\*0J\GM;\9'<%7D-RV_O/1>_#5>WNZD-O='4)UW>C_WS-Q5Y? M$!FN+U5^CK\VA)1.GP,+ZBSB4$TC??YXB&G)'-Z9^:*KEWD0``XQ:8FTL6>O MN!@[GN<\L"^@EJ"SXBSJV4E#]:2367*9]AO@S)$Q!:OCX,CZ4@HOCLD8Y5VX>C/:#KW>/6X6:#$\IHQC!;)C$!X&)VWX(NAZHYY*8,QU;6O)-K7R M9-ET#!&H5*WZXX[,%C::ETVX9;_\[;+Y-K)W04V9BA&E1`G^,HV%+;QPS;G: MLG;E7[[JZ`5%8^4F?3JT^4JF];]REO\EOVTA3?WL41Z@RCF3#?W_V[OVY[9Q M)/VOL'(W-4F5Y(C4.YE-E>/84[[;V-[8F:G]Z8H6(9N[$JGA(X[WK[_N!DB" M("62DAU1,:9V9VR+`IJ-1C_P^+[Q8"A3ZQ8;K]VY>D1RLS;,@34UA]4=RPM^ M9[YTX>S<*UM<*X::(M_B08::%[%85I&._9#%LN-/?QQ?G)P:9Y=?C/.+/TZO M;SYCS#V_,"Y.\3_77[_0YQ]/+T[/SD48KKNNC!"JZGE$%(V(D<*CCY+,7$ZQC71_91<+3(X6"+QV3H1;J)(B.362VH#;^)-CU!'4*P'C MHY7L_',ZD#Q>9#+:=*0X!:;@]YGHTE1VO9`0OP2B]4F"R8QFQ3@*JW3*3S:T ME$N'-TX'*`D.T\_,#C^G9'HE=D_SR)8<2!-T$R&M$;&>T&/Y"V#\-DJ&JV4D M=!"@!`2>SG"E0>WBE[3C#+IUY6,E@<-&']#TS=2?3_ZS@8#AQL.+_*9BX(+# MQFN44!HDQ<8^+#.EY=@6,?IIO&*&HAVFA0@\STLS7J:]W+4E/K^3A5RJ9#UV MYX,!$FYZ>NJ6M$4V#.IZDIH2?$=R_1"O2=RZA.F**,2VP&*3+.)] M9HJ@J`#/W>'_102DK(,YH4PRM28;X=K&^P`K",+?B3@-^M^WKB?F_G4M+)7G M.VOF_1)2#PYI'[!NIEZZL`X#`GGZ,=U=3A8EZ?MI-B>1LYCHP0@A!?C%ZW8BVM3*#HRSOG]&[P;'Z6:QAPK]A)\V21++ADQD<9G MF:K.4G66VM8LM8#MP/=[B.HR*>02GC]\1C@IR9,E>$W\Z+(C$BP;HAS\@;-[ M.O82''"8(WX0=]M2%[1O#]2:U0[4Y MU1[%N70;%YGN?7#E@F3Y2OD+3/]'TBG=D^C@-PRP0KN#&:4RSSG##\OU M@Z/]F_0O!".`)`)+L#\Z$YC1+7A.0GR.:8-@+$>3I6,>6,A`Q1L'4,$=I4'. M35',T'O@,`@L*)P\HG1*SB#F)T,>(.Q>1O38NQ.:]CJC%CDAQ8N4IQH5DNJ] MW.:Z/PXI[2_9V=F(17*=W6JD224N?N&OV*,US76=Y]C"@4"$SY]\C) M[6N*1],&E&4.]<'"_J?$>B?@X?AN$@0OVY#N81K(]-T";[G_1:UT;U/9%]BT M1$A3<_%(([_(=M&(L4^P_R:%6"<]*6LC&OYBX3^$[_:N]N'^/5ZF=\82\&)U M$0X5^[XD?=7J`_6)183L''9Q(SA=GP47H.:H(4'^>AE=:JZ@O4DO$P1,=1M) MDL:7&/8>Q0>MJ224)*L/PYA?PA@S6G:]EW`ND74X,/UM[5W:**E_2* MN+`AX@OQ8"T<>#(M,L6JD55:TN=>&T^/&`ZNJ/%S%>)'#JA.8%PP4&$,!;;8 MRI!G27K.8T64G-0V[F7P(=S_J%GMF27EQIZL3E.EL00M$F%O"[;G6[924>)+ MVL%$U"XU%19TZM9-NG8ZA'.P*9?]%$P2H,->+)TN=]>BNVV MLJB4)+MR'H#EYNS?GO^P8,Y=BMB7A)YXU9T'OA?EMBMH,2U)#F&1W-IZF)5U"T<(OL0DKWY`4^F6;>_FDOG#20%2MC%]_ MS4YG[7T\^BTZSD%4%+C"\@WAB&0S_GR6Z;_T[B-W19"I_\MW:?N<2(D8)N$+ M^`WIB!8<+K=DLSO=V>;^&#JZD^Y&YJ;>>N](IXN2+7>:E_RD-]0<2?4@"KID M6P@7X!/XM_(319+5T'+1#$]!.$IAV#&6N*3(>15O]W\(+7K8_Y:10%:?XX7] M!;/#,@3F%S[12O8CR\V-1-6C#2/WSK46`!0&#"I,?=_Y'4 M:0M&P+$?ZQ<UQJVP^&".FE94-(P)B-A`C&9`/"()$2^B5A8E`_] M&3]PF([;WM7T?Y!/`SY<\Q;/%6*9D"(%/ M9T_.(([(F(O(/I$.HEF`L=H(BS90^!8V=*$`?/G>'+.VTA.QE>U`SE5%"WJ"'X]D,31GIG0+?\Y$3G.XC@<#_ M9-&QXY/S200;:&2QNEG`:^N-<7'ZIW%\+F_.)WX^K+Y07\?'+Z.06S M7)\):!2MG8?@?#_YYV?[<<\59(IN9633V[B.($38@1,:'WWXCWPL_.SX^J,, ME25X94N^;'Q=T4UGZ^"+XQZEJ@``!I<:,\H?H MWC@!X_&7#"G+^6*@N,*(Q(=8[RY8AY_88O=X+_9;RO".F^'^G<_<(M`_])F9D]AZ_M%RI`$*56+.,\CQ!'QJD=8+GFB.OG+@X4J,WI+!@#C)X0OP M%3S%+7LH?\W%\5DH*APHM/#@C9-=F$^]1G:GVL:[;3#<>"$.6IC1`1V\SC9/ M'3)QKY+5/MO:\99A^.=-`@0W<`:%C?$N#7(P@A2SS*%QQ2$4[&2(LSAZG0Y; M$M?,][_[.)F&XXH+!'&(984]$"1DPXG?@1A.^.5;V428N2\2ULX9F.7'O2-R9 M4`N5I1F22K(R-O?]"$_.2J$F+'FU@A.>P^,@%"$%U7#!^<=5!UQPAF6.*75* M7+R"!Y!EY><9T:/P4+/>*>373@_3*-:P%$V%@<%<+^_$=#-+"]=C[W*SN M'_7IGYXY'`S,R72X^EXE"?_X&R02-@KO^0%4P.*O#\R]NU?_2()D?Z-7A\+9 MY]D5?N`Q(_07+D2#N]O7O8Z!_WOS'J%/_.!=_H^J'BK(IW;Y6'ZPEF",>+?:11=RLZ=9[EO.':<%`Z1(%6-]P6(0SPB/\ M&#<0\Q.S-T(UZ20AC^.9TBE4?R7267@J,_65+^(Y@JBF6>*1\=$.^749D1OC MBRBD1CP:BV2=QI"O8]$%&7D5(Q>;Y:222]TP/)E$@^]=_ MZPI7'1_YOPN0\&,5M__Y%F[TY->3_\5,?HG;HN',+*&P)7SS\#.D+&RQL#WF MQ^`*>.'J9:OBHV8+TOWQ:*PPV6[L)R\7?[1$BG'3%6ISTNN9/6N2R:*V7;-G ME=RBXOU'XUX_1W!=I]NTLQ("X:K7-(>C',L';W%3+Y->LU<:]R8]:VA5=,&- M,=ES4)A+)F;C%X->K9'49VG[C61HMK4RS).GU.P_`&>WGL!ETGBCQ1R,)KUI M3HSR+M93[:@R-"8`,OO6:#(>E?/J5%'8I-TV8_(QA]/)Q)S6V&""&GK.<*WM M.@(W=WUO0RPXCJ$<"VA1+NE^DQOC7Y(E.+\X`QEZ!4[UC7UMDNO*#BX#SFA/ M!-97+*"OI_)54/LDSQ>$[!V!GULGX;I>JS7(^=-3Z38YP37:JU`;[R`O"(3< MI>]M'L=I5-W7KJ&R`2;*TT&Y M5+4&D.1-1;":^IQ!WYR,2GNGAFMVJW(@;O8Y^-+CNGU^H:N1Z`%QPY]4@J@- M+`@O@^/Y'%P5C%J(YZ5`3[A(=CD_X807U&(JHKK#7>4692O>408E>*7;,5>V MZYQ[XLE4T&'CL#$R3=,:2QI=TT4S.1KFH\/>L#?N#9]&",DD4GGJ9*;?0_>= MYR[^]BJ"X/W*>+MU9\V2T;'B]:H[4FT9SQUQX-WN3YVU^4Z[9 MN&V>-5W&$:UT$>ZHZ,?L;7Z-[1)LJ:>FZ3[$[>>0J"QC?*(T"A*-IS`%/$%\ MRO$IU'EB-O97XY$US"FDV'HC`9IY)4LM7*MZYXLZA5Z;IWW#X60R5A>+FG39 M+,/KC\>665B<6K,L,6<9:FEZ,"R[T?"9SF2U'77S??J()DFZAU/RX8"U* MAC\8C,:#+85*C97;[M_],,P$*;D$O=FU#72S4,YF5B])WJWH5JC;YZDUOJ\8GV_JJ$,&V=OYKC7+^FYU%K7 M]EHS6M"P2TG MYS7]4@U1MDG;NLJ@/YTTS5*UKCGI#9Y%CF;961?,8V0VEB,+VK@G(>Y&P57B MX0<*O7]MC;;+3P?@P"7T-D*DHQW_52WI-4\O*]ILM<8V'UG"=7J7FMSHD=F;/6/[, MJWI-K\(S=$>XLCI63QPT[5X"7JW\ZN6#QX+PWEU=9<"VJ?05QTNNXI(M?U/@ MBF[3,Q?94\6\!#,POV^`T6R;("&M!Y2*8.:?"T#G^?!L]\8YQ=_G%[? M('8E_&ACLWG(@XB7LK*GN!PVJZ(8PYO1"QFX)^A>B3\)(?)3Q`6 M`]$,KCB8'O(-JN#3'`FI*$VF?Q$I&/$#O#I,/83)$A!^Z]5!%BN!D$CX8*DE!=C0;88D@M`@20>% MUOPX()!(3IJ90R#)H8_E6E>(.NS%C*Z?A3AG`Q;Q2SRFQ@6XZBV3T5D(?@U=,0'2 M$`0,#D@V$(\N6Q#:6JIV@L!+@!SYVZ5#;R3'F&TT=SK02:,M@,\SIO")2TR!\G!N@L)E#D3W-YNS)+.GM"*@C9B.,CE3CWAK+^A+!0C%Y(/PGC%IQJ66 M3GC-&T1/""OD0':3T#WP7$JXC/5ODB8H]@IFVW=AL_\M&SD49WDK3^AW7G/O M@\0DJ;6#[XD#\@V)X&\VF'U.[!0.S%\X",HIRV`JM$._Y'*PE`Z"!I.&SZ_] MWM7"4>J8O>(<'%I>O=F0EJ6[LF)GXDZ3^#XXEF+/@BU=ZD:*&C'!42\8!`UC M?>$#G:_B*!=MC]>\)X7:SS8$7J-O)@*X\HYFFO$$.::/#3YK#WX+B^#9P@ZA M(C^)@]`/KGRRD+*ZEO_*,QZ\TA.N[!EH%9=*Z/<5PHJ+WY,7>'"=Z)[83=X; MMX0MUYTA& MT`J.X7=XR)[]^XX@>],'Y_1/Z5!%3IDR9L37V5P;S5YW\WM`IANQ+EH`P2X^ M!/8J?21ICH`>D[_Q7NM@/^ZD(O@&"`5*Z;]Z(G4E@RP489BKB"-)[FX_FU6\ MFYIJ>Q*NGCTC=^?\:WZ$;X/UW;WE;UK-P)$C6WN9LZK:FO6\J^.B#VMBI1G* MCYQ4;Y,@7AK2GW>"/4F4WMKUYO(=V1A0^AKVLU=;^9ABYG_D%=;./G7+M.TI M7:H\"/3M>MC3DCYW\LK5IF+^4L>_UE4A-_8V3IKMU5I+AR4#_>#+MA^D#O6MK@_6SQT-6I'?(BC]K3&K^NAPZF'DO/% M>)Q,.4ZKJR)=%;7/^>BJZ,""L=DQAR/XOUZO/,R,5+ME;8MML<5#5V,K'+*N MCG1UI*NC.BU_0K1V]S:FRZZ\0M)[1BT)P]KYZ.I(!V,=C'55U`IWK&U15T7: M$6OCUU713U\5G:<@,+HD:E4,WI?G67\7MG5NZ)#KH[VJ6&#]J7=RGW?M;1 M!-HQ'#^^)0MI7G\]VU39QRWG@QGB78?S1QXC['?ZTVEG.++VG#('.5>$SZ%K;\Y,X,!U\=/!I.>C&P0SN/H+/6[ED?4N(T')!^S9'A?16`9#> MH`;N+%W;`R3T0BKQCN'/# M8S,6AG;PV!&\&ISQ)-^%P'TOZ8)CI'OP!M!7O'((.-WUH.;2"-" M:MH.PWBYXHS,0:18PQXV,!S^([ET/!$U@X`E3 M'OD(PI@%'6,.!AF"&,S)TPO0LS:2"AJQ%[D+^""*D;>Y8\3PJ_L?.[E>]_G+ M><=PW)`XE8C2@O._K/P(WA>9B#C<_I'Q)Y-(+A+UEK&S<$E3FIJD\3Q/Q6NN MP3RU!G&8O,F^"F]TRS*Z)20C6*`RD``D;Q+VDN0OT)?(\/1<9O6)5.Y9PKIR MQSP6V(L%,M@0O8>@>4I8D/*L+.P[\@RE[Y(0]HA^?'`U+@*[%(:8\]]0#V'^ M43'&R,YDPXWMV,DC)%H6&K:5L:1E=';8(?V M:@7/$;(]GUJ)*:G$,7S4`\$SM6(!S0YD1D!BI0[RW`3$BP??;6S(I)A$*G@N M;\*",X,LQEZ$/O6(1`RA/W-)0\1_(+TU,D*PX%>5S9_HQ3Z,Q(?O:-B`S@)X?-;62S(5X(Y!TO M(6P\7L[7,!'>H&F44`L6Z5.?A5I0>" MYEQHR[S[J2:6YES0G`N:\V:T>M)5?IM#O6 MMM@66SQT-6I'?(BCIB]OOM1Z2',NM#8,:^>CJZ*?(!AKSH56!&7MEG5U=/"V M>.AJ;(5#UM61KHYT=52G9QL$,\:[#J3D76CRXFG.AE56AYEQHG3WKX*.#SV&` M;AS,X+:*I3Q&Q MIPHB]N"5$7LN_^7K]:=7AL-F[M)>A`A9_<&TP/+`\'Y[NU/W^3>XLA]IQ^[& M/Y[]%;L!R[XP7H;D70[Z'[SG,7?WL5!3'8\-MM.C&53D;-.CD7=];. MZSK^P!<+]7R$%P2=VFTV^Z;CJ)?*3CSQ4-O4V]9&7YCH" MMW&.G`K.IS@`B[PBY/[K>QNL%;PI?22]O`J3/Y;DXE^213N_.'OUH9^7K5Z/ MM:3\`^DC2H14/==XL_*&M03,=[:+%JV>ZK$FU5HT!S]8C59/=7F3C6H<]W96 MXU7`YBP(F$/?Y:]R&4=A9'N.Y"RMGNHLS6K]29)5="/Y.!(6IY"@PKE@X-+" M.$!XWX_,8W,W"K\P"AK.C?^1?6(+%S(CYAR'\+;'2`QR`P^'T-WQ7<`89W1) MWD+UOM.-^NWWI@.AXF>3C;^ZP]QWIU[D1H]?V!UZ>=N++NPERR177;CUZL,U MR$3L*=<1XY[/O_LL>LNZ)'_P!Z,,VQ M.>E/Y/:5%K(./OFSF!A#'E?2:ZB>W$)/VOT';U'^2K$A;LRGGO,)Z732%HMN M^P,B@7=[TVZ_EV\WUT+6P3%\YN#G9PM;LO@2>I(Y6`;C;>:^E+5U0A0PT9D; M0J;^3V8'!7E53PG-=KN]?K=O\H;7M:`.W9F[8,$)CKL?9`-G%C.S#]=@T/"L M`2'*#R@%.O$AXGJ/\CCFFBN8B;]<^EZ%BS!5YS6L=A&#OCD93@=FSJ(V=%:T MBDQ/9_"7S)6:JL/B=C',6X3R[77-<\-1.BAF=I0D``%*````5`!P`&UL550)``-H3F94:$YF5'5X"P`!!"4.```$.0$``.U=W7/; M-A)_OYG^#SSU]639<=NY9)KK*$IRHQG'UMCM3=\Z$`E9F%*`#J!LZ[\OP`^+ M'_@D90&)^Q+'Y.YB=_'#8K$$X)]_>=JDT0.D#!'\?G1Q=CZ*((Y)@O#]^]&. MC0&+$1I%+`,X`2G!\/UH#]GHE_]\]X^?_SD>SR@$&4RBY3Y:7$8?00:BNSW+ MX(9%C2_>C"\OSK@1(]Y_453T("4IO(6K M2/S\[7;>:)/M.&JX,FXYKF@;+_EZ&)HLTUA M]6Q-X8H_$Z1OSB]^.'][>2[:_[[&/#F>+HR0`PU_6)01KO MTAP9`K\-T?`I@SB!225<*-*C*_/6JO92$C?:2`4L"6WJ7Q^Z*\"6.0!YX+D' M8#L1=DU@FK'J26[I^/RBQ.'WY>,_IHS![!E)*5C"-`]?DI<9RH1I[9<3OZK/ M=I1"G&DM:-%(#7FF:=I3Z_HI;9H&:%Q)Y/_M]'LS*)04O,14V.*".10@:A":1\`AM%CQ#=K[/\O][Z]`J!)4I1QD>) MOF/5A*W>E1'Z@VPI\[3C>@LY9@?(*L3%GK)\C^W.BHV53IST*MA`<8;;9;%X(@\*ZDXB-D<8T M1]I&,Q379%L,`\\^,[BG9S*H<$B@&:!U0+`.`4$-^@67!;GC"^#J9E$-93YTI3N8&)=\S#2 M=VL"*GK_O6]=%K`RN6=E0"4[+)S<9&M(+2L$6MH6/A2T_K%AL\:U,=1]#:N0 M&A8>>)#?`I1\>MI"S`Q%1"UM=SZ5T8:"!TV8L+'2<8VI$&F!A*]E`6),)(>O M0V1-A#669F2S(=B8E*K(VE6<#IE_:-B!P6!@GURT*S*LKK\B^/Y72#?7)(/5 MYP%504)#VJY,2$G]P\"TW#9;Z+;@ELH+"P"Y;K6Y6,[!%&4CS^4V!FB-);2%LL%3_:+3+ M28[KOCXIS&`-NB@?AQ+P;F$J=J`N`,V';0H80RL$$_M`:"E!$R"-$OQ#U3UP MNKEE:$`UME9"\(XW*XJ"J>>NIVO5-%[1]%=@'/SMP^ M@4PI.2QTU,IO7Q"+89H"#,G.J>QI8%370)6,_N'C6!"U<\&@ZJBRB;``I[ MS2Z?AC_"%8J1*DK9,W92?C/CUP(J9R?T2]S-C92@^BD,4-5BJSX#5Q.JI[:` M\FGCMQRC?8X?`584RL?\667H1W?#S=;"'-+68?X(I06-#]"IX@3PPPH7PTSG$&*;=KBI.F ME&*P%GN!#WN#55L!/6C0&D8GUDB(O_ MY`'NA&HWPJ=,W;"V3E[#S(A:*4V[,M6D\8]4N=(DA.@HQVA#X3J*3JIH6.BL M]"^4?QY.ROE.2]V9FQ34_K&K"W/$U5XYVB1--#&G$!T6/JX))DU#RCU'R@J\ M@;Y3;U?2^UWLN!INQR1;!%F[P$N0-UK47AS9^D`1HU79J MIGR&F"8;A%&^FD(/!CQ93RCRC+T.MF?Z\0;&RBNR&H^WWT%:X1AHUP M3RL%<[@(9-_7L]VE?A\X2E?*HJV!6EHMD%#[Q[3E:L)D::_,7R+49NC[2]/% M_&>7HMEY01D`$%PR#K.U`](,J?#0@D6AHCZ74%`I\!!0KM`+"T=/-SN" M=?NF`JC(QRMO)7D>:,6]!PM*'A"WX\/^-P;YC/R57E"P@12)_CBD$#'Z$ MQ4\%Q/J(L+I51B7"/T![F4Q>*([)\>NB8@NM@U0+"]X*:XJ5X9%G(4>A=K.0 MM5!_IWS!/E]B?R:4*Q]#F.0+\2L"<.U4C<*5;LSM<\"6S/[CQ9$00P8ZSFFF MLU2N<1;94JENC/"ZI,ZW:-WD^VD6*<#Z%92>6':UC80X6$0.2+&L'//2N99* MB4"/P[]0'M%O)CI)'F&M6FC5E::E')SEEZ=R0[GV?FI'[FZIUH[;/YZ/'U7Z MN>ZEPXRU5J&=JY-[X#/"`,='3H<=A=JEP]9"_8^%%XKM_=QZDMANK5I89ZJ[ M@[F\<:NJ]MI?YV*%&_?NN\"[AE M?#9X;O*]&@AKW.4%M4U]PCJXIAQFYBN975AMHV]@ESB?,.:ZWOU\@D@KNS(Z MD*-QBE7!P?H>:T0%L]T2LM?XY"RVJ%W M]FJK&SJG>4+N3%K7N&@!5WHR-0@<-Z])M<:PG,V(WS;;Z\"NUEFGQVU;G:JB M?'3,RO]"XQ_U3V"U>[<.]T5PXV]6U9L989W8.E1,Z?K^8H+%K6L5C!S-F4XX MME13X+B_>E4US>*2`"^7@!],NN4#LOA"?+.JW0>V_PB7ZGO!W=@[5X7;LG]+ M4!_HO)>"N+M:5?TL?&A+1ZL%IK5\&C`K^+YU%-NXZY3P5>A3E=/"QVV>W&O_ MCI.!6H/1!O6WCDRU:TZ)QX86575LR.U!Y0OQC_@S\?S)7U!+`P04````"``$ M;FY%GQ(\KXL3``"3+@$`%0`<`'-U;F0M,C`Q-#`Y,S!?9&5F+GAM;%54"0`# M:$YF5&A.9E1U>`L``00E#@``!#D!``#M'5UOW#;R_8#[#WONZ]EK)^VU"9HK MUG9<&$ALPTY[O:="EFA;B%9T2$S3=WM'!X=[,Y*&-(K3^W=[.=\/>!C'>S.>!6D4)#0E[_96 MA._]].^__^W'?^SOGS`29"2:W:YF5Z]GIT$6S&Y6/"-+/CM/PW_.KN@S8>OG MY]?G-[.3@-W2=']?#D_B]/-;^<]MP,E,T)'RXK_O]AZR[/'M?/[\_'SPY98E M!Y3=SU\='KZ>;Z'W-N#R:92]#"@#?S=?/RR#QL#4<2IY#'=3)P#P;Q\$(3O( M.M'/KPO0HS=OWLR+IR^@/%(!BCF/YK]]_'`3/I!EL`..S<#[);IY_)87/WZ@ M89`5"C5*+Q\3,CVMP=&[K3D;W4KJ?I.TO-- M,=N\.U7B;Y)*7]B/R%V0)YE#&A5SNZ68+H,X[8?@S=0NZ"VFVE^2Y2UA+HFM MSNN`T@=!%`OS6[+_(@B']"IG+U.]);E.KYR:YR(:"Z?G&1/A]SXF_""DRWE! MMGRVG[+(3&L!^>KPZ-O#-Z\/"Z)V8YU1PDETU)J4]6!GM(1AD"S;"V8[W)V6 M'CO(9CW8G9YHVEXRZ\'.:'GN0,JS4TIXUL5ZL[J&1."/TU@NS3*!J,Q+OF0D MC<@+XY(&>Y\O<&VQ)32LH$AD6D"9,F`5P>HNX+=%Q!*)WWT0/,XE3W.29'S[ M2\'E_N'1)@_X9O/S[XLPI'F:\0N:$;Y(HP\T2/DU"4G\%-PF1'!+SF56N,6= M!+HB6$(N"H'6K$T- M.J)+/>8L?`@X6=PS4H31.H4&/[,I\*:=6K M;)%-P-6*4+.+%Q\KI9.:Q8&P->O2P+JT)%6QIVI&8!RD=HPI34:%H&PR\,2] MFH=ZW_C[*4D^!DRI9NWSC004SX=6IZT#4C-7&KTB,4EEZS&T57`G00*EQ:HX MNVX9:"^)LE(?+4DMNZ(3$B<0T`=+*WX_\C6Q@%)]YYE%0PQCY1:O/#3%3IM& MP,"&VS8"2>H0NT:<=8VS;_3/X#0%LY\9Y?PD9ZPH4.E36]Q(5:)K&CELGM2E MK&DO"&'8=9.0F MDP>+KH0RQ8/@7O/@F7*Q[H3!,[KFZ4 MYG$3,D=+(;@S1#3BA@G^`)O@C_.:U`7^ST,=C2O.D8Y68@O2>^CU>.-YO92V M>SY>F5#2`+YX5$"H^.CCK12J$MB4,L40KW[UM)VK4IA3S#&!=Q$W^2TG?^3" MM]\_B7\,IZT,T/6#A3IHG[@%:]Y&>#/'H]6^3;JB]FRJRUAJ/)63C\;Y)^(I M<10';'43R*+=34;#SP9?`>$5MJ.!'X_G'26RO'AY]XF))"(HTE/8<=`#ZU)` M#!S%E6!5T@ZL:[U*B;+B5WA48QQD.8L9S\XYSV5RIC_/`H"5C[4HP8;-Z2WD M3=',J=5OQ/1RK`7",(&P^C'X$B_S)9A<*F%J@:,&,_"Q)T7R1W'TZS/,-7C9 MW]7S3$#)]00`NML"@!JR+>=5)_S;1(AH.-%"ORU4H##D6$[.1?DG0$Q2U5J$ M\.1-(1Y,4HRZFD,KL34G4XC)OQ)ZC:U&00Z.2\WZ'1B;/NCN(/9S:\Y(+!"3 ML(5N'0XH*,%5[.;Y!,_OL_6X/=*>K!MO@P2=V72\0\*=J>M]C^3?@1FK0JS^ M=&;_I5C(6+"U6)P5M*_&^J=>9_5)??@8ND)IBAI=2Y3X4.&^2.G2@#0UE!LB MEKW(7$2!X,I5%#6<]V44!'M=ZR@@B@G$CH^">V,A1053+Z148?PJI`#T6Q52 ME/-,0,FU(`4J&X2%EX61XH(Q`NL7!(N0H,,"+`;3,Y03NES2M`A\-P\!(UQR M%++X44I#?U,?,ZAQ9Q\>-*H-@3M?*W9;[X&16'H]K*I)+BYR*4BQ/I8ITIX> MM!E23CF,0_RSD!:L6MN'%8Z&=?QK,A'GED3'>?9+&HO,:G>("QEYU(.1$:@^ MV#\[Z\2^\XBDP=:PO3?]1Z9?@R07V?H%D9=(3E:.=P\%9MMIN5@5/A2,OEO+$KR;$8H;4`BL\Q#_S;,%JZR"*PM'<*`Q0,MIX MQ#61,HW3>[1K+'B;,-H+'D5$=8S'/^L=2JB=XFP_A.W\).?B+UKDP4%2O@GJ MP36"30/HL6+^!R)[CS`F2UI+S-L!\X!:O(<&C+;4K8G:F@P'2UX@K)+9!NRP M<0&A(FK'GM*[]6C*2QH\?6,M._3P4,?E(Q'.*\)3P4M4A!W>B+8UJ\$-JIF/ M:9`'K::5).+Z2IN':IM(0T.'./N"U*:R3S2:;:67P9C5K:`1&!$G]SP_)Z,* M/\#-"1,X8M52W9L8XHVVD?1&-$^>\YB*-K@4'0?+^RZ/0A"[5!&&5IM.`'3:HVZ>5&!8[YI$P MBC'.JU4I^BA2T8=DM6DKH5_?8?CF&J^#]]4D;%EM:19X-+:]UD:MNQ6?.O.C M12&T>P8@P::#RKWQD&&;IO<984M)E6EG!H#6@[82=(PL$M(+M>)-Z9:*Z2LA M&IIV$C6U.@=P9@@"&VQDO)/HH)8`(['8KRLP0'8RO08954CW6:J9#LM9QHV M#S*IDKJ4"R(&*W*B;I@GX'PW),P9B:0@X$/A.KAZ/;\)-W`1#8Z'%,\2*APK MCH!KIYV`.3A8L_65G$%7;:B*TVG11E9O'"_;0VS!-<&.LG57T5J4NPKBZ#P] M"?B#S5J&G@RSG"$FF]:*9BL=IXL:'OD$:HI%]]*K8"6W544STLW?\#D0Y"C5 M=T*@4;ZN@';LMEP/L4C:&E4_IP$0GHROW]BZ*69F1"7.\[?[5>[*K?A16S_5 M`'#W5QW@W<)@S:4;JU(B:!B7?]6E*A=G00B?8C>!@Y93!I^(W6@Y=&,UBNDG M<-6LRH/LF"^,G@4)RF::X*#-E,$G8C-:#MW8C&+ZALWX]T&"[?<^-EG+YFME MBS2ZH&D(?GC.8J3F6RS@2&^-RI[OMO9E@ZEA:H8/#[CY(G.9A<52_!L5F9Q( MF.OU;?R`ZC>;P0'>V8@UEZUVN#@$8]Q//TKP?S4 MN9FC5IJ&IFV66P]'4?`BBN+UO23M9PG;##48@GKH9(P#P;DK@P%1*8S(Z:MV MC!D)LF):[X!@`M.:QQ9L`J:@Y*B[VFO3*NYM'[P:6L>;SE)7+`[-P4$%K-5W M%7@"6@>XZZY[Y>1-"W#Y"=&_6E7X\0C2H,/:/&_0@;3<>[ M.[UX#EAD.-RHA*GMZ&LPXQWWD,TFCN71E1.ZE*>^@[6WO=P@X,>K'Y M)DGQ5?*`9:M2BUCHLXWF$?6NV]`(WS@'0P)J#([[\9P4HT#:CF=U*UH]ODKG M,:[MGE&V).Q4)"JA&`)\SPN`JWS02PDW<+]AE+0IGC,;U=<_Y`7-/H$8 M:EQ#=$M((X&WS4#0$]OF&XB)IR?N]0::_RP`,WZ^J:+\S"AW+G\S)E<*@3`- MW.G+G;':)(R=5:"^#-^9&:LDLP,34XB/+YT%VF?;N.X]CN;7MOCI//^XS21< MB8?B:@>&-A,=J2D[F)J*J?3XZ$$M^$W:<$K"T-14F8?W0B=>@])_(FE"52C@ M=LPH12C+S7A+/RQAW-]\O'Q.Z M(J3X.,=ZVROVN?GC90I\^P\]J%Q]10SRS.:[K/VTI:C:67(+2E^JP'@*_;IH MUU/(ZJFF,42$FB5\BXO:CR04J9D\#7X$Y2"](E3E(#TA]"P> MM\]!AE#(4#E(O[PT7?[@A^\'.-.J6X7`7LWH09@\9+3NS:/F(58-H$?)0Q`] MI`?XI:WR-D0,S]5A'5F#US M21_*B0@53:^N"#+5:Z<-R\3IC.;`D4[\*$S:5![EF2/TF35IA>5/TJ0@<0+M M8)SZ['7,/Y^)U'';DV*H-0K"V^<*I<;KF5N.OSXAU#.UU0ED:0(=?5J7W\2R M'+,"6'DCO[?Y796*F_-_->[:@[A]+@1K2>^UR]'([E?\\ZL(.'%Z?QW?/V1< MVT]E$%RNW!+&]:=V40LU^.RN*#9Z;4W'(X51>.N MB?GH(DUETQX>L-6`G@IB[C!DQP@+:@:IHVGVB_)B&]3^/_D>A2+*HWA#W%(=&W!^XZ5R,7 M;#77E"W6I1@'R=NZD&G=%W2$@/MR`F'-@9KG"YH^K=<;*2G^B69!4GY^0GEV M0;/_DFPGEO*!.TW\'A1W;3D8"/>4?75,-0VP6`W+5C,6^)=\]2:1=5P\HVSS MDX33O;`8AXBAHH.&B+_"1$?%33E>P/PU`X?AX-^HS<6?1^PM?I($G%_>_2>0 M"LXN65$R:YAL+=S@!M7"@VG0:!%<21C4J\X\`,.Z^VYRVNOM2'W1%BPJ8PB, MKQP?$'@0'>`\OSBN9!+HSFV$QYC7R)VYE32!K:`0(S!\C]>3VZPVDX/A^W%K M<1F=:WKM[3?T@]],5\+4S*4&,VSZB-$%Q?&#-XCF=]#5\_K=9!.Q1I@<"]LS M4X_*Z%=.NI9.-4!K._6-$**!/GVN(C2N1U]_,7J`7EY*NM9OQUY^Y8L\>Z!, M;L?$1NR<\UQN?SOON+5# M^^8X;BP2V[_&OTO*'3M\=&S4X6N_#3=6V;8E1C>;M.M:X?+NK2:[$BG?DZ#A M*@G"XG79>?$FOGBGK[T&A!U3SL/,8WPUHC8L=\G8T*BL+X>.^P'U+#IJ<Q7?6^'@-:.5VL`QWO9']^R^,H#MCJ)BB:L4L*@3?' M1OCZ^7X]_)!O>E"*HO9L5OP00E(YCV^9;`##L/J^(2%-([/"(;C*XJF$\U[E"/:Z MZAQ$85+Z*[=*;RQ_C9P7SIV:*3*8/WWPX'AG0964/HE.<_;29:4XBLPOR'/Q M2)M060VN+XS(P<,X"5JCM"/[F*Q+N6.VQ&9RG6]'38V">MULUKA^3'N'G=6^L\Y MC[:W@DXZ.]YNL+9YG?YCVQ#(W[Y/U!+`P04````"``$;FY% MVGJ0Y'2>``#I-@P`%0`<`'-U;F0M,C`Q-#`Y,S!?;&%B+GAM;%54"0`#:$YF M5&A.9E1U>`L``00E#@``!#D!``#MO6USXSB6+OA](_8_8.O>B.Z*=795.F\\`$%)'[HK M+0$XA^+S/.<<``3_Y7]^7Z_0*\[R.$W^]8?W?_KY!X231;J,DZ=__6&3OXOR M11S_@/(B2I;1*DWPO_[PAO,?_N?L__P__N7_>O?N/,-1@9?HX0W=?$`?HR)" M=V]Y@=__/33MV_?_O3](5O]*?CK]^>\3IZUS"0QW_)V8>? MTT54L)]3>1U(V(+^]:YN]HY^].[]Z;L/[__T/5_^0'X]A,K?+TM7^!8_(OK? M7V\OA3;__!-M\5."G^C]^AP]X!7QF0U1O+V0NYK'ZY<5KC][SO`C?ZQ5EK6& MHK[]F?KV_O^AOOVWMH6?!KMZGQ;1RKV_33--IU?TH\_D7RWC^'N!DR5>UN:I M`NV$%*ZK#'^>D6_WOV`XJ5&M]GN0_25 M?HS8Y__Y+S_MKJ[_B\RS]MV.LD7M+_FGXAJK%C\M4B(V+\6[UN4^9NE:ZTZF M^K]Y]1,R1J"_('$'5*1(/:@CA/S]O0E&"A+F\&<+H#`S-E`A'6>75[]=W-U_ MN;BZ1Y=7Z.J"_N?NU]OYU?D%.KNXNOAT>7^W#\C9W0M0[-!A?X*1S26.J6;^ M$_T'%CO#IO,["RIB_-$-;C&5K*G?9*$4F=QFC\)SOLDR M:C7.%]'J;SC*+I(EJ:6Z^-%IVI`C<=/!^%5Y,5RD)!;D8!9VG%7?H/(K1+]# MY$M:M>+Q,:Z\L:G)#>#@7M2E38$10`.N?U)#=NBAJG@(^)$JYS`$`>CI8Y0_ ML!]FD[][BJ*74E3QJLCK3[KJ6GW\]_FW*%O>$ROS[W'>0:BT3?4S"-H,XH34 M[C`%%0TM!C^_QXS]B>C?Z"O]9.0:5WZK4JU?M@-L;ML=HO5NO*O$X&.ZV-!\ MY`9G<;H49P72=HV40-!NL+1+[0]/!D3#R[6ZC^YVX8. M#?4SQ8=W_3LGZ686K2Z3)?[^[UB<[@G:]12PUPX([P+[4!K8'UX'Z-U>-XX("J\W!=NG&2>\W0OZG?IR*>T$Q0\-S\"$5&Y+BS"R(;;< M88T0:W6"RG:HT3`8*NF@@LFL!W7Z[M8#FTC_[ M;GR^J.XH=SU`?OMYZP&='OP5`6]8<;9\Q+-C!9K6$M*>PD9K(>G+9"^6RU!28%QP]H"6V;,.%#LV>/#]7*:I",X-U="2?$8!!SHM%'Q@I/ MV'$LJ5U+EB#BR>I^PLA`7,V!-(+`TKU3$DUM?LV1T?)K,/0WK<&)936J'K19 MXQV6Z9_A@+=U-[AXY=PO'D#9SD$N)AW<46<2MAU<_]:VA&J*-U=+?^2W=]P= MOXM%NB%%>O)TDZ[B18SS^0-=P5H4'2SI=^CN!99T@-D8K/0(:)>PS([&EF%Q M]]G=KU^^S&__AJX_H;O+7ZXN/UV>SZ_NT?S\_/K7J_O+JU_0S?7GR_/+BSOT MM>X5RAYC-1[Z&XYU,5232=V1LQ59'W?>Z99?I07./Z=1DL^3Y:D``7J`O5D,+%0B&1OXUZB9ZHQY5#RHIU(??6*`KW<:@BL'W!"#551K2IWJG MZZS^'%5?A$5?P;T5$E.*!1'EVIW$9/*(';-"23^2<*S80H<]AMX!SPFJOMPG M%`GK+!@@1@;WE?9%K'.(*9P.N.3IFCX\I:F99!A% M&F8"<*\*D&WP\G,<@:%+ M)T4;C*]Q$[7E,J9'ED:KFRA>7B;GT4M<1*O&]C:17FMW[`JW1D<8PFE[""GE M.D8U.*@>9K9K@V@C=)F@JMF[`#R;WRG.`N$'+JHZ;/4E/$]OZ-BR!A1/QB_W%%*V$JT-JI'%^']ORN.6\_OT M%M/?-5[A*UQ<)HMTC3^G.?G\/,J?;[+T-5[BY=G;KSDFSE^_X"RB.Q#FBR)^ M966,:G>-0U.],.#"%!#WW?T*4`'(B8%2/3]]9\D=J@L3+']'6"MJ9"6_+DDN2<233.:7[:@MODB?5!R4@CC(/ M1XZ.HR1ESM/2DFRK)>2/!54.2D:4;H4BVH[REZ,\0$-U[P1BW$0PSW$A7(9O M?=E-MJHO8=2M90DHH:G'U!".LNFL_&\@G&W_^'V6\6Y.CQ6L$0?'\#?/,)CT M7^XEOH>Z\E\WGK%W>J'IW4VURDGO9P!*4JUIJ6I"65NNSO3:`B)7X`>D"O5- MZ,*YV[/2J.VB:WBEB/3>"H`OAP*?!9T^(E)X1(Z;?%IHR1)"S3=:A">1PX"C M*:!VT`E`7K5T54M0G?#!1D*-:&`AH`WEO+N[&/N->XH[)4"YD2ZJ4.WTSH,O M4O='-[WQK((O\Z8P8Z4I"C1%3A<'`:C?-=Z5.I7/"%K28,S`I9!1`"4+2=O&J5L.+FBHS/27$C M]L9-!FA1Y7(Z?TX5&GT= M,E_@I_/*K&_7EN?=D:99F8GPHDEO.=ST6-T90Y?.(Z+53V7&,PH$5D5E%I$X M535'K/WA(-@R,L%@F!.+7*+XU`3%+RQZWA515@!I+[,/!>C3&M`%.L-/<9)0 M[*:/565Q0/@]'1._IU[Q^\$+VPYBX_3!F#;"* M\OSZ\:_$H2@IKK/;^.FYD"UQBNJOP!RI$D9C1H*.P]8U]1RE5? MHC1#[.NP5C:5=[W/.TV@])@FZL=AUUC8+=[Z,AWW<,=R=H^.93PK2%+?E7]9?PJFX3,L`X"]#C&A8T6 MQ\J>FBSSA35_DMZP-PAT"EG?:]C9B;L%\,(3^(OO.%O$.;[)X@7>?IE7W^;O M3:1?=RR=H*`>RQV%=:_#-;4U_+"DO'+D6=T"O=`F5!.^58T"E@!M`.J)@R&> MM41#-::FG!C38V29N=JL'W!V_7B'%YNL?*U"M%K1@[>ZKIL(COFH.M)C,JH[ M$3*_-H=YK9$SEIID8$.^:VR1+0M`) MI!,!T,^N,AF1@.%5.)\5;['4ZZ23.'P&?F.EGF<.P_YGH[=3*H:0S2Y\#NWM MDYJ@T*.["$Q:7/XL?K]D`"#T%^G:)H>B43';=2!XM(LNUH@,+S;C&@\O6B1C'34)Y@=C_J1^ M9VX(V!02O[]PLU-U8\"-?#;">AV7)_S3#5%I0@_MQ\F"5"8?XWRQ2O--AA5G MV%B-T3M-P6@,H&,6+/R&.G_!S+3.P0PF(\[.K[]\N;S_"SJ^O[B^O M?KFX.K^\N$/SJX_H\\4O\\_HR_S^_N+V+KAC=.P`QSGIP1ZW/2DP&8MW-L00 M^`TGB+2C57#9 MLGP@DCZ?@UCC<.BN"QDNQ\WPQJ.U8@0^EX,!J[/HI6,7!+4L3K5P^T)P^\K0 M^D+0FA\.6K7"D`N\AA)PI.=&")J)0PGH\_4"ZVY89W#&0[=3ATO1IGA.L_B_ M2`#XYY]_/OFY_%])JKQ)M?_^\Y]^_OG]_T#_].'D_?_[SR=__J?WK(`B?_[\ MOORS[,,V=Y#1Z)?IIL@+\@^2RYP@\MT+IN_2Q*NWX.BJ>M13CBT)#46/;_I! M(?B!#KSQS4'8EW3V\0FZ9-B9.CI,9%H3'Z$(<+FAJ[Q-:AWFM1;+<;LU-!]X MOK@1YXXE(WJT^G8XTM+7X#C"O=%+LY>4-O[0Y%!D>V:LP=27W+LJ MQ`>JN8/P9*+`5H@*2X_GVR1.5Y/[/52ZW.SAADU]GQSQJ67(@E&-_EQ.H5V# M0&G%N?UJ:@DQHR37KJ<&P7P"S?7L"-?>(,3U=;Q*"Z(]QYRYI%NB+BQIO]L\ MY(LL?L#+LTWQ:Q(;9=[2SBK!%W1V0TFIIX["@,BF!3_Y0_&#PZXM>M@4J&X= M*&OE$%(36`>"2B9S!]$@]?@0-@LPKSA[2*U"C-@X%)K9XUSE%R]%G"8YRO`" MQZ]T_U\=A`X)P^;Q"!3%044IKH,#59%?8^F(%5:7J#""`2HE,AE;KT\1HY7JVSM@7MZP2 MS/N)LM`3U([QNX&.W%/A*7CV!94SY->[Q6'=>I;3157%MKJX2?PY7KF<36J; MLTCOFP/PYY(:Z_9ATIZ+!'4B+\:/,GEO=-5(V?VBSOD"5-?6,-")EZ*N]Q]W MYF6C-?+"DOM63#*UI>^92]KL&[>=UJB%DY=9K0"]'T<.$ M]BP.%TNZV`"/<>'KD9HQ?P M#)[T;A@=C,A3\23W7N-0^78=6!SVWZ?C,S,A/W)29!%UY3;.?S_/\#(NZ+^$ M:8FR1R\GD?0`8J#2)Z@X(#.D0SAQ_UGK2T0_.T'E]]4?P;]+6P,:'"[JXJE/ M0V%/'@='!*&CG35R>X/06&8CC:_9:3$--+)'&KY$_SO-T/F&9,UKXO1^HE`C M+8'!X<@E:I(365DROSJOD!='`F67?BB0=(&BH=(KL&`@LZ3%/_$`L]:WDQ!_ M-1IXO-/%$(=VPJYHI`>,+H<$O?KTT4726+R1G90J:2GE"^2YE1(?7/!$_S147K_9W>(9 M+SK]-- M(CIO4M5$Z7OC@C4M*Z;4:73NQI<31+]$Y;$>2,TVV/\=2W'MV M=7U_<8=NYG^;GWV^V"\4:6GP$!R-KL"-=)W4.'H59*.AO(!D#5W4CPT/G)2/ MY?C&U2/MUD]^Z*RI$6C&K"D27^/"0UV[-V`!EF\L6>P(/ MPWQ5%R`!*>1YNEI%Y'9%*RV=[#>7JF6SN0-.]+UQQHN6*5-N-#K/=O\.D2"< M^ZN@B1`1/]Q=5AA)L@ZN`Y/@R(1[AO+@E MGI7GX][@C.YJB9[TED)T!I!*MGP`!P34\=@%(15V30DJ':Y/V+HYHNU/ZK/1 M=UU"I+$6MA3$-L"GG.BR@534#PKC'I)ZI7E(L-/XM$5W1KX[1"@;1BU78`XH MLGV)"OH>[[>/Q$.M2,;K((U<[0X.6,SSR$5DZM@Q)6>K>S_RU%^CCX%RDWOC M%5R4@$7.O&9'%=.\`LQ#6.B9&X(T*OM;:"WW%%J&LFX+KI%E.XM?(_K^A*9+ MXLV+TM8]P1:T!B*3U!<"LTV: M5VGQ-US,E^E+(3RC=]!8/=6V&@N(C`.N`TKQ[5S0X:_-R+-&-[J;EW1$NYZH MW161ON@-%ZCJ'>3VF"%0Y4C'<.3W9<5B3)[H3(Q(CF*>K2>.&,66K2_^BN;G MY]>_LG?3HIO;ZROR[_,+]L[:(T_Z@`B0*>,&[^U&J.O'\W3]@I.\?!`9TU6F MY7F:%SD[HN(LRO'R)GIC_BNWB,*,V@WH0T>%4228:P,*\H.=T1"G@39FC5VN M[)'1W1"H&@.Q0:J3[MX]T'%0/5"(H1\(WGUQ`^5-3^2&C(EQZM M_"G7190EI&++Z[>[$W&-%_-D^3%>;8CC"HDR[-W1(NW>(*)CZ"M@?J1O6:TE MNF/-V!?LF++JJ[^$(1>FD.GI@AWFN@*@.4J?Z4&"%GI;M(E9,,S2#+UN2G=9 ME@7R">HA.;@0Z`O3RJ3<-:I'3;(5/MJ%*+O0Y(?=7CD-P61-_DZ"M-9D'491 M8VKZ@:*3>2,=FX,Q2:/*YS1O('*_X3Z`5_4HL\MDD:XQ^B,- M$C\RC-;O(0DW6$#!T3A8#`7DN,%B_;)*WS"^P]EKO,"[Q83FC-U5FKSBG-8\ MWZ)LF=^G1;1J?D^G\LH=#;=XD3XE\7^QAWGB=/DIS:J/:+OWHM@SBA/=4.;9 M"1@5&N67`PJTOGW7D$:_+LUJ>Z@RV-K_T!SS!&VMHM+L27L?!36ZW3.YLWN" M2LOH,@$I=5^\4(;,L7,Z;E*[-.T#<K7M*[UOVPX[FO%^I\"3^8[+(X:LEB>`J3LO:V>V MT'5(;WCU2UY_$4NB'=["5-,'C]%IJM(UK?R[YWD@&C8@VSXJDG^H'Z`FC9LH M_V,3%V^7>;Z)"!+KN7OI:VMTNG334FD7&$G6\`I21^7F-,1/-L"L6H@JY2@F MC6BZ]))5A3[*`UJ@TD%#7U7T,=23`DE7#H/'11[X]DR5K6'`*T^O?<6K](5N M4Z<'7SYA=)$07V),,OJR+ZH[G^P6]H-ZUQ(\)M4!"@R5HX:#3U&<_1:M-GA. M?%N7\>GB^PM>D/#V6TK2I'A%'+\5GQ)H/D`G5)@,`$)?ARWAF>7[_H#]=D?,,2=U)R&YB&Q3@/: M[I-#Q+$RD# M+#B_3BZ^TS,8-W'^3&=OKQ_I&?:"(*'=KQ,E-/J!\%3;/\`XH6-3357U*#/: M!*4):G]+3PVDWX=!47V`]#AJBJTN197]^QP-!I::\>//)3`3_$1W'@!`4S.. MZ(QS\/!4QA`7`.5$$5<0/85-:O;IYCJH7#%?U?`/BJ=*8!D<58\RJ M!NS0EW835+4)A)F:J.CST@A./4[*>W,8&0(.G4RKZM@<#$B6SB@A&8 M5.)DMZ MX^DS(4F>KN(EVU"];9G3M.SZ!6=1N=$VM&/\5"CH,4X/-EV>"7KU^:6+,]^L MHJGA)_++D;M,Y1R%]P7 M7#RGY!NZAYIA1_)`T!%\?J;0:J4+\=UE<^//YUSB:A2H9W%IHP^ M,)OUKMQR)-08BK[(G@W%'*(K`41&TFP9)U'VABZ)N.3LN3VBD`6Y,2LZ?.UN M2,+LE_0"L1]#>?@!Q(LGHJ!TE#^NQX8E$GU&2%TB^?8_*!W<'M]9CMB2LJ,X MC8OQ`Y>G`.I;XG]5;)^16OPQEM>WPM;<#)?3&E".A;Y`9HX\([KJUN\[VVE/ M/66$_EA]^6-(6B2^SP+=4`&#S_!>+Q$;/2/)R3RES)8UI!K'CU)0W63I:YS' MH9Q8!P4FS8!A#Z@N!H)5(>.M6L#1IVW9!CJT%`TI4?6HB%*%E M=OV;)@8^]^X*X5ZVEL#<)0R@MSCRAC=&05L0<8[HA],&@[[Z:<(A#+73.VA? MU5RD?VZ.,5=Y`TP$F\/TA9T;M`C_]'SE;1>3QNR\?%$W"8G\0LMM+FIW)KZD M>TM\]PU+^DILC::QM3G#48X_XO*_E\E\L:!G29"P\18]K$1;H[3[]=5:U0^* M6WK^P5),:5.+:8I19O4'J/HD&-)I0H+'/B,T<4@H[\]E8QA`=)!3:Q@$P&$E M_>Q+],>ZV8\H3M#A`50G3H!#-+S(D6WP\G,![66^7XTJ)K9PA-QHZ'3B^AA6<3!ISR`,-0 MVVA]*,"UBS0@T`TLWEP7SSBC>Y`V64:W.N8YEFT!-.FMC#J"WHZH+?45]&E! M?=LV'.>/-9LO7^EAANP=3,V%>D+T*UR0C_)-QAI4:S?!WP07N#XE59X M1/Y,:RCI(+K5E&`0MYFKU'/'44[APH"$EC_DMN[:'C)73@^'J@-:X-+/9W5` MJIW7<@.IT/J9OTWHRICN4?"9FVWH*$S$B#.G.P\@QJ#D)TQE$>PYF3`P[.EO/ MP#@4G,M05<^13W2*'!C'MM.)0$@>.525D;..2L&4O"'%:`K%5Z`-H M8<.SHL/`?K]9H!-TXGO)(9'JQO?YTNO!(X='E,`7&'P35B`I-;D%DY,RO=@/ MM&CHJQU>@E#.JN8XK]:'DN5NL4BAI!H]!" M.D55=,^$O-`[);736HQWIRAP5F[VK1@#HI6L[`4DM-,375`$D994:5)=:NH5 M==W6\L)NU]I%VM[UQ5V!U[!DG+]O^W8S>'I`_)0F6N0X4*7Y`N`H$OWMW*DJ MV?>#-,=%8LN,-=#XQ6+][7ZAR;1P-,93$$HM/<*EWT18$@*>VM&WZD!]#8YM M:738@C\LJ*O.YQ#>1W$5QC^7P^G==J6`1J>SM+HT2_5PCF4QO>?:0J:^ZT%( MUFYSET*X^@T%\M5L"`KKO@<.I*QE1!_CC6[;[4UQC?[A=.5*\BL\3)F"\;:SS".%^MV$)7\R/56V5,.O>"L5YG(`J9>`I% M*DV;.C33&FIV>?7;Q=W]EXNK>W1YA:XNZ'_N?KV=7YU?H+.+JXM/E_=W`;Z5 MQ@A%'*):H+!/79U!>'2V0K$_@G].DR>B.&OZ6L-[8FS^/19M!I4U[9"7WQ2$ MJC(O8(@IL*"F(;?CC'[ZCG[,WLAY@N@WA&3DNT`()KVO/3IIH*!+'EZ7/E6T M,#,>,3ZFZRA.-*G1;JP@1]W8"3W:GK@AR-:&.46JK@*2E-\&2I/./582A8L) M%57*3FJR"##DD2YT3^D\6=Z2N!:MY'L&*S`\@J@A,:#"%VW.V M6U=@#?(31!N$M?@MO[]]HFC`H<<37A\.37RCQ\EYMV)+EC"BDS8,-GC?8*.< MJQD"G%&GNTN/LHS<;O8V3'5.HNS`E5I^!T#&R#R"%%V!'5W*<+O/V'>H\668 MJ8KZU@OHI`$7/J-X'46TTH*8;V8]9;A\2>\7O'X0/G@B;E@!9MRD8^?./%G>%>GB]^=TM229;/ER8[5\2KN)Q530#9H[4N_`A59DS8A. M_$&:(HRB9(G*SX/CE1P.,I;I`$G".&YW*?_&A*!K,1<;'8[%G=!W,=EL^X<# M0:A)5`#":#`1(\\W:[Q\KQ$D.BTE<6';$IR''1_@U7]GP(QD=;^6QE>?AD>? M[JV4,H9_WV44J7K(6>$<)&YF_@1VK-#R]PY>HO)S5#QGZ>;IF?P7HS7.GD(Y MH&8HA(QTU@1$H:BI\D@::5NQHH(?.R/U`UQ5#8^6X?=L3V'LO@B.&CJGR.C@ M0$(.V4DQWF'C.@_N6++$3R/CI?OQ[NE^O)`G-ZQ19"*RQC@*16CK\X_D#VFH M.RAGBH$?QE![Y"97Z1NSF1[E!]5,4VC!13Q:*GY88$5K03YLK+`U! M5B\N*1#[Y;#>MTTX.2.( MZO^04P,)%O2*.?-$M-]7L[3SB3S74[,"BP,AR)+3-'E"$YH\&(@[N\D$2^2% MHOK%;;"0#R;8=1%RV-!#D/$RMWDPD0YCON@] M$HJ=+P0JC?+^\N+.S2_^HCN[J_/__W?KC]_O+B]^P.Z^(]? M+^__=FB8'KR%8SBJ1PY?C_@.%^32Z3;N\S1A+N4WZ2I>B'<`:O3I!2II'R!> M:_@%2F6Y/1WVRD:8T:]1OOT>+>H&H;!4!P<<:NK#I\]&25\>!4=&'?P4NLK8 M0-"5$^D$=KL6:-OD!%4_]-?JO_?X>X'.B#S]'DPR!`])C1`!!\H0@\'N=*XO MN'A.EU<;^L#<]>.VP9>HV&1Q\G29_`U'V?VWU"QPV(^O%V1LQGE;[P@8Z+R,!!2]<`>>0Z34-V_*T/4BI/@$O5%"%T="#T'?A"D]A=SI M)L/K>+/.[],S3%\7,'\DT*;^?XI?A6?#`0YMES$IAO:II%I7Z35/4GD$)IMR M0X;943T8Y>,#9F_O0!$=L$R+Z)"3DE$]]-LJJ`FW+*53:L):-:?"7$>O5`1S MS0^):=K3(>8+:7-"G^C),*/GD92F@)H<+:>0QZBR,>+2P'3&Q(*;>:#20DAE M8O.:@YH+JASS5B$R>V[F@^C0DQ)9(Z*X*B$Y;'140E)+SHK(,"D?\MS0UC^O MW!\R/W0D^'`<3ISB>Y!A#9\O,C#@)+_R7X$:7'%(V17T/)*..2>YU>0FE4PH MXDAXX2:8-`RY$MT@J1YP5@4_[:1GT#:G>CP2>R`$)TWM*:13W1DWH+U*RF%A M%MQ&VK:@O+I1%]J<[$,2&P%88)OJIB,URJ'F\(&W&`F'!YNY#XV982VD.=I` M)#/#7T";Y-:@$6CG:MG,(?&FFWU\(G+@(OUHC@N9?Y3CCB]SS>L+(`.IW'&L M;LP*8`Y"Q]L#-6QA'58..30"54,Z/K`R"K/11Z/]#/"T(0( M.(6$1#*K9B@W!J/D&Q""K34[@YAFJT M,[W+9J8GE)._'&4`$IA[)0132.L^10O\6[3:#-P#WAO&+B5K#.-30WO>@Y[- M;^P"F/;M!IW1?Z)7^F^J;9MDB;/5&YW%>J''A;$CS=D%34K.^JBS%2L1?BV% M:#NV!N*AA[%!V27N>(TB3R M"UZM^):T\MUIGH6CB?'!\J9#H:&*Q[4Q7`:#9^C8V;78*4\$'9*'-[9@3/F@ MN5%Y#)[+^V3R%.;5SJ,LH_%FODXWR<`54?Y8=EE,=RR?FLB_#O]92L\/,-'K MC#QKZ!C;+5809/@V)JB`_;.3@;4FY(]NC_D8:F0)H4 M$:>9H\`^:J<_/E3&,N[#,OK7.W+^XO(Q.@UK,-G,Q)^9,R`'G*JZ>4).;0=0 M84.G>&B)C]OGW[3L2=*@-)EZ$C0":]VE1!YY.X4$J;='NW/4Y.#CD@P,N#GR MVOOQ+`97',JA`RZ.5-(QY^;(ZZD=\V)"$53\D".OC\0>",%)4WL*Z51O-PY4&J4Q,-!>W;&T5.,*`]BEZR97DIG1V9\[ M37G4P338GC[H/$=B`&XO7X!<#&4_KJL41FX(8B?N9.N4D?CJ;`.N6\9..5V! M?[H(Z@5GTH%#D,BP'BIR\S8SF1G]=&7R3R$`OKA(GR_`X@?ZZ$&`7`PL77'_ M[%#[Y6*0Z"1B-MX[S%W?,G40&0S(M MZO#'.%^LTGR3X>XVHH%YC/;XEMF,QOA>]5/[>OUJJ(Y;<#JJMC9\/_*TQ%.? M!M82:LHT6QE5VK$7T\F1V6KG\3WLZ:-Z3GHDMW#[\01/*0V!MV`)T)C,G40R M)$CFAKX@7CTN[%2.[Q=1JZ\OG&DZJ>:5IO5>0Q/$#ZY77;_.5,/0\/IU0LP=>^[)UYM*]0P.F(W:IQ<: M!\)X\*FJ<3@_A;2INQCH*GLRMP-S"F(HBFQ^_:.>BN@GJ3*P.GQ7TGXIM06? MH(Y@BHQYGR7H9>WJB,51F3V%[*PW/0>\ MB@B\8#CRPD`8RX!.9_D!%O;DA^958:9!N@.:KXS[NAE MN5XVN%_(%I/ZW7ZJO+X#7CT+OM)98`7SYZ.0V M5&M@'?:=AW`;I\7C`[_O,"2&AO;V+3=;H:5V)&_;FMRIHJ/0S^T;1QT1<-R$ M)(V2_"HM<'Z?14L\3Y;7=$?]+5[@^#5Z6.%\]RS^/5O\[//%T=F M]"$0(#?&#],[_ZYPH=KIJNS`"[B"#G"B(/4(,'2*[&BRFM^]2]SPMF.J;SJ? MJ#I`X7*1VU%`.#UP^>14\G2/LS43@IOHC7HF9).X:8]'O*9`#!)[`1HSN69T MJ,/I.&-_H>K/$Q0GB]5FR9[67RRR#5YN=RZ$PB')K>:P1PF,/F_Z77B,\0HC M\&4GD0T[%+&LJ8VC*W(K-UE&ZNM]P8U&]F.+G%%SER_1]WB]67_!=$>+0&"Y M;3K*VFD#P@6N71@*=(=6([_=8U;]B;Z6'P228_#O5`_@LAO:Q76K;1_0\OON M$<=QHL8QKTT7Q^TV,#CFV07"<6=H#1RW>LRJ/T/#,?=.]7$LN:$]'#?;_^<$RR[\MDD:[QYS07[5%D\<.FJ`/Q311./L*_@SU\RVYT%]^MMGU\.\>#DQG"O@5#8+#_KX%T]M_NA>W_Q3R]I^.&]W.H_SY)DM? MXR5>GKW]FN/E9?(I3J)D0<^*6A3Q:US$.%?,H-H/U(^3Q@-!LBK,T@,7%*A3%=H-U?W0 MPQOZ(^V*XN1'Q.-(<.L&6P:/,PA:[G2-;$3+JH%:-MM*K'<%+6Z0F7'!DW) MTAQ<6[ZFQ#)/>8")-ZY)II$?\'AW@G:#H=UH1SKJ@&L2A`PQM^"D0L-S"\-! MK2M]_ZIG>&7N]928B`*QO69N9Q*EJC`\@!,XS#0K-DP"'S MB*,3Q=5V01LW7#"&QN=]6`9SP03`^75(+H08=3E)PO!Y=,-!K6M@_S-\AE?F M?AY=WR'((D%G'GT?*FB0B3L[-M@7"H.F[:;$LO&J;_AY='TC-E7Y%.?11Z8C M8.7N@Y`CYQ;?YHM%NJ%N/9$+2,@_%^Q`M'R>+,^?"2-P?IDTV\3)(GY9:93X M8"/WL@R`D8%$$.P:H700PB$=*1QN9W9U\5WU%_GU^ M\>7BZOXNP!D".#QS!`^:+'W-&VR!)WSP3`Q"^]BKM-_*_U>=GF@[C+ZJ"89Q M+6%2[T&G9HQ=&*10_$'EYV@L@?Z6OTWN!-"Q^.&1KWAFQWCUA3D9I%R:%?^),OMEJ++`J^5 ME8-I_VXDU>\/HR&F_D+&3@/;&K*A/=J,-"VG,@+>=&N,H[X46$*QIP"ZXW"H M'RJ:P4.AD6%`,)>'U+'&C2DX>DCV#MNL0W@UJ4>$JZ.HFP/#3C MXOL+3G+1X:/*]OVX)6H/Q6RY/V`\%IK18JV@]ZSYU?9`I^K;'X,AI.*6\PBH MA1(.W?C]N/0:!UA.WNHKMS8`830.W%,?JI]OP%#?V'2SKT_+*@!(V:X] M%A6KZ!4E-E48>6 M\C%F\S5.Z$8:6J[?DNJ1OER0SEVOXSQ/LS?VXJO`3C#610F'IR;PZG-4VIO' MT`!P"3_+I#8W&):QX\Q M7IZ7K[[0B!^:(TABB7($;!=V_+TOE>HUXV5JC$1R7>Y:A`U+3@"87=UVJD-)\^_3%]P7; M+KQ$CVF&YLM7RC+V[]T+V5&^ M'Z"@[YG01GZG9T]#0YQ3$MY:$1^D2!"0HMU'R`T%<,:9)U*N1XN;2F9^P%?V MQ%[`S^48KBUS.K+W?=^AF_G?@GS;M_2F2M-S[47B?A=YNAW"TUAMEI(\3R]F M-!K*`P9KZ"):-#QP$BK*\8WC!.W6>'72[HL3FD0'1`7^O51%B/Y]5X0'6CFH M8H-+C+B;'.R;L0%+G5(WD+(/(-%-K0UA,GZ*/4^6G],H:;CU2Y;FN<8*DUY/ MGIJJ>L)11\]':"8IK6H22S'.[%.TP.@U6FTP2A_9Q&)`5-.$!Y][1MCB4E$^ M@H";H0#3R52)ADD07&XG54X0:]5Y!J:90;!N(2YS.@2O7B1Q`-_Q8TU5)NCO M7M#?I>!NL=9QK.A9,:M6^5L)`F*2X$Y*"U3S#0!:JT'.,>)REYG]VKQH#3Y$ MW1V`%J/E=!.\C*J;V]-$JVW-JJ?>E>T[&BII#\(2I3^`>BJSI::,N/?L^N;B M=LZ.<[GX7S<75W<7@1SDHK[9/>+HXJ-+'F&_/H5&@Q2T_,H-#4!4^^CF^MO@ M9I@AX:549PB`A:74N@JMJ\RNZ..8-'94X1$D4%88L,&4`QK8=X4*)P]=\ZU8 MP*/QD/4>PL1<+#6`$H8XEL_H?4YSI3SV6XH$LMD2E@Q]'UR0H67%@`R-?K/Z M:5+ZUX^M=Z0'<\RS[,Z*.2&$@9`3NQX25OC`C+-\M&/""C+M'+0%G_V`B[Z( M&@(F#"']C*,<+^=YCHO\?17:(6='`]BENG@2$@W;F<)\\;#GS,!%UL;"K^VK)=- M4-GF8("HK_P@4!PW'F1/41+_%\OSSDFJEZ[B)?MCGBQO"`6(`+$_KQ^K%=AH M=4=/-RA/5U?,)4..W8TN,&/#B`#D=0(I!9!+&G("8FEV??O+_.KR_YO?7UY? MH?G51W0VO[N\0]>?T,WMQ=W%U7WY37!3G*`0[^N4`P;UQ`S"!D?SG!!T(L+X M,GP'+RPV&1KNQT=?@ M7K$Q77E0%Y:3$XAQBU=Z]%993=.SVZ7;0J5MN]D2ORV,%,K\@,Q;!'8T5(G; M`V4]$C+Z\-AGF]0@0=)H1%+3.W.LBV_.4&[[_8'/6K1'X"? M4.3W"XD,>$5`@-.-D18K.HJ%6=@1FE`*#]U(MMBH$==$PU2TBUBCX*BFPH2, M=WIXDE!0,("4CV-CT:'2RRQ"0+$?`UH-@PX)#G!J$BP`D3I^&#%]JY%>)U[X M:B."3TO;U1_+.`BJ.BT`G!T!HF!P*Q6VD M.$%)*`>'N,&<7A``0]WXXO\YCA[B%7MGI_S97D5KGMSS6L.Q3.P+-+FXEC0Y MQ>E;3^>$E/U+;BR?04HD<(G3[R5@C&_H.$GC!6:LD;-+V!O?!?8H,!2:](1X M`)[&E][F\\KR5+O?CI]=-]M!IC-]^_#Y2\N&=L+2Z#7[$GV/UYLU>B&7]4SW M\;YD\0+71WFCAS?RP?:M0.R8[X`HP[W)HN1%B`=!MK)K+TQ0W$/'B<3V#%@@ M9R>K`1[$,00ARUPF"7MGJ# M]+D<((8U@\*?2Q0G^(F^$T*=4Q@8AX(SC2(M"*/>*PX."<+*V.,6Q$%$J?MT MOOC')L[PV2:/$YSG.&>'NBGBDZJ;(#*)NX'R6>4=;#226-,GKG"0700B,*O: MH%VCZI##L&BK1(>0L)JX$A%5U%U,T9$1Z62V75S'I1D(<]%R3TM8PP+':H4Y%".98 M"U0W0:S-OL).6_&'`R\(I=^&(3:SMMO-K5T5B/JIRH)^/S=9F,@_ETD8QZ9% M#M8;9;M2RV:HXO;.^\NSP#BI1H@Z'5.`2YF-=?MKI&-CX=)5C)`;!(!E*UHT M"M=R#:/1#YA>"Y?,O1"T%Q?F@H5L6#,UK65DP96/;KDRW:%,]I%O\7^>3]SR<_ M_\S^5Y(N;U+QO__\IY]_?O\_T+N?WU7?HIC4R:0;/:4@W11Y0?X1)T\A4K4- M#P4O>5B24[`,N0J^.08>>&4B,&&%.Z[,LV].V(P57NX':@RE6Q\W`8DR"Q)Y M>=>TM)G702K1[0X.",/SR`5K.G9,J=/JWN=/^77`_.'>>`6-)&"1K6Q%_'[%FJ-RV:`M.Q^?;],]`R_N=-/2\VN=/U MEBT[QC6&$.K[KDVXO.,`0HM[0B#IL&_768^!G@'H3?<[)HDKSA[2/5H:N>)#HEM1I[-U^F& M`/LAS;+T&TG!V).C6=F(+MG25J'0?@@8.;(P'-M]T;`8DR-)_N'K7E3XP03N_H[VK8P/(+:T&0#='#HG`$B"+.*';)X].G62&MIZX(M-I METS;)XT(E5IGX+QKLNCMR*$^4$+DT.FH'/I@PJ&7-(^+^-49C3XXI-&''V:W MC43M#:U(,Y*[T3,HPEE5"8`L'T(FRX<`:T6FP>KSK,QZ:]:#O=Y.I43@JX?P MV[=LKQ/=L6:-[)0>-%B)0D#'6!E"1UL(Y-C3)7YG%'VJCPI>7U48SRP8=E65 M5O=0J\/"LW7M!(7H8*8VV4.1%__8Q,6;1GCBM):$HU9K<`9S?'$4;MJ6S"C: M[$O"R7I-Z%<>"T&@\X`#VRHLO]-2MHFA(>-6HY><2]ZPY%+]NV:LH=17]_*A M\?+;_4*3D5;;X"D8+:ZG;ZX?;S(2)@I\LXH6[+6A&M*L[BQ1:EEG<+*I/76D MXU+#9ER4#-4A9MR8DUN4^L_VY=2/ZA7/6;IY>J;'PM%QT$L]4'@LUH"8E-3: M$)4Q7#R(G/"!0-QE>%%8A4)X/_@TYYVKUNCF$'%L%*O@D1Q@)"M37I;Q&@4Q M3C^M^-7JYY#7'/]<$KIMSI;)S5$D%&Z6*2&SEX<13>**X:7'V$9_7;*.@$RS M8&.U^49L%P"D_4C#RZ8.`Z:6H6484)TLX_,MN5ZR%UN%`.II9W*G>@R5'C=X M'N7/!P!/DY5T,'CV5\B]YCN/.,_C-(E6G[!L[R>W63^;Z32#XAW7.EBNTAU= MBTSM3K/F)^A3.$\RA0JLY%_D^T.!H!SW'B#DLJMB_7\#0">*& MT!BUYKLE]Q3/O\M]WU&]QO<@`._9@]&YYK!J).]:S]@_T5?ZQW^&@=W^ M'>F!5G33NEC=MNN#5'Q?/6/S"UX_X$R&SG8+'C[K%G`(;=L$Q.AV8$V45NUK MG'Y,UU&0#->]K3I<[I:DK![G#<(*UY;TX+E0"'-"T)ANZ\KH*3I:=&PT3GZM0]L=/0.20BOG!.3 M5CMWFX=\D<4O;(M>:#OS0F6:LJ(*C6OCUFM;W^^)J3+=4Z8-_:;"7*#9%%A2 M^EY`1^V6!1/&-SHVXVM@Z;3L?DI8*;S[8J+MNLC8(\&*3T)L'R)YN\^B)(_8 M?MW\8YPO5FF^R?`]_EZW%Y_G]Q4?R]^W]WT+AJ3F>./2U!66?U=HC\<@>,+*A=V*9 MF@8%-LT?6\_XHF8'M.N!OM(^B'4*)C+Y1;Q&RN@'\R.G@EP_%3FA1A^]Z`:< M)6KXY93E1GFC;`0QBX/+)W6PH,M3S0Q3TE>;B:'FG+)E-'4//=9!+K6I?7+* M./WE.$E_&=M"6K33N/^Z3--9V!/WU&;9V(M_@B@\?\B+C/S;L)CK=M.LX';= MG":W7>_O=8KMD;B.-&OD(Q7->H#K_UQIJU&K(73=8Y-/W^!-6MV9^A M$-X,2!RZVR"Q3W:M47A4#Q#*3O8.F]@&PW0Y=]I$-9'5[(F^6V>QR((YG<,7 MBC6F1]WB>.1IT8+$3+R\B+*$>)G/%XO->L/\_(@?XT4LCE:Z'7N!2MT1B-BZ M'H(R6L.H#I65P\P:GZ'JPU"8JPT-#FD-8=5GJVH`'E&#@:2S36%:AB&`2<-+ M$YJK-`_F%1!ND:D125Q@$^RA50U31D^MZF3T6A9!8'E*LYZR%:J;H3]R1/3' M@\"JZOE51U@=\PG66_R*DPV^Q8OT*8GI].!-NHH7;^HM3YK]>IF.LA\0;S7] M`\USU#9U:*L:958U08TVH?!3%Q4<>IH!JL]-17\>-0/!(OPV)!V#`%`LR^8> M&$]0V0Y]K?X;X'XC=T#52'G@H3IRP?P=K=.D>`XDA=D''5`F5U-6@FFF?9^B M./LM6FWP/,\W:_90?4Y?+[TH\/(>9^OWT+F?MD&H!%##X+@2KOV+A*#B.LXZ M%'*U^5G])UK%CU//X?3)`B?@I@0%TW"E84`AG[XH0,_U./9T3$U@I\8,KQ>I M'<0,H8:E$[05'&KL*#@NH;[7DC/-!+)\.=1E0O2 M[I(*-,[#.0)M;.["!290,0&+6<.\`@QHAZQNP63?`)<1K+@!Y>W5>RX;7E2O M`2V('^BZ3N.WKJ"M+V6V?X)*=X[R&I*\NBL*]D1@#ZN1$ERSAY"J6F MX+@T=F'1GR(M%XZ&7D2PHP'#<=G#7^0%%.3SS_B!?E M"P,^O#]!1!`^'&BDY!%^_'`IEJ'1(V832N.'S?T21[,*I93'NR+*BK`%,M2* MI>TB1R2_$.5Z/BIDX`H97E41K$:"/3\ZZD4`/YDZ^K4$+HVG@GY1T[D,(<.+_#>KR#ZYU'HK/%0O8JLK1\ M-5PQ_=UX(_#480'LCZG37/JJTKUR]>ZOF#Y>@I?S5YQ%3_@7TKOX2'+`[2Y" MZ&S)SCI4+F5J?5PEMONM0E!I8\\=*KBA+WNTT\V2:W"J/XCL8!'!S`O`>+'/ M:A/,SC0+MX,1&Z"=9]N9R-+L":H-H\HR8J81M=UXO.2H;N,0YD#U;0^RY7FR MW#Y*D]*/&KE"Y_IO,7W;0YP\G:<)>\7+)EHY>=#9F8-.'"9 M.]#%^8JW(.[N:_X/*@V.@J@#^7(392$<=16(CQ++N:`PRQ6P*YN2PKHI>MB[ MC[:/R!-JT8_IDMK6/TY9M/41-9S^IF& M`%0&CY?#=04Z+%IX!!__#DKD0JMF;"\A2(V#KD\:+AQ@"3)U[71>5$Q5/<;$.W(QTK?5ZW?L)N$:'6'"B;:'0-JO8T]#J-7# MS&@;^HPB:W52OHR>_-EH&=B[Z0W0TMI M%IUUY8JY73^,0EQ^C8NW>SISH7H#'MS`7=(##`PC"F!7""0:$/YHB,IP,[-Z M#"8\@K3NI)2DQB-]U6#H*QLNO+>F`4*^KUS0=.HIVV`#'.7;'ZJZ>>`"QBT? MG&4%6).U#6YNF7FDH0F0)D7$<2N+K?O7+Y@^[)$\?<;T&N9YCHN<>:I,0]1= MA8F&K"NP/JF]A$X6I!9-I$4R4$LZMNU0V1"5+:NP'EPLU\"-1":T42>6`?$0 M,J(;8'8,(G^.'_$=+LBETVF/>AXCOTQ><5[0C[[@XCE=ZE<9M@,*26\^(+`4 MV%Z1DP3%PAD3[3`>OJ4HNV8Y(A7X%2[H^2`;4F8O,#K#"7Z,B^U4;BCK7\.1 M*Y&=@6P0BY'IP#*)FAS#P)=XAGGBDF#=?)_V1[L!=FPZ:;`/E8-,H$`/@7,& ME<"8K`LD\Y\O%NF&"/Q56N#\-75K%H%0-6HPE3 M!OVLK)BX M-7RR5M^:UCI+<_M,+MT_$ZHZ0G'#>+;7EGZF4[[:=LQG?NT9/HK*TGGJYW2U MQ%E>GIU((\1?(WH117Z=E>]E-EB:MAM/K**FXT&KIMWU@*NDL1M&JF@X>G_= MJNK\A_HP6=K_!-4CH#1#Y1@3*&1M$2S3ND&DD&B;V;A2+9L6SUPO'EMXXY!P MW:FCJF&XJ\2C4\AD37@T$HT[#X07FPPO/^*'X@M[WXPHM(O:=4-VOQV,1(CL M`X58SO`:3.[UFE4?(?H9^EI^&DIL$]["/N$4=[M'HVY[#CU\`<--3.!:L4`( MT_`*(U05]@@C:K&U0,GXS^?**CM18:<^?GZYC.D_HM7'.%^LTIQ<=3Y_R-F2 M@4B"Q_6&]YSN&-[`/<8VWF\)_;SN*%>B^3S;"+[-)O&VQWI,H+5.L^O\]ZZ@AJ^H*^U-Z%DL4=Y[3#P*+#"'V@/ MJXNKE.TYPLO;=+7ZE&:TD_>B0N:$MUJ"[T3@457VRTVBAZ91?O/[K0?DGUMI M9,.2))]ZA2JW]C[1#UDH1TSK0Y3*:2;QRK.(JL-,\4T6+S"]W$OYO5_&2'*)BTU%/IV%+4@;M-1UO@_R_2J`&7!P]XLEU]VWE7M;1*? M;][;]'W7?.!S8OQ?*X1H9>[ZF!-A'6=F[&^\G'CTL26;Q]DF*=W]S3*UW?`Y MOS1IP9G.]#O'[W#TQN^4>VF;GJY46C^*W%BD.5B9.XC46?N=V2/EUOKO]!XG M^=;P;U+!4OOWGF#ZKG-MX<1;M;>'60#H*\)HP=-4M,:*K4H_QPN^!Z>K4ZU2 M]"YL0K(Z;IW#64ME31#U$5$G$?/RJ/E3T_Q@*JHIJW[8-9GP1"N=BVVMX-A6 M7?`>F-95D![XB?#POYG/V@C4>X`P#>C/Q.H;!]PSCV;.!,`X6L%Y8A&/#EF% MO%<2P*X')4*ZU8#\)-,3HX1_DIN+]DS]AF?K>Z)_86?[!Y(`,7`*=X]E-TS)+H4G;NBB@K MPA`>UY/N9JYPQ.<+483GH_*,ANJ#TQY.'ANP^IP&LAAHZG,@DG,*LH1'++XK M37)6\SI/0):&CSKFFQ^'IV.GP=7C1A6T42UA:^!HQZ%WI/<$S=?IA@Q(DKW2 MT/X<_;JWNAS"N>D34>9I5B_L_V@9%B=/917V'KH:D9B`JBZX)L8-E)*K#B'[ MY[OG,)+Q##9>.OI:?H->]F'R289X.'E7\PI,K#FF`,5W&NP-)FT5^>:7O$!I M)?L/JH;>CZGGT=CO+EGSSO]I)E/Z6:3R,(L@9H=MO/0_86SFY52F3VQ^^\G, MIQA>7!`3+$8^CS/CHG<\U"%.NU@IV1@S,0,D=X2I&1-O1YFM.<:&L%X!Y/`: M)Q67+,USZ`)/;0GX_:-<2T&\,D_R M&X00#J5>NG_A'<_NQ`[6&\`!\!?3J0D'IOQBB_`OEIL4NX.9I5>X.`JY@>;L M)>?5,3-'Z8!%\IZ)QS33M\]Q@B\+O`;/UGH#0R5GC8''5>O>%8XLS4U_'.KP MSLQPT45?Z6B(#3?U6=L^X.'D5$0F,.W<&@"42C%1)Z"+@"5^P`N=`:]NCJWN M#G[E4$[SA+VT:4Q0'\)IH"Z$(]+X_]&[T$]M8HG9WV,EJL_'; MSG8O(Z-'N0;W9C#M>ZR74ROO\C37%Y62W*@<.Z*\?8KV/$W8OOY-M+K'&?Q2 MI4L?O+TRX'UK_?4JS1QP7&Q+/PMM)9>.KW(B!QP`]0*S\Q643)WT&Y(,5 MT^E49<97-14M]5N'-3P[KO?OG[*/6'/M@[;O=Y4UXNL.A1[XKI$J:3`>\0:YRUA>Z!'DRL>`GHK(L\C_V7`(;T;,4SQ M&S]A#T3^IIEZ;RN'>9YOUN6E52]55F_A=6H0*K'6,#ANW-+^14)(FW6<=1B6 MU.;K5X*'MZO:+5O@8H`I0\$$7VD84-^GKPK!)*]ZGHXI"D"I:>.P]H8EDK+6 MBA/:'O^]41QW2690FA-V"IDK#I6K+V5[KEQGMAHDK73BA&FJ">R$GT#CY)?S MF9)"7P!`1()U:9NZ3F4JPPT9S>.*2U$PCC2@SEA$GZ,X><^,X;T/39MT,^A< M]Y#BK?7F.<6][1R3S*SW4A6'9^![I8MA9^J**VUL*)DG2[9TS$8077G[Y=K0 M$\*@3@&_0F.H4T&Z/^1_HXM[M[(`E.?A!_Z#B`S8W!>(< M_,L#CJ(8SMP[W-6$KHG0;TEI>(.B9(D:_DA+DJU7>[&W?*]UV?F[6O9+F:=9 MTR@WZOS&3LP3_`(!/*1KZ9^W?>?&_@6^"]3R]PZA_G%P;6-N(37UMEX?B1Y6 M4X^[SE3!XU;08<+E;YNHH9\^-Y$>N+8&4T8YN;`)2:O?O?NE<](JZR"?X]T_ MS1_QX8#]4?UIUF75MDI/:AM^QF[RLA%,"J_M M[,BJ`;V.L3.&&M;0U]K>U-]+'+`4.5]?"$F,)IV%=M]W7Z787C8V&=D&SDHU M;0<19HQ^IX"R5%V_W<<=/4]F[(M]V5%DQB[P^&!#;N@HH>4#?+38.VT)+975 M=SH0:8%.;4NCS7GBQK3P7N[#F8*:.<]Z0]:S26?!O2<<[M,B6GE)@DU,`^?` M>J:#"%,FOU)`&;"FV^ZCE)8CDWO*%I):X"'#@MC0\4+'!?APL6>R$EKRJ^US M&*H"G?IR'X_=RY0W?/ERGO"&*V#33'?YY^R\X$6!E[^E*S+,*B[>;DER#YWM MFEMV>\HAWW*(!YO)?J,@SS<3..S]F#.N'VY/.RM-HIU-1(U./!Q94-?U`6@: MN@$6BO0]<'X@VK1%RRR1'N>X5J'?0:@7S:5WGQQEQ2]J#TQ8]B?#O8WSWS]E MF$Y88R*&A:_\5F;797;+MQM>F)#]/J&&"('/GL,#UXL9_10]DH]1MI]9IY10 M;H.#!I>=!@:>?<=A8-#42M MIIG"#^=8Y@73G?K!O\T^+#?+H34U_H*?&^XTS@;8X]W]8[Q)#2(,+C= M&>?SF>9#4JA@LNH![@X?#5\A)Y^ZFQPTZ?:\DI$\C MGR(>U'OH('_7@'+^H=<3WG&YG7<)'4\0!WV9AD?9@8Z)@WP;_Y#:O5/#T.J+ MX1<3N!B&2R\5`R[E&RZJ-4^>/#`8G5I)/8ZTV1%X0QA#!R/"WT@E(+PR_%\G2?8*K[[W[Z*3KRZS1$$4Y2A_11[S`ZP>N;Z<3 M+NW+-T65`_F_.DIPT^^SK(?[`]P^3_`GR!BWN#?,Z#UKR'7 MXCXPVGNW1V^=!6,Q>#2#$A;HZ&;M%WR\.UBM"VV%;MB%!"QUT"MZU7M>J\6\ M\M`X0@OZ\?:$4^K."=HZM)]GG.Z3X#J?,-D'R9WT>J+ZJD=89H1QRGOY,8&E M`)A?=E*%R.C+EP-=/,229)Q9-E#9\1\I_<[('>5P@K5*`(NG@YTQ]I.$)%3>/WA[F/<^NEU9;ZR M>I![$SO,<+DLSB6AP^7OTI[3A>ZP^3Z-W8(-7T=@_4'N`/1.>I^[^KS1/L2= M>I5GX>[):S@X!MM=[K,K31S%`@Z]^R06^[WMS6DA9VK>^ZI24&F@Z:\UJ94B MCP6BMC.'N/KC.BA84M[_K*&K`+*GHC.]]1BOY:F!.R.ML>Q3DCL=F0M@>61L MH9OTDH?@(GVMA)B:]Y-`ASJ/:OIKA9]`C[/"HNW,[!:OHSBATZ]IV76OXXO' MN15+XGN*+A[F8?94>B:21H^URF/@CK\T>F_GBJ'F\ M6FG/W4ZB(!\95/X>X>XL&N$19['U@]QIY.M).EW2.EQ5=/TWD(0%!JXW'+TWAJ M,^4M4(VKNDU7JT]I1K]T7W=RC+DK.EO&0@L,G%\BH)47H:->8T+3]*R::B+) MXO4^K:HHR.%2M,5D=*C7#:-.Q7HJY`]M[4/BY5CB:V/_=$__FR?*&L/DJ6N./*=VO8)O\#3!EFOI9F?*C_0-^ M!4^Z;^V0"S M\S19$EBQA#')TU6\C.@.EFTGMO!`^R'6$7VMNX:B,SKPZ.N%/JAZO)=TY?#7 M!(JC\/!3G$3)(HY6-VD>,W'1YJ.RJYB7DJ[0_%1Z"[S6[@]$;D-_(>>,#6SK<%UW-$+X]3I-$.N!8O8=>DPS MM"#?AD)N4QAQ&&Z'Q#[--FY MC0GQ,L;Y207QLLM)N?I\4OW)$']^D(A7SQ1ZP/RX\WE\+UGYF]]B$H9CN@F: M-6/5[R]9FN=F,4]S,+T`J!S,I8!H7HG[T*AVQ%I;5$//*M7(MBU03IN-L(N*ONBLO-)N6!(0O-N M@"I*5ZN&;)`CFWB8"9)/H<3Q]^KHW/TA^4V@Y<&(\N;QT9C+[[<%8-XM`//- M0[[(8K8,2R+=`L>O`9U*Q+N1,HX9\.:]E`TN0.$P$KPWU_?W7=6>ZBTW$4O% M31]?V,K]$'3%C3Z5F>3"YQ2EC7EBQVD,AW"A)SI(?\790ZHM@3Q3FL#O=RWW M/*&S_IZG=X%M@93?;SY!5/C@$J7724`9OWARHIU\*[9@VNDI":N_)G%1(0C1 M-JAJM$]HTA->:SR-+\:BQ+CA;UZ_9$.XL=]Z()-9(L%`[LM>Z17XFAT2.3&P MWN4/.]O^,R`NVP',K%K5`:M1GG#0U.%FT4(XO6;(+6%DWT M&:W^`J_4R,,CID,$+1(B))FE[B(D&B7KVT$,$_1QD&P6'R%F==JFH;"\K6/9 MHRF+_JKH(<%W6+4Y&,!PATGIF8,^&4K?*AAZ3_5VVI`.98NP4S9H."O/1'(+ MYU%/*Y*YV-J%:Y-Z<05#ZFS*@O MPZ41^5L#&0K`N-CVNN;0MPP);;-'.^I8=[EC0/#/=CA"_K`\#@S[(S![!HKH05/H0S'M>NJA8\UHY@%@Z15H]J$W M5@_3$YQ#@P6QY90##(A'GW!X3E=+@M;R)#'ET2^J#KS,2M`!CKM2CZ#I*C*F MR5!^]UGSNS^@\MN`*"B_YWS>Z>"$2S5N1P&_QL&6DX)=;&D(M+9[!CK@0O.B MR.*'34$?%:,_[@T)!J1@#^_`($CXZ24L@P$X?A7=N1+>CBT;%K6&F-W=7Y__.[J_G5_=S<_O+Z^O[B:0 MNW"QH$$O"8;41&MVUB&=%'MCT^]CG"]6:;[)\#W^7IP1^[\;,5'27XN4W/X. M^2GQUVEE*[9M2UW>:!P6ATQ=&7@T6:S&GQZA.>/H[3K@+[2+HCU"3HZN8&X17H(#_)QD\G-0X[_L2'EX<4K/55=&;U4[;O12MP> MAMHJ?R"CD<26!G>%O6=WOY[=7?S'KQ=7]^CB-_+_H00;Y;WN,T\3'CV>B?IQ M>#46HL"#@]30`$`Q\=]^B>^/(=7T:MNMI)(NE6\H)N:1"%4[FV7[NGTN!Y[6DWES*F:NF!-RPLG MC*DM&+.E[-B+.B3HT"_"9$G[IJH8PH.`@AWW]?J+SL"AL.)SG.#+`J^%&UH5 MS>7L:#1WP9">-TY8TK1BS)1=9PY;Z)>(?1LF9?IW6T4;$3X4U-EV4])'C*C1 M*/0%TW==Z_&GW59.GKJM"^:T_7!"FZT)8\Y4/3F$*;\)DRR=6ZMB"A<)"IJ4 M?90<<0\<-\]P"RU9(HA7&.\AADQK82,4A50#T[>(RE]_K&JOR.4;[9TD]#U_ MW&3U33/FJ?VN=Y\\],O07O"KO.?*5%\$$U6^O^VG3OK%R!J53?/OL6;BWVVM M9E+9VA6/FKXX8U%EQ(I#K*^(0?3+!E' MV=M=M,+7CVRE3\$<:7L.=P3MP=@C]0>./R(S>@SB]Y[MOCI!]$OZJ%#Y;&=H M/)+?=2Z3=(#"XQ*W'Y]->MCRR:>7EQ4[XC=:U2^CODP>TVP=Z;SWV:QWCVN: MO8&89^0K%`]UC>JP4F^L6;/A[C7MJ-$VP$44,R!QZ&N#Q#Z9M4;A43M`*#N: M&-"W#89I-GGPZ\W-YXLO%U?W\\_HX^7=^>?KNU]O+^[0]2=T/K_[-_3I\_5? MT>75I^O;+W.Z;?`OAP5MC9D'M^`>=7;BUYP$U(N\B(E/P@-!^(TZ4:G;"(2Q M?,N`M.P94'.OTV6V_6<8O!'URX%VXS[4/=Q\Z*U,G-%-[SV55_() MS>6WGYV@FW05+][0U^J_P6UAL@.(4B;-(#*JZ/TUHF_HD*]Y<=MT)*_3!@3T M7+LPB.\.K89[N\>L^C.PY0?^G>K!679#NUANM>U#V?E]=Y*!]BT8`H#*7?5! MO@<84"J:"0I"T+-\GBQOXZ?G(F_OVE=,1ACVYFN@NCL)7&RHPUX_L MB,GK39$74;*,DZ>S*(\7Y"H^QJM-(7SCXK#!NF2W'`R&^X.N!#*0VCJB(0]V M0\_J?JCJB,J>;)6A/)JLT3L0'1D&S+ZL0`"]IS)6@W)$9WK$@:ZW!WCABC;9,E"]<]__O`S"]3TD[_/EZ\1N2^? MTNPR><5Y0>=Y+Y,K3/Z/Y!'TJS.G)_J/<`Y>P`%\"DHG&@ MA*E23$H>),<$`.'84AXX1PI,C!%FH1,\J]0]`6/`L+/[9XQ(RSC#:+D[!HF^ MXB>=#-?"?#ITW4($5D#F#7[]@;1CH'9"#[#O@ MS*E-/1;,1HT`.")ZC\.('+%[NX,\_;Q/SU-B<55$24&SPJ";HR6?5 M:(!SF8G)3`["79U?1>MT0^!6)51+"0H1&11G"']?K#9Y_$I/J(R>,LPV^@:4 M74%"5"MG@@`I:"8DLN$@Z9&9&@;/1BISGZ)=&Y;8W.VU,&IE(2"H@\TMF))< M/]Y$;ZP6JVPO?Z6R,2^B>2T6W#3#M',KX]#O#$`R4T\AV&9@4T4[[:%F95-T M_8CJQJANC5AS1-JC;8<0R&B,HG38O>425'>0+E>#1#'HEEP+TU!P9HLR-7I? M:CR7*4U!\J"/Y"?\$A%(W\\/"IUGU(4K9IP$00W;O4MW?F0=U3O,.J/WAPJ.Z6[4,DU)2Y"AIIH$[%?%X0ZC).#)J?64#0MLPX*VS MAAU(&PE$M.V`%FE>5+@F=^:A!7BVW()?0"<-:76?57]LX\4(_#HT[W!LL88L$ M$&)V-#O)^.`-0.[SEIXU6QS5NT+-BC:]^[*^%ZV;?!,L@H%N!R5W0OF%U@S)M.@O/6A`G`^UC;LF,.B MCJ]%O,85,A"]12C*\_B)+2#228`U^1>M^Q/Z7N]=\1]PLFC;&MT!0/X+>[(7"&(1+;6R`ALCSZ"4NHE7\7WC9V".)N66MJFTS6(K; M#L>UR@]`D9284J!XJ3)_1" M?I[GJ#R`EO^T'RUNTLW3,WI9X26=B@UII58)H]3H;O.()>K38=<8((7?4"BU M9(E2&M+/6QC=81&'4-``@4@>NP?""":*"T>'#.52([88.FUCJ/D0PUYA2!KC MAV((-MJO2$I^_5B=A7F=L9,PZV.TMB=D;HKG-*.>T`)S,;`]UQQB&:5.FS*(A4/1P:*3*U\8D$E.W9VP?-!X>YX8Y"-*>D MO>EC>?5[*:XSQ$:HSW#=?96CW2CED2#'$"6%3JC<`LV"/^('>N)(D;%@,F?S MTO1?]SA;K0S&45'8;+A)9'4!FIRIB"[?+NL]T'J*"?!$!-O?N=FM\1 M'KVD'3L,&A=73I(UM<4A\*(IUT><+[*X7%4@>5?!GFUI8Z[^?$G&HM.IU6`A MI&#@6)0G4F!HA$F'Y"8@,QZUI4$X/*4X?&`GD%4M4$/X[O=5^.29!1S8@/.# M5[Q*7^CH=W0GZ7FZ?HF2M_+%?M)S:BH!:7AO MQ?4&7$4"Y`ZXL"E1%>+GR?*"!-'B3?)*]E9"9-"OE0YI]0,@IH%_D*F0GED5 M,75&F=6MV-NKRG:HT3"L-V\8X26UOI5<+FKT[S(Q()2"ODI&VR``0EEV4V-T M?L2H(M5Q@U+8M[QIYYB`)-FY:,VPTAI1MI M-@6V]>&A1S81K+28MNVL232_%L+/ MZ:8C_:UN[MC&\JD)VM:&0E$9``X$C);2;PM'6-G_%"WP M;]%J@Z\?>6_\O*D.-:C>(I'GN+@G#?)'\H?LS5F`PS9#!\BPP]D,>'6`X0?& M*X4J0!AA9VT\DH'0*QU)ASMF0DM!T*U6.A[6#UBS(91^OQ@GIG9M@X>#9.CH/M./T5Q5CE4/R!, MGPG&2U:TU(\'GZ=YP7UPUZ)[NP@PZ`XA3,;>PN4*)J:52J,_V(PVKO0D;3RW M7W8@P;VJ][>/E+-N0>B&.;2Z^F`+SHX*:`_38WNH\':R8&%J'P[E[.6[*$D3 MM(CR9_08)^0K^B1:M"CB5[K9-4X6FRPC@%_&&5X4J[?R`%WZ3')]'DSSS)@P MJE"/!%`EJQXH`)5\ZAN$33+-[`*"_[0E\M=]D3\J?*%X4-H/P&$SMS1;X^PC MD[-4LNM;UJZ5BW';`1!28A\R^/#-J&C&ZS4K/T7UQZC\/`3&R.YEJOVS$@"ZB"0U8H(.F&EU\!+0T-A`ABC3`#B.PRUR_I"2Q.Z<_0R9],E+6 MKJE[_';#42VS#X!IP?`*1'-[S7ZYOKSZ!9U?7YU?W%Z%]2R8]"ZFVC\X#\V\ M]ATT:V$#",O2X'238=X\D^-4YL1D;*-&PWY+) M?8"(/-I;@P2FD.P+5'V#OH9U&,=PN$A+:'NX@);%GW&4 MX^UB22[=\ZIJVPRLXK;#H:[R`P#K$A,*L`M[SM@WN[7&T'8)*N]N:G03>)@7 M]>G`?@SLP`=4J25+$+$3V]/7\DQ.5G>4E"LOJ1)\;QZNXG>1%N/==KW8[2H/10M MY/Z`Q6JA&2U*"'K7I$B6J/P>50U0U2(87BCN.H\;6D#AL(/?C\N0<;#E*I9+ MK`T`&8WI-:JR$F0O^PHNG5@^&%Z0,5U@P5UMYP?;)\AO^Q MB>D&C_+]R/&B@[T0YO2@P:<1^8>##S8#B!_Q=M@BFIZX\QHN\9VY+IE8SLR;8MHXQ#H9@:9=,"] MY!)0:X0N%0,#JX/40]\N"&II.L)PNWO4Y:7&[>Y1EV\4M\N#P:TB;W&'7*!< M1L^6DZQ&WS0,?$^-X!M$FN,!O_+4QR%^P=.A.UR0*Z#(.R>)%]UAD%\FKS@O MZ$=?0@4;P\06\XRE":A/"VU\G16)V"3X+(<`D]G$NN\GY8#[URN35? MNFK7$[@B.7U_25S3/$H*D@&_4)5K4)Y\SV9;$QK)'^-\$:U*$7A,5ZOT&]M3 M2;Y>D6YYNP$9XW>,7\JOJ?U\ETTLMME$]1*YZDWM&_9L.WM&;Y=EK,LL@SA" MFH3Q%O?I:8^R?)J&]H12C-VG9_B&T&/^2/[^&X'[I_BUJW9.;0"59`(;H^J[ M]+K'+U+2C2I*K@J[440IM/+N$P,_=>]+5&RRN'B3 M/8#NQ2!PX2>!BL;145HNUK;".$/##0W!=U^8^ MM,2+#NX]'E-[MEOQCNHS7?5Q7O>&H3_!5,02%XW*8]V]N6[= M'55^3K?S8GEC1\-?CBKA$IO[K1*AE:B7B>/EQ[X!X!*T:2`(`>Y?<1@E9LLO M][K:,`>%2H`N)'0^]DAEX1^AQ_7#BXN.Z8/,D/H$69$3MW!9D#0-N"C)F M("1=;UQQ4`59Z9R"K';0 M)^^U"[(CCPNN:0JK+:,5^*7MIS5)>QP?=)4MM4<:2I/#ZZ MD51FR96F!DKZH*NSG8=>^:];GQ5'/@^'W<09'5B15OH4=)6V<]$OJ8'KM.(Y MSI;',FW*&N2G4/.@08&6:M]2MX7:;GPW91H=/R1MWUUO4"4:<\N;EA-KKLJS M;^E>"6F#'JYDM,=`1Q+Z+74FH.&1/.R2K/+/(]^UR[$C?X>`;<(,#JT((QZ% M78)5#OHD,7#YE6-"Q&/]-5G9\51[N96=T.JN^[2(5HYJKM;8P/56-780$MZZ MSC#JK-HE]W)=6@*NK]B@^R&1;1*`RR./8]#"R&S`BV)P%+:JHEA/]Z74SD%/ ME.:74"<$!D=J6F%J@N0,ID@JO0FT0-HYYXN:I#`J;WL$41X='\X:7R54W/.:X]'5#.Z`QK4V:N+P.FP=]3J@M0\ MLOH'HM+0-#&DZE":\"^/FE<]0C6B]@Q8+54&+:L4NK:B7&F9H&#J\F68>)JQ MMY:7+766YVZP_H7=G!:X&/LM`SVH0 M=%G(>TFWR]J0^U)PAP5BVUYXJLS[/0(L%3MN>I;EEG6G>1XS-<77<0TCH%N- MEW#>J)Q+],>.4QUU>_<8CC@M-"^3)!U"`J+:+2Y/Z%!0D_G<8& MI2ZX#`]]XVYCQ$3U:`)UM,#IL:6)7U&SE#5-]G#2+1P5\5I9CZ\C0=;8'#TGT67D'((EAU^`>UZ(Y+YAW67,'O#S4 M_R5"K+%'6W]NF'9=4^_QRC.';HZ5?H0UYYU1U[H^"3F91(D\XCISR[BH)'X\ MRH$C4.ZE(`1:\TYI4;GC[6B:X*ZV/2XF[ZFV^2UFO6O;!(I7(JS^BM>&,??% M*S,6:FAI_!+!%J^ECZ.$$VK:3_%*+.VMHC?IYD/1^_3VH.?$J!<]#UU.IE.\ MULZ.I2RRXO4H!XY`N9>"$'+Q2MV;3O%:>SN:)C@L7LGPD-7K<6DV%'$;H7KU M*6[A5Z_WQ*2_M=>6->?U:V4MT/#2^BU"K6!K)\<(*J5M+S4L,[6OPMXFG0=E MY['"D/`!6WIWV0JVIV[XVF# MNYJV>(ZSY;&DW4>)\U_4>I:X"92UWU)_1>W.EON2EMH*-;SL?H=@RUGFXBCA MA%CV4\I^2_=6SAM$\R'F/5Y[$/)OJ1<9#UM&IE.^5KZ.I"BRTO4H`R[PN(=" M$'+!2KR;3KE:.3N6%K@K57-,>'ZL5?=.U4:H4_VIFH\:]2;-J-!GU(/J"5'@1/+YMAA-;UR1BA8[NP1G0>\@ M2U)HYE">WE$T,IX'G.#'F/#MA?SRSU%.$YOG+-T\D5XE[:+:1,`IA7^J694Z M_LCFM%C1,._K72J:KCCCVJDCKAVIQ@-3F%3SDD'7B+DO`=/QQB1]UAM))W=6 MC>1.@/2NP6'6K'3`4G$4X\KRY:VF5'U[:7/`FJ*)23U!,0*XEI;(1]04DE#9 M8I8:#XG5&GXXH0W-B#]%)`"_1JL-II%Z'^.R1P[9);\>6.0V[578]C@#K^.* M&RJ=@E$IY'+2)Y>LLEL?7`+-:[]$W^/U9GVU63_@[/KQ/%VOT^3N.2)LO'Y\ MQ-G.BRQ^C0I\LR(H$Z6V@P=K9K<#!ALN-8.O!"#''>*#0F3LAYY575'9ETX# ME[U1V1U5_7?9;CD"V@X1@+P,QVD*BQ:>Q%@/VE&9:?+(R<3P,&]<<8JFP36K MDI)5)'[G)9W2BD[;:%W1Z:7N'4*X#H9/\@1X=$;!I,'VYL%G?X>YXHQ0ISQ" M+45HNON6;R@NS?R(EW\KN;:D6H\,(5)-=`L^2I-\/IEE;YA?$>A)FP5H=FMJOH,%PUM#P"R%I5=A2DEW>?-;Y&['M4-4!?RR;_&0!' M]6Y^:GY[>$R3=NRP:5R0.4GIU!:'`(ZF9H<).7DF!08Z3D8T1*:K,%$'B-MM MA&>6[]*5R6S&\-%:`C]@-`!B#KX6B-`PQ`D5C>W'GNVF,K9S&&C7OR(]'2'H M20T`N*;`F.%*A_6H75V9**'_B4O'X##L=7*V%OJRO4>?9FX%@3_@+$E@Q,7V)QV;`T%(\II[NE-? M"<2@:@-0).IE(2!(!,TGNMG*[F'8\ID,7D*AVZ>94:C[#&>7KE\`.86&*06G ME"/,>A-7S9-[RD8!T$D;#*G5O>+12=6WPZ<0H`>?6VA9'(A!FEW<=,O/YH$) MT9ZC4)Y@`.,0)L506G&18V@9'0K&*LN(ML\*-H`8)RC:SI2PO2'TO)#&3A): MI(>0?;@"JC3_@`8J:`9RBXM-1A\.+(_=N,G2USBG*<]U(MATS)9]7I6N2_6W*0\+:+A.S5M_SGB4((?R,R19[+ MC<`5F'S/PB[X@INE#_!4.06BRH$S19I,CL$4T(3S;O&,EYL5OG[\M"&>X(N\ MB-?T.,+MP6_1&S&?%_-D>5T\XZP^!([^EZ[XU0?`72>7-7+.2N!L/;ZG,W7W M^'MQ1CS[G9>PCN=%,^$=PXOAFC?>;P>0<(_BO$)J1_!I5MND*7]I%6W--DXD MKPPC8ADQT[OSR6OCS:/)2:6P]0!5+C1.^/C*O$#4#<3\"&%#\(A2D(X-`TF@ M\>]-)U`=Q5'/:R?EUTB7$9Q0LG/7HX?-*LK0,LX7JS2G4DGR6_:VVE(X\58X MZ].7T0MSI,A/4,I4$]>JV3J,F9VT]O!&OB4?)-&*?)`5,6F%:VUM'-&$';U#O4Z(<[#Y8X*I[1DOS[I':/'>KVN$J_L52PS,#3C+@6Y>@;7JWH M?SE7DBXP7I)OB%*61M\0^6J3QCY<+W/?G?<<0K5[P,(NK[8/4-IAJOT1 M_`:?+1CI&L)3]M-&$IQ*DN"3*@LN2O$69<&E4M]42BW)@H_*.#H8C\K8_D$` M9W?H!NT'>B33>;JFGK$\8?R=-M_/1< MY-?)/$GB5R)I4?;VD?P&XBU1_JRV9F\\6`6(6=Y^&XC9&1_.JD*1>Q]FNP%0 MTPAJ6$%G;ZC1K#*$F)'J_RM;J#1&)U\:YA"U%\Y&-8\434?"/S>@.+?>#2!' M47*TY<^3SZ.K$YWRH.U01@4DHJ^,VHD*G5@XJHD?X!Z(G@"5YN[]=+%UTY/; MXXM*M7WTM2DL.%H\]]2E\\*Y)^)#P;X(8DIQCW5'7ACOH>Z$6_C^0D'OL>05 MV'-6[/;L!:;_@M\CM`*W[Z9/G>]:=U;4,D/[7,Z*Z.45@\]$]G9X\QQ?,'P6*6.)QD!5J9=#^&7AUU[ M.Z9BG#9GMD1J<10+=RC=9[&`+R?/U)Z>=3V]^,,XP\O+Y`9G<4K^6V1QDL>+W^B;D81%9Q!>]4K3D;T" M"A-!_+909>[8%Z,3:<;UL2R9T9E>S5RU:Q?-I3.HX4VU0XGZLSU_>^L1NF9[ MEZA/]/7SI5=HZQ9B?H42`<<&D#!.AN&8*):.ZATOXAZU>?!5.%K.'O^:@A=I M.LVP;?M3U?2HD"$KI,;DQ%$CNS_87JBDLR7Z\2\K?*&LEOCC;3*Y?<,N+I/4 MN)&DEH]%%31)K6=A%MLD-64/3+$D=;G)ZJT`&7Y),[8V]%*FK1'MLUIL5FR_ M_L,;BEY>5F]U\^IQ+3H<,T`/J%K0+]>X>$Z7Z2I]>@MF9O@HY'(^'X5<^P>; MPB34Q7><+>*,*FVAUC[,U]]BQ(!WT M,S5EY6#(,7[`+Q[TA)7==8T6[6W<]3:-U7`.U=ZARCVT]0\U'$3,P[V.\D.D MRE?`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`"^O-T5>1`G= MBM.9]ZH>`L(WA*6>SU2V]<[/7)&Y=R$';]O?.N@Y)(N+&BV0&_OJ;6YIZQEJ MN-9?#:J]0\R]O0[@UL+D*Y@/5$Y/8=W42V\A_K"EW6R.JLSY[XHH*T:;J;*Z MPLDH/9W!:BHO*:](N?:%R.`S^O#^!)&$\<-1;J>V-X(8^%69\/4;3 M8J7D7B3+Z0CNJ'-D%MYR!/YJ?S2W/Z4J!&9'[J-H0;PAC5A3)M6+ M=+U.$Y07Z>)WNOZ`ZZF)YBL3=X[M]VK#_BGYAZ.2#_X!)[4Z(;N8^4/.MN.. MM#1AXIKG=0D]UR81TDU^Y6FL2&A>T?@!7,O1$=8B%.L/Z&OMW'\>1G0W$B+O MH=U")GU'=1T7_8?T`Q/Q*>V/-;^P::@Y76\XKN[NA:2.OM`P75&=RF-]6A?5 M.`4FP#J)XUU`I5++N\D'6LYOO2>1MGUE88?:IJ\'=GREM2($%6#%DA52A&T> M5QU4D-U;336K7\)95#*YO,E(:ZN0V2XJL=DAXBC.4)(F[ZJ'4'I/OZ#H*<.X MG(@JGNG*$\YPXQ7/48XB1(QL5N7!DHO%)LLP^9;^%;%C+^,D8H_%X%S14OW>HRV:(6]P-"]K.DH^FF(2PT-!X\B/RF1'WM/V.1% M?FK/.GZ`:5!C?.^G>N[T#S>N:A(8?REE;>Z.90<]RA:R:>S&[55_+ MM,[D,KZT:4@G[XU:+A^`.:Y'3$.A0YZB"EJA)S(U]1N[H'FRO/C^@A?DG_Z;^H4_=V5R2T0S>N"L?MI9/[.P/F)XM/ZM1H]\-IZ["FKFOLRV M;:<R9!A2*AE(=)LH8>P$50O9<:\)ZNL_._6`DA\Z4W#]C]*V[ZMUX3=4C M:;Q[0U5]=&.]FGU\"]5>2:&C^8WIB.'(,Q/F_@;Q2)R=V^'((,@C;?64\-9N M?P*8F4;4-J+&R_="'Q5N',(79KOQU&'KP2YJ;:VCAGE$ M[:/34(+7*.SGQ+`15:@?R'PZPXMG1S54..WH<2GOEQ":+-)YC>`F4P]1HC3F M$PY)I`!G%[RZ[>SI).]7$9Q2\9XYRK8)UZ*1<-'CS-!CFM6SI1&UVYB)/4%Q M@OYPD_PM^9)\O$_^C?SG[@^TPSHJ3EA'_#U:OZSP"6GU_F___.7]AX]_H'.V M!'&X/&*MGL(EOCS24X'IA&^"T1N.,C)"_(K1FCCTG)^@*%F2]C%IBA.TC-[" M>9;I(&7VF`MV?XYP=CPTSNH99<^#C7W(70]F]L>??+?YO0*8?#=TV_'DNY$W M@)/OS1.[#F;ZW8KAL!/P`T0&=`+>Q`_@*?A]UKF`SG6Q]3X@P:/3$WMUXOPT M=)*%$8&QZ,/`[JK!3;"PA)CDYM=X$]EE:.N\#V4!R=[I.8BC@&M5>B M.E5ES)T2EBY`[I,P=F'\"7?+7RV`/1+FGCN>8#=U"&Q_1'W.TJ'MCK!E/.R, M^##=`9T--W0%>"Y\_]4OO#T1-A<0E@P&>"CLH4F2VYT0DQ*E,'9!F#H=XAX( MFVL(3)D&[W\HCV$][GXX4%D]YGIA[GJX),[%21XOV$1*]U7MD/L;Y)8@=S*( M+(T_?R[_#0+8G2!TT/$\N,`NX(Z#K85R.P'Z6AOYSU!B@CMNP4Y/:Q$9=!J: M;Q%XPGEJJA'>6K_$SU'D@Y;3'=H?N0X+O3UC.Z?D'3$WN]X4>4%J&))$CK(C MU<8^9!YG9G]\G;;YO0+(^0S==BSE1MX`YH<-NX>S(]6*X;`19H#(@$8=$S^` M8]$^ZUR0YX`97T!`FF=_%EC:4+CC/K`]DT:W*?E$Q#&,3;)&'ALM5Y4$O4B6 MC@MYXRL(21]/?Y@U<[F(O>7O(U[@]0/.T(?W)XA4:A^."C4>U`]9H>"V^OCR M^(.Y0MT545:$I%$?`M.H#SR-^D*$X_DH4`$@_9`%ZD-(,Z!*=UTN6!L;AYS[ M-#`^?CPQ_J5"6;$R<=QQ_-!W9;<1:]^G)\T9"!L];!4`-'!H.P$<-?93@<)X M_Z.5UZ$($,Q[&^MU%STQVZ_M.I/1-;>SBL$KFX_M`/0%84F.;_$B?4KB_\++ M:^+5'XP6^8=6T?FZK/Y8Z5=49RY7NZU^',Q'7B/: M'57]43E`L!)I`%`=Q3/&NX9\J-K[Z"F)XYXQ!*5(EW\_NZ!,6G1 M9%*V8U`6%='#Z@VEE$GEDN@_-G$>DPPDKWCUU7DTT3K=).PQK)R%+0[9,>[---5+TO M\WQ#3V$[3_,B)^D\?4\T-R=6-6XEO>+&`-*A\@0B;9784!%>V+4,EZC^#K$O M4?5M"`Q4WN+4[$9P&23JU*7(*!!RLZ%.:LT63FRK6EI$JV:(8`"+:X`M&,!> MRO9!:#P4PA09TE",`>4XPN&-DABM`D%JRAIBIS7$XJ3(TN5FP?*-1XRWJ-HK M4,E#_V!0`0?OC-P.MM%TGI`T(LDW*[K/=/Z4839-1Q^'SOF1W*1G.ZSK]82@ MCHF/(`%?TZ"22UKCS!KM$&F(=BW1MBD[/RL/@F%&B.G2S0)N'>;IC-"C85A8 M=3`II&\7!+3EA,\.MI$`MB?LD)(#P:TJ$7&&7*@41L19E_'RKM("U[M;&U[3S:_8_>2#5^N]V0=/UH%"E-??"FK^P9?3.H') MCR]5DLZ,U0\&=68@2HM[/0?AE]B<:#2&LO2#D1-'H*&V^)B+\^1Z,QM&I MB$_1HOE@,TF8UW&>I]D;2H@+G20\+@7O."]Q,,JH,3.QW]H(.#?AQU]GDQ/^ MW`]'(*OIBOWLSJ=&Q^ M/V>*=Y2?<=!\J/(#>E0[._CR^O%\1:)K5/I/=.N9G@#$F]_4:-Z_V(RJ_KZ;6Z00#"HG._4]-[PB.NI%N':>-ARLD9 M/"I[]OBB$QJ_U6^#8PU0&;!R]%*W"2%W!L68O$0'01E,$2PS`'X*C\K8`)"= MJD%VTJ@"_^V-'>R7H,_Q(RXG_'/R[W5<[)_>R2LE&"R"KITV#3V8)0."YJ)D MH-<2@8?`DP'1_1:30XX0(34>M*GA%U/.DP&>/7M\ M<9*!L]"3@<$8TT\&K%$&GPQT#3A-!GC&!H"LGPST0#;19&`X%K63`7LLND@& M>!,5M_2TY@PO[],S_!&OXE=,_K@QV2<%/C@GT8`8'(S:<%<*-XD+Z9J>:`"8 MFM7M&TM0_]A$J_@Q)I]=79[EC26CQE1M.'H""'JN^H"3BJ=4PXWP=6W/2`OZ MWC%8KWPQ=I=YDMI&L!=PR^G[E'R(MH/2%]N$O"MP,HS6RH3#Y31HE@W@CHMM M);#>>6/W:6_7G&!71U9SO'P;R'++TR']SI51\"\!]EJ`>>. MT4X*@UHF[5$(HFZ**$0W4`_*!+/7^-Z$O4BWR>+&_I.])SNJ[T,W%& MQON=ERB9]FTF2_I]AQ/=U$^`I,G`I(+DVB/-ZI;LW4UE6[:3!.U:(]H':1(-$W0TER MH.;7G#2G_!J,9$UK<,E*-:H>/5CC&O_LI9#AH+MU,[@`YMPN'D)I,SX('=Q0 M9_%[.[C^G651>,+W5BN>RN\N)RH.49$T^SU.GLZCE[B(5EPAX;9H:4FG!0#Z MN#8A%*4[L`IZ[?:SZF]4?1`"_/BW)]7X/;D0;+7LHM#QC7:R?YUCPNBF,\FI M;ONB^EF6^#%.Z':_'"TV6497GJ)RI_`*Y[O/5G'T$*_B(L9Y")-.%E!1Z)4^ M6(!R^?:8>AG[GTNX)/@I*O!2%9KZ%LS0\ M^A)E7_#Z`6>\J,7[OAFSVM\/1R;/'J"(=8970++5>GLVQ-?R@_\,08JXMR=5 M_J(\"#;;=0#H\B:#[J+M#6QP@VE\ZM[BZ=UA>:#1O,>PJ?&G.,L+>DX&7>00 M*XVD65-PN,V&0U)B'0"7_-$5X.1UFK$/4?UI2$"5W;]4][?F@9;3O(-=?YB` MK^%%1LS!P0ZY9/"(]PT>IPG*"SI=N]QD-!^G?=C#G4$\53P,6-*LW`Y8H/GY M'2;7OU1'3UF[9OCDMQM.!)E]@``J&%X!?VZO6?EID#%4>A=3[1^^PZ8 M?6(#/I`*K5B`A(;2"B8AQM*!,)%'4TN@P,13[L@N`JK0D`U:^B$U[X!G8C%U M*,"D4=468*!QE9Y*<8<+XAT%RWF:%%FT*/++Y!7G!?WH^EM"1.IQF7[<893K@A_@/$=4OS"I):C3IC!Y7LNJ%M/[3K>(*V7=&N;P", M'83#%`P2/+[;C-?1@RFQ`SZSL?;"`4UH9M2X322:Q0FY!DP+R(1%L6`?Z!F9 M(O*L:R22P&1M5I9=9'76CKA@2O5@QDN++>DV?*3"$S,RO"+729/"\H&,#3WS M9O5&/UG1&+5[IN,E7<6+F&25WY[CQ3-)-Q')@/!3FL7_5:ZJQUL/\_H]#1E^ M23,V//DT+MY"R#?'IJ8T7QV+FG;Y;G4OV'UXC/('=C,V^;NG*'KYB>;!/^%5 MD=>?L,SXW<_OWWUXSW+CZN._7Q.DE,_PYN?E)HP.^]4-JY]2UG"0\J@]&):? M2L<7ZX6DVXQ]5IV%=X*JC\>EG\9]3/5_\0Y]Q!UV_##`AS_X7R:+#$+EQ?<7G.1=DIAV4Q*XV\T1 M>?G>N2)NSYH-:3N#B`A;-4-5NU"Y*H"'!D^EP%)SM-U=AY^>(-F7`L)YL^))]MOV>]`YC-&P+" M%`H0O)D\B^$Z$WG3(0;\,I2M$_`,*2.<%D?>L5.0Z#)5W6)Q9(GJ5*]1>`*S M%&5CV,5*E*T?#LA2K4,MHOR95-2/J_1;R1EVMM=R&=,+B5;;I^P6='4B?MC0 MC^L5J'*EZ(3/I1`6D,8EDW3Y:!PR#3U<63PM#QI8%&9LEEG"+M"'K;,HRQR[ ME1;84N9NLUY'V=OUHV#5\YZ]0EEV[IS="*UM[H8C`.QS M\695>QH7Q#OHOK)>C=/I@MA&;0>S%."^<_?%&HW4W3$;..`=[/($_E`,]DF!FT\G#"N8NP$*=EA#1PV85 M9,^G2_8N=,-G12LONMT MZ:R\R[N`5$(Z7L&LN"LLJ8LBZ0"S^EN*J>K[9O`*HT[2PD"O8C)`3K=RDG7M MUU!&>!MR/$^<;R=C1&P7$VK($*U#?DR'`#@BQLYKB#-DC"VK#IDQ''#6["`K MJ\)A[2"@I1`WGGO:C=E0W0-Q@@<]?$UEXP`L^MDI3(TN>2?+/%2<*\YU\HET MF++*U*B+NLK&!V"XGW+@SA[RR7=ZOZCUOL&#$&JJ<8@@K:K\$F',NNIR_1+% M&7MVZ%%=4BE:=_TAU(">SIK/17M1[-E\L,ES/SS1.P*`-PX";P'E) MR%?=&>'.>FX_WH9ZH0&7>:43+9/9LDXPJ8(ULLF0)CZ@$TGU\QH#4TDPP;(+ MTA_,D\F+1.,1(GMO7*62'WZ8W:>CO\(EJ/3Q0\CIXX<@UH(_;0C:T^2)R.WZ MNH-7MZ0DBK&ZJ5A[1&$*\4:(P`GVMH^0Z\CZQ@VR;[5X[56F6ES M1-N_HQT0ZT$_K_J@JE,8$F(#,4G:;HI3<0ZO'$F6T@<(=L=%IIY]4-2S$K14 M:_;T+;D?607QET.&N$&AZA;DP!O=Z;,7S^EJ2:!Y02KFXHWMN^)MPE`T;6U= M%S4%V,HH]P)B,[K0@FI#HJ#CK/D%*K^I=I,'L85<<5]3D]^?NTV0WZ6['U`3 M,Z!@_QPG^++`:^ZN(XWF\0:A,F$_@U7 ML4$$$04CMMV4K!"#:@`S?HM6&WS]>(O744P75*YPL3W4LS[3\Q:S&=7E?7J& M/^)5_(K)'_/\IGH0ZYXTSA_)'T\99M43F"7+#WSD5$%**R]"6RD6UE@_]$$&FPDXT'C)9;V:@. M'%BDZY2N/OF:?U*_FG-_/C]H!!^@]4@^8?:E./'.Q>=69HV-(R"F\A&!V M9@D]!/^EDA#V:GE4U+E(5%L/82_MU`5%NBMWJH(R=&>";&[&+*?0?5!88LMN M`JYZ'J/UR.]CFJV9(Y191<52=0`BW2 MZEO56*O2':QS?-X?=XT)Q7]L+,BKM"`QZB9ZH^KZKH7T0P.Y>EW6.TKPP2G?#GS-'_,S^1?YL/Z(_-]#E&/RR?\/4$L#!!0` M```(``1N;D4)]PF]0T$``.L4!0`5`!P`&UL M550)``-H3F94:$YF5'5X"P`!!"4.```$.0$``.U]6W/<.++F^T;L?_!Z7]>W M[CDSXXGI/5&6K`[%VBZMI)D^\S1!D:@2MUE$#W[UZ]0'N,DS=>_O-Z5;Z(R M3M/7K\HJRI,HPSGZY?4S*E__Y__^[__MK__CS9N+`D452EX]/+^Z^?G5951% MK^Z>RPIMRE?7>?R_7MW@[ZAH?G]]>WWWZB(J'G#^Y@WMGJ7Y[W^A_WN(2O2* M\)&7]3]_>?U85=N_O'OW_?OWMS\>BNPM+M;O?GK__N=W;>O7^^;TMTEUZ-!M M_!_OFE]VFZ:"H=.?ZZ8?/G[\^*[^[:%IF;`: MDC$_O/NOKU_NXD>TB8Z-4WGC-QV^R_0O9?W#+SB.JOJ#2C7YBMN"_NM-V^P- M_=&;#S^]^?G#6R+$:_+]7KUJOF"!,W2+5J_HGW^[O>[1+'<$-82YLBH(3-8I M*M_&>/..-GU'?_CU0];PF\RG2SS5#[L\<"KMD;,;*UR4V)LP$W=VRHW\L#ZWVK?VQHW>;35-ZFFLS5>TC1/'_2Y:;M;XR=:U4-J,W3H;^]K%?K?JK#) MQ[;0AW#3V1HO9:4/F;JO-4[6L3XG=5][.D$&.D%6.<%EM#5P,8?^=KU,GACZ MF7H`VYXF,74UB55?H\].W=>JMS'@I>EMT=\88*?I;-'C&/#2=+;H]3&7R@RN87 MTF?DNTT^:AV7N/[#Q-V-QK'-X0IMMQA%Z?8!;&N1RM:<[]2_2`,CE+K+&RHN@-1;.['VEV]\,?:Z;[%,Q9O<=5E$W/ M;Y=,E^EM@4J45W5*G";N>SR@'Q7*$W3`':6CD\.NZ;44,QSWB&0T(8\+"%C^ M>8GCW8:PN\B3SWF55L_7^0H7FYK[Q0/E(CY,XQD5MAE)J1_Y-952H=\[=?FZ MFS(EBM^N\=.[!*7OJ,CT+[7L;]Y_V.\I_$_RHP,S]V38@9"\7^]E&?^ZSW(7 M!(NBSWY4Q.UHY*\C!/3W1?8MWFVC@HSW)GY,LP-X5@7>Z'P.+!7OIL/^J[^\ M`I-X5>%7XZ%QD:#BE]?$#Q&UK%!1[(U=('8M7\*HO6 M#$@P?]_!Q.#WX8%")*`I*@9C[V'Q4P"P:*6\046*B:#))7'.`H_!;,=P'8-V MX<$%(K`M9S*@L8?/SP'`IQ'QEDSG5+*\^A9M6.@1->N`A]TL/.P`Q#6%#IO$ M'CE_"`8Y%T3<(LJN2>3XX_^@9RYT..U&V!FU"Q4\8H'MH&=$8P^?_P@`/A>[ M@FK^*BWC*/L'B@K^U"5KV@$1OVEX.`**;0HE/ID]FOX8`)I:@1LIFNGXBORL M%$1"W+:,:(C1-CQ`006W%14QZ.PA]:?@($4-`P:H44LNG#HM0P<33VB[4.I0 MV0/ISP$`J1'R*LU0<4$39[C@ATG,5J,@:=`J//#(A;43(`TH[$'S,1C07.#- M!N=W%8Y_OWLDGZ%<[JKZ!'J:LU)`\$[CN%O8*52$*:C"4D0N)-AF&]^;`_"O M[Y@9_?F2_?4I;S-;6$7E0RWHKGRSCJ)M8Q`HJ\KV)T/+V/_XGXNR1%6YCUPY M>P&@MON/+VEK://Z8<1.A2^,T=FZ(@`^'%67F MV!J?4F^VY%`X%7,B\6.]B'S$&1&HI'%D]0PW+E!WOJE)NON$1IBD6,,%R?$I MI-V?&_@T3P6QX"@/U(>/3<_B/09?*G*KR.N7X4&#,KG093':93=X#(5G'W5Z3J`':RKPBM\3+^ M1-R[<@BB''3`PXP9Q;YIOU3-G2C'*F@Y$)39T@-+4@F=Y-)RC0@2)3&'MV\_ M'J<4I?&09E:1-:X'1YSU+719/:)B*!O'1H5M!U;*:>L)@&`A%T1>@SP79_B@ MX?0%Y^M[5&R^X0JU*05>%"]H.@SBF4V=8\EH\2R7WN:RF4DM:*01[6RC-/G\ M8XOR4I(Y%+8=AQ>LML[!!MZ@A0BKNR'+&3MH("WBN-@1AD>9)7X:6MQ^G(GF MM7<.*N5D-$ARTWPTCXA]F`6TY-;,25M:C,.I!^T+.H?.A`>".,V&9W]&S3Q` MGTJ0(I'3:(TZ'CMHY/2F3LCY.$-&.0HL)-K,;C]Z\/WKM=:MRA&Z1-=;GU#/+?`;SC``:NA)YB`)52D MDAID4UAC>W![W!`_H(,Q@I8L!`5^)$8NK='Z@SE\T$#JR"W?4)=OH_L%&)-3 M*[,<4PE\%CMZU"OR">J;.'OIE\5BM2)"DH5D>86+Z[+V&I3M:M%H-6?,BK*1,"O7^;"-]C4M8Y1E48[P3FE/3=*1 MO\'&[>@#Q%F741&ZBH@Y]LJ@LTU6*$GA0"1Q! M$&Q*1W`.5?T@5$T[UH)3*5G[``XLU#--DNM$?H#4>)@>99$D]>Y`E-U$:7*= M[Z=O7CY+W'J8X.*U=@X_-<#!I#8*M+@DP@87[``2\.Q1X,>.ICMQQ#ULI%[F MS(>U*7C+'KQ7?P*;]-/NS@NVY8/'$'..ER-*V$WQ9IA?:#/)K4&T,DW"C4,Y M:)1R9OW.'KI:',;H"`O)>AV=8]5*=,;7Q12!6H^:!T5&]3%YG1,V4%D=4W\< M#/(;#C#':N@<8RJ1FU12@]B--;8'944-4Z;@$$[2FI4%>2`?&V66Q1^*2X()#ZY?5[FP>WO"@3 MNW56)S:<,AK.RALT98H7N^J1X._?QT\MK'3`ZR0L>C#NY-PUZ%YK4M*&I`(?BW" M)B99+T:$>3YF]!B&-,H$].#?5CZA^!*N!TM`%!(,>L.O(YEB6*G0DP_*$PPH MU?5B'Z324#+,K.[(#(5QI*2US%,&'T'"Y)_*0PYB1Y=/&EH$G#QP5'A3"];E M=/`W>;P(>E[,PIN('J2-2XR=I8VO<\(-.GP<2:98TGIT7(C3VOF1J(:SY1:1 M;\(W?TEKSN&H46OG1B_[:HP#4F*1.2;.H<,Z)#4:/^B4[C>'1CJV`8-"6 MV1Z*:1=-GZ(RC1=YU\D>X13VGXX@?#;.]SAP"M4EO51F2O$+0C$:S;:PQ@V M5$Z(S8_B+9I'E:+S?3)TGPU0)6T MEW.0*:QXU%2@O_*1T@GZ8,!@74=#2MBBNMM2O*!N6CJ'EE90+Q?:1B3/I!(T MK$:>'#KS0V=\#P"E-"'*!#69$1EC:X/'BS/??0#JMG0.(87I M3BZJ_A3''#OHXHJM1Q5'49Q6G.G,GRC):"J;+B$UHC!%Z4&_K50U,:QOLP!* M01_,4LU$JR:A3R[_/&?J69YU5@>=#]/&KU&:EW3Z0^4R__R#BK=+R\=F]_L2 M/?`26.!^PP6YO%^88%15B`U0`F@&?4KP&)S12L`7."<2[HB0^^@-Y^4GM,(% M:MK=1S]0^37-ZQM[[L3D-T^D"547+]QVP`'S9,),'#@W M/:7]?U>?QN1,P8P\!UVEZJ"!O?O[A'*TXI9TD+1FFA2C=7CPEXEL"E7&^$$? MY?V&*FF*A=EF&$OWVX0$')%X!HNS_JCV*S#XK52]XQ?ZZ@;3LW?ZU(&U_H;2 M]2,5YXE,CVOT;;=Y0,5R54O<.6,+.PMB-MC`_G4'"PG35A2F#W%=\GO$?PP2 M\;?H">4[[N;1\->C`E7MKT/"&40.;OKL$C^WVZ_D+O'MRC&>9S6#Q$>@ZQ[?!&5CS<%?DJ)I)^> M_U8BLOX[?)Y%7*5/3;5`\5&T*4F-"@%/0W)A5]8W1 MV+DKFA0LPYIQ,FWQ"G]-P..HXAR#-]U#>22^><#N0X^[W7:;U6X_RJAVKC+\ M_3I?X6(300ISJ?4>XAW:V_GV.BW`+=E;[S;A;*PW39Q;L^I'8^RM,X3EW:J$ M$6-MKS=$@C[T2MP/R^7L[Y/N6RLP,3KC+F`BZ&!1'.\UVC07K!PP$LW[A0.ZL/WJN MP[DK7'21\@5'>2E],D*M\]`/`#O[Z@P@P,"&NE+S"`*.>AX!R(ER4.#76[\< M):FOXO4'@CD&/U?@I[J=9_`US7;ZU`G+-P$##=AQ'A--'-U5GAR"F>L*;:0& MJ=I_?%H3VM_MR]"W*-G%%$9<1;`:L=YW[C1R;X'*GV_XHC-/9/[!/QC!T1O. M'4)!6URG[%*;'Y`9&:0+OPP\HXMSW($DPA;G?7D-K!$?`Y>O3#]HE)()KD!1 MB2Y1\R>1=5^5I'U>J7Y1@G]03:7W^.`:K+=S&,^U3Z"G3T<;!V!FE>\R^K6H MZ2[8;M%VOY);KFY1_=333514SX*K!:K=!:D[<7?G5F(_@Z>@K\D3>6)>@K[L M#<]ML,YX&^?V1(-JY_G8@_IJ(XJ)+:NZG23A99T`G=#@-EO.+."YVU(::8TO'?4IB:N"$$&00 M:5Y(/(ASK+I+#REHUYLLD9AGY?(3?B6+X/D&\Z6TXJ#:!^;"6DHKIINLZG:2 M))0IA^W^1)@57>!K4'.#4AQ4^ZA)6`:E?DS#GFZG.M=AQ&'0A?4.ZU64?!#= M[1DT8=WH.31QCUR3XPT"<6T>;NB3L7_^-]P4`?RP_S0I`B']H`]J,X-OO".Q M_DWT+#AD#.X'6;GU^SD'K=/%FD"'/JW/^FP&72*GNX5;GT]H"DP!-NL9K05[ M\[W6SD%N?RN>KXW)=]Y[I!W51.7L_WQ)5\1BREU!L_\W.$MC(L_-KH@?B2DE MOZ75(^-DB$;/[JX/M*=[$&IO^&@IQ]I>#Y1ZT.5YJ6T25=`_J&D]11F=8FY0 MD=*Z>_TY@>,L=888/MJJ-(1S1*L&O`8:,@QUU2@'7?.7FV'^DD8/:59/,:K; M%8RNT$V*7E?GB'6^-<'7I$\![XC3H!_<[DBR*,O=AI_J$;08Q8D["^*9Z**^KR,4NS`Z0L*&D9]G8/33K0@ULDD8<*( MI"Y,MW6\09@I*M=@Y=Q6.$X:&O=<.)UAUUQ&G9WCU?$M%[$VO8D6V+PJ%Z;U MZ]C"^=T,R[&%O?\J71:QNCK'JKM%D523WBR)6)RV=R$L/M41@*?2JQMLZ*?`1(-^/86S$K_0 M+U/"[`I+WER<"Y1`->F-EV)QNBL)A[@N?AYEU"S2^G6Z7UZ_G^;Q8Z?V0K[$ M-DH3V9/:L&Y2.QEV>\$V(M2@-_8QY!)@&_`-`5NVP3F'):VX3!2W7$GOXQL, MTSVAI36,<_LP.S-H27]6#Q/J\P3`_BD\"X2C![QU]BK0LEA'>?KO6K@+G),,E[L"W1/\?Z)[8(7S_9).,[;BCB]1]NLBW%"/CV/MA^^UB3-L5[7347NT; MYQXT3?/TP9T/;?:;FN^79776JOLCL9M4ZSQ*XL`Z&SJ[$L5OU_CI75J/317S M\_[O5"4_=U32_+3#%R_FE#?2F<4>SDZ.'6>E9L. MHZ<+'SR$*0BP->4-'(DF8X?LG!9#)^1O\L)9G#%X?(SH7!);R#L,[PP).KB[ M'$69JE^:N2^B!)$0N9[VCFPJI+B,QF(I2WTLYT$+`!78KL8XL0R?D=XU+#T& M3LGE;`MW.?_NRPGD`^1E5+_U)%O60+L-;$K>S9D;XK$&=SX:(P#5XZ>C`6,` MV]`1Q\G(F.BZ&B7B)^1@RLI=\J3>T7W$&5%FV92,H;Y>^NX:I!.K!)Z@D]L* M?R/&X'Y%N3](,7[Z%."7'U8+U-`.]XRGB(%1_4`8X1/R)>M8QY=P,A"_XC1? M7V!"KQ@=Q>VF&$3MNCD$=CM[&9/N^,*([(,%@[\> M5I>;^U0'FU3_3@27Q"E9-RZCKF)=\">RT._9+0J;4?/07-"R$OTA#*\I0S? M5=$:7>#--LHE`-7HV0TRH3T#@:&^-K20IT0NZ!>G_E:BY>IS6:4;,KOQ[NZQ M&PUE]OG:=433!X@ON-=G"D_0*#I:HFC"`)(!9TA<[/49$3%="ZSW>/Y$/! MP`CL-8"BM%=@0%33@A$,I:2"+M=&R^G?H:IJ2E30)[6H_'O'SSM8`^DSJE`L M[!,8_%0T8`0^":'0*QLU+_3"')^L.>_1Y-!='5!N(YCQ:01=E:9W_1"X%`%T M&:Y`A%T"0YN"_&;K#2&=/>H^AHJZ&%%'346[3=K,<8<_P> MX4$.*+TIXOADVKSP^Q/8=ZKOR.3)^8[<9'?DK(?;1R:_HNH1)U=1C$2%DG6' M@07E@F&Q:SN9''8 MX7M\QL,&B/J)=&IL!?;X\NNMR5M4[8I\N=KS7-?"*NEY\F7.D99E!/JC=#&O M,TJH$#?6F!U$Z[#A*'FMYM8/+VO>/Q9XMWZ\R5"R1HMU@>IV"IX<.!+`>4M' M"A7,5C0WJ8N6LN(H&:X(:EPT%50&[-.)YCJG>Z`JN`8/!H$V8+!30[>J_J8% M.(";H+/N]+&*ZYPH8T?%HJN,Q89F3S@K35GS46$I7O,`4:NH`VLK1#X]1]EX MCG>]B+9I%67IOU%"T[F[K(H(NVB8M`"U[?I&?ML`0:0BO1W/QB<6=%J];Q47 M.*/W=PM:`!C@N,;-A8ZKVSQ`S"GJ8"+'U:77IK#FAIYN#FOY/2>$']/M#2KH MKD&T9GHUDW&4LE3,<0)$IBVMS92'8C(">Y;"D\V@?-BK58'[QK,Q8'#]YRIE*T9?NQR*:C^UMB*[K( MHK*,ZAII!U\@L`M1]`/AZ4,,7ISD/7Z/F)X4O ML3(FQ->(L%\[Y$T.<[FZB9Z;U5@C]3Z0J2+A+*_8OM.*\S)-4'-4]/XQJG[#NRSYA.@FT*?G_77OZ]4BRYC**%#[%)KB MRF]VXETKF9%X\%;FZD-9MM(9Q?#K7$`C>%0^NK7TF1D86_ML#)R(Q;OY8)-8 M_6RB.#HM(;+\)E".GFE%\8[<])E1-+W9STI]9/,S43\-@W?QJ::P]IGD"/JR M:'_S^CHG3!%-WT85JI^G3+@[P?H#",\@B`<(V;Z,%6;/1'18:5'^]J[-]> MH,^Y7^?QC@I#_\Z!H6+O41$F8.]3`*R>JNRC&,S'`=J>I/_N>FSOCT_2?[1! M#K5(YM4MM9[=L!S:,V2`ZJO(!CY5W"QF[FLJQ[U7E#%@L8^$`M/5YS>Y2E8-2;KL!+!GM M3@&',O'M`X]!L46:)T?,]O+=X\Z-!US(IC=GU!F`]&(=-N3U"QI:Z2FQO M&$MHMWCSZ3`67OW?792EJQ0E+!FYIV:`_4;'9Z3]@D>@AGJF.%`CY:!%HX6C M6\YO".2%SN4`6XF![?ZXTB'^OJ`'1U"QI>\R?HLVZ!)OHC3GI@84^X^2`^#^ M-E]]R+Y&Q5>T>4`%RT>P?M]_P:'[>^>7@-2_`98+RKG?`Z;5>:NA2^-X+MYA M=<`^OXL?*6\U)FHZJ@?(:NH<&T()L+D=8"8?7G#YEWL^H7L M19YGY^/=[PI0`63:&9+\%I3FDP]1TEQG)9,-O.II76$V= MFZ.5SXZ5-"(NV:G%2=^261SX9K1$MEK&(["6)%'H.7R,#=+3+RN%?'MLHAN(@0J8Z#W'!B'NZ&JBI?*M?85B25=#!W=.I\2-*=AE:KJ!^^UZ0OC4<;?CLJNYHSNT<@`UL6VL< M:^>STGNV59<%#^;CFM,C8\S5-Z@M:TH9MW4.+F%H-IPP)+)R%^-C$J/I8#PT M#PP.E&1J4WB2%15'W9K,=K^(&9.G^>$`29;I/@B;^/'>N2=G!,^'82<,V6V= M@C6)W#6.OX;YJNU-@6.$DO**?#Y:GPS%3;7/P5S%.QZCUGMX2@;:.V@XZ^G( M(I;!#-@OOQ#V3*B9B1.UX_V9F[<3_GX#3R(XIZ ML>E!Y*2#?@?Y$A5$^BI]0E\C>A2V>KX4O/$N:3T*VSBM@P8C3`=6`S(.P:!? M/#X$EK)`B]]P].#7N&'02)-*;A%D+%JZ=1J>4/&`O3O:M"VV+@\WU9=>;NCB MOKXL&]61J.P!/&BWT9:SK)O;W.O^Y'"'3?*]ZKI5]3D[P):?V@BL/"UT!.<> M!(R!82972T?<_*Z8B5&N%TJ\C=:54P@L)^,XB=!5$LVB`#('O"Z"=,&X2Y`0 M5=""!4R*J0&J>,]^V-S:H=K]`F:Y`L(3TF5\=%;0)4AX*FC!`CS%U`#P_,D" M/)V':&6E]5`Q]_HNCG]_Q!G13_F9+-VKYU&PW;^S*VW>OZ@K:.[N<`;EJJGD M_UKWB+>[7.PZ,7P,YNKZ5`/C(VU`CK$HJ`;N]0 M!9!>&S2%>;5SK`P:,4I60K!.+%`*.KE3`?VB-T4:<\]%C1H,1>LT<#[!`C\. M!LC'VT$04NC94&=DBU>S_''F]:TT35_.[@MSY<.^I^#)A?JP[\B'Y-J=@[G] M."=B^AK]2#>[S;<=/9RU7%W@S0;GS>2S7*WH`PGM2Z]U0AK=9%',+6]H/%@W MVC(8+"#G:%5OVH[4E(O6Z8:Y'];HA!HH7:H0LZV%%CZ+"NDR<+'B+@%!5D,' MQC.\F%8+OS!WQ;IYJE9"^I*\T-_J=1:D&$6=`P2GEEZ,80JEV@+6DW+HKU0DHF)J9H.IY-H$@P5D`E;U9IY3T.2B-8`PBV"+%K&6\`\;2R$_\2+0KZ2U MJ<`O8\+5*]\S./_FYU>XH`]GZ#A\Y@`J3GXPP.E`6ZZ?:9WY@'*[NQKP1@O' M<@TPS.^OX*A/%L%2[4SJD#GX#;/"PC[K6*\SJ'7>[1[*N$@?4/)I5_TM3VM9 M]S^L3T?(;VW9&')4;LMDR`"!;U&'QK9@QHO%PS,>F$?9DQ-H`.Q.$H@/.YT` MB(5ZL`[3(;46B)X\_WR886C.DC[.P"G"#6L\.C;%;AP0B)3D-LN_":BTH`ES MH^WF<.!Q+")O?P/0A7,SDMTE(,AIZ,!\!T-(JX5?F!MM]56$Y>JWJ"BBO%H6 MM^GZL3HDNU%,[]G1&PM1EM%7\?;MRGU#[NQJ9]3A]&LZ:H`XMZM)\PGY9O06C[_0$6ZQO*P*A9"FX@L!OM06U(EKI3);B&I9-"!77511E+E.PY*U7IJD4?%\%]$: M*,U6";\@M[3],,W*;^_;&5UNO1FHS+`SN:/J,8+A(7?_E-/_SB%WE)*6DENN M.A?0A'7-X1V'(`1T=.\)I2C#!JK@N40>T1Y``<0\0RIG=KU*B[)JEXK\ATT$ MS;JS*K.9>QS!H8'!\O+@(Z5UF%69-,)`#5E"X3R1PT;4KA>-,=N%"!R`Q.;( M81.!!&-VH.-A9*)X*5@Q,)&/#E"^^OW/GO*=W_=>QS;O>_^*TWQ]@0G!(N=< M)I6VZ[H0=CN'E1PJ8K$H^1P5.6&L7,3Q;K.K2P589CR- MQ(XN[%QG&6^C?"UZ67+T^V&`>?R]6QF$+P`Q6K#D\,;ACK6.(<+PJIBUH_5" MW>XHH:*7FB_ZUX[(_/F)GG*1%2"2-&=X2W9S7P06/LLF:"H6U)M-3]GGPDK2 M"J8`%I7AWM-X]!.Q&LG;PI+6$BAQ7@1VCR;A-J9<7AB8F)N8S,%/"$OB59VL MO1Q/7FU%BI`B!I5JF,J@)$&6N]CTO$,4S@Z1_?>_/#!%RV=45-P[9_A03SY] M37-:14RXO&*V&3CR01OGB&&MHC!,)-$RJ^G0Q<1@I%!Q,("^$`_"MN()WAM\ MR&=L_O2NY+]Y=`23^W2N>T['TI0G%#L65INA8^FW<0X&L:M"=:_["*9$/;2YVT%\\*)%_+O`)^8QV2WMRJ"D7 M];1XU="]TJ%)))Z-VU1JEP3T1BEG)FVKAFV7'U#U75>[@H:>GU".5JE%7'L]7/7 MR3W^A"Y1EC[1HO\D+EN4):KJ/#'A?[$N$+?VL_7!N[.WQ<�/:D&M6-""SR MXZI'+-2-IF6<8?(=92_;:8W!".(4QG`: MYDKYO">P^$28^-U$8:-!=#36&<2YJ].#";:D-HYS4V)J&#"K,&/O9+YSEY5O MW?FK[M/L$K-Q[EB_._.K M;P"GV'A@QN+?%6_]BDCQGIM6W5RD`W->Y8U+]IMA,/1P_ M`^3B6(D`3/V$XK$TS=.'RMV:ZCI_(LPU'C[+EM4C*KH_$OL.M;#?8"#,NI37<)YVAT7O4M6#K@(T"S]^&+& MMNQ,C#::\<4#[#:;J'CFNC*`]6J-T+,\Q1&"M1H335E"O"(+D(JL)Q"7E[@Z M)TI/-U%Z]//'_%17@/HPW+(YGKF(J_2I+7\*C_%-!^;&^OH#.W>3]C.FUO4] M>=+4!LXBF<^B#)_*4?",>N/Q':+J>,[]H$:"UK8:S9.V M%C@Z(3]6)W)+7/^A5QG\G-"=6#7`W%Q[4^S0X(K`/\K^@:+B:U31M_*>)6J< MCM!`Y5,0:OHAC5UTRFFH<5".C9 M.(A`,)]A*I>K0,#P,YR"BU4!K;IK5?\69BX5((V&*P5)8=^%GF+,K.XCYXZ5 M01P&73?./("@2KG_CB<+C0?C6X^(#^,[-[A0`F'V%PDT_CT(\Q+,F#%Y63%? M^;C6HJO@S'7VH&H*\YPMEGI1YBAS2X0EWGLD$U"89F9M*(1BK'[,K8RO$O+L MVHBC6P\V)(/F.31S0X:,;'>.#P5LO+7ECG>S-R&`0-;G6+#LEDG,ZQU&YUU@GTY M-BES3NG3M`O9+H%IYM>:0"BVZL?\.OXF(<^OM33VGUWPSY9YSLS8A@$#VYU? M@[)9-_.K;1N==WY],3;)=4Z+%1%CXBF62R,TV]+]!$1^[*\D1K>4X-Q_8<39\ASY3Z M#SM5N(HR+R\XKM!VBU&4;A_0UN$U1^`G:(9O,W"9 MTTMW*"1G6:I`G>>A3B013Z10"VY3EY2&%:N3\E;Q5MVG.=$)/T:P;E8;V(H. MUMK7,W"ZJK*JNEL3&9VY8,?+4"O7K*3#VEIT!G?)RM%:^/V(48VORH)&-AJG!S614F7D;+UZY(N8F7-2Y-^3,``#\0PP`DI3!,Q M.S;)H&-FN9$&&34';;:*082A"1M0FSYV#LBT/8V>[1JX9_&S8S/W(((VOPD(3!(Z.[;&D"-GN7V&&#@' M;;%JP8.A]>H3FSQJ#LBJ_0R:[=JV7S&S8POW(60VOF@I']=JR!S4!4N7(;/M M.Y8N0F:](@=^3,``[S.VO>D(3!,RN[7&H$-FJ7T&&3*';+&*L8.9]>H3FSYD M#L>J/0V9K=JV9R&S6PMW&C);+$\"&MI.X!QH<1(GL?-T)4IF#9]-"Y7X,1\+ MG9W`%">E83F.]L4XPPRE%E/>XPS0R'V+K"=,E;Z@.H M_)=$$QDN=P4:ZLAL\0D?7[,^)F!\YP;HTS)4^8-XO!:%R*)M6Y%RADZX3&VS.L,F=86`9BLKZM M)4]O^3BAT0:Q-IJ]/J+Q(FD.CEM,V%PMG1P2WHX"YG43.U+E#-4OD5 MT:KL0HDY;9G"CMHZ]S:`KX;5).8MUKF$>JMN-H&]7;\/-!%V@3>;=.\+\X3Z MNY1H(8^)T1_S!I(\L=88`Q`JCN%,7W?Q(TIV&5JNEEM$W"/AL@9&LBA+5)7W MT4/&.Y"BTG6@'5A7YQ:K!P1LI"*.32NQTC5S&`O'$I+.D,ADCTSVZ+I"&]X3 M`[!.`_3).CF>$?/DE@(@V\=APAF1TY8Y(X[:.K(HG;UCE<8`&4BL1:`92$@".83+<46?Q( MN2^\2)H#EB%-%%:8Q_$IL&;K!VH32G`D:B0`1R.`B%4 M9J:4^=Y9W'[LH7GMG4,"/JFK2J\]L0,(*=>' M]#&?J6N-2E&T)9N4T;3W09RG%W.7#_!=HH?J.B>\[6K/)UC/"UH.YG%F2WR>$70=!BK,)LZ-W'11\)*@G+LF$&@-Y4R!^XF#9WAX!NN4$D< M.F59DN$3-1W@@-W4.0Z$$F`5H^;@@$6@"P3FP%[@H,^9+(,D:2WT?-R?7I MM_W?Q>>'@+T$:S]F+^=@A;M)-0UH.TTIF:#!US?*]ESL953!Z![[Y8O=@7]*(L\^8;SN/D'!V8*/4=7YP$]0P*?NBKT<0BB=:SJX(G3 MNL!91AQQ,;JT"FTN=%K=YB'A!BBT+:?5):!\BVO2E6N?S\6&_#^I4\HDMAPF MZN$=NBM028<04*,LN.9*4D)BCYP_^X&<3[OGARC^?;FMOQ4K+)(UZZ*$V2P8 M;,B%U$0$<^`]#CYZBX-%DJ3T7U%V@XJ8BKUFUOQ2["K!"[MKR!@"*,,>KMC$ MVCSK_+>0('`CG*:8>=%?T(P+H[99F)!A"FD#'NW`+10^O/W)1RQ\3?-TL]O< M%&DL=S:LQEQ<]!N'B0Z!P#8PTA^^193NT7'U#5)Y=04\(?D(Y M6J55>8O^M4L+6AOA$[I$6?I$5G@)`7Q]"/*>-"T)]\(#"]8'[\+0XN#!P'8J MA6K"W"([K5G`'^[%FL##[?V+0SL[IR#+O/-[%#^2AK24A=-*/%K@4OK M^I=3LO5!1)2<>UF+^,5S?A7>709C<7KG2*80(_`R#;5\DL/ZS#8#JLM$@Y]U9L8*DX'G,5' M&8_5*Y:KKFBWB.Y=$&G+JJP%>^@()JOT;6?0X1Z4X:`>U'C11Q&L$(RE\;G5 M8HS'=^Y[+"&366/&KO9Y*U6_B8KJN5Z%$VF)$,*I'-1G M8`R2/O;R5U>XV*#B,BU03+KPBXN(VG6S2NQVS@T2]@TP7%B.W0CI'/(^[/'] MA;<@?`?T@$';DYNW$'FPGFVK0688&DHH>5DMQ-94A6'+16G-`D-^NI]CP,=+ M43_IM@49:[39,J^OP#%7%:(M9VY'P$;:4\ M`03=VY1?F4_5;^1W`A0@3=>&3Z)RSP2NV?KNTIP>W`;SQSM']I9'GS?;##\C M=%?A]CC"KP7>;981]Z2U2I*Z'GA#Z*@8U*"K*!C(H+^6YM^T#''-YHOZ)A(FKT%__SV MSW_RY$PBS^T(RP*#.T%F(Y\*!3N=C11K#3N9C<;EBO_@>C:RMSYH3/7OF*S\ MTRRMGF_YU[-GI#SMHIA-V7]#]&%U#/AJ(2Z3V6*UYN[+Q0JNAR*]-!92C&Z@ MR:O;S7^KF73ZXFK0JPFLRV47T_:0^0WG:$R=768&WJ&+1DF'EX%#%:VY0*"$ MOV,QB-,(GV[3\O`$^&+AA4ULH5HC]SUH MNL([P4$=>"](R-3MY;^Y3!DQ/)M:N*VW3]6)7<2CJST+(UZ8IIG;)!3_QE_)Z,Q8(< M:@SYL::S*.4RKZ\,TTJX_`II<]#KKB.GI7=B-CSW%YK4CF<0YE`DZ@1M>9'G MM,9+&17/,UJTD.ID=LVA>K9N"U\K,!OGB.2JR)=Z$&@FV(36IP>8EN48S7>?IOE"S)O'V'BJIF)]HG9M,LO-\OD-Y-@K<\(,^B;3$F-2[W"Q?Y'M!UO MK]8-$W-Y$0X39W=B_UN&[5);CL"ZLVV_N]D.'/+.9VY;% MK*K>U[8]!6JKQ&82%JR*8U4TM:ER6T^]=U545*XC--KEJ\\\/?S M*D*RF3:5`DYQ7KC.JR+-RS2>?!(04[+I/'B43B$4[\LV?4C.IC==:#ZD%[9K MEV!^FOA<^,FF\-ML*2<*TH?2O82D"O=N//.QO"ERO_8YL/;JF@8'I[3NGS(' M/-E7#S,/;%,=QWK(`9[+,/U.BR2I]X^C[/BPENQUNUEH6HYK)#0]N'O512X: M0O86T2HKQ)@N<%ZSO(LR6@SX)ZL7L%X.<1F%$8W]ZR\HDGFC.$ M*C"_Y:4K^HN>'\YOF(?B0.;;@)K_7?/9MJ!$;YV?'<`HDI;N@#CF8E+'<=X- MF3*+9O;%G>^).%/#V5EUW/=>/;-DZI5H3QS1<&B'[8[FR^#K?,HPL_E`24_; MJ)+TNRQU* M+G?%H4YHK:&R>\NT%9M[C%M[H*$GT1CHE+R!+,-BJF=W"10-SD.W+D.E$BVN M4%K5R>J\4X'[X)LF6G"`Z5I>;`#HOB13G_DK!IM:!0AZ<"06KC"?HB-Q<)74 M"D]S.Z#SJF2&:ZQO//OA#8.X0O]/ZV]^G"_1^WR)?O2] M3])SJ5ZC_TGG(?KFU/?G/''MJ(Z'C9:KKKYN41955(5E58Y.%,G.2-H9=.!4 M3`=U[BLL:64:N^<7)N`8N9DT$QEL3XJ]??I4OM7@Y-XAY>3R<*PV$S:/QVHP MX=SV)ST=:OV`K.EG#OJ(K(;P'GH:`S7S%##/C7]UZC:O[*I0#_M`B;O;_MI? MV/FYMMG%=^18_,B!C+:YZ_J@LQQG4R%M.?VGF4VX21X M)P-.I_CSP5WE5)QJX.BT7N8V,.==O7VP%SUDR,'NL!VFYGF>$LQ4\"[-CYUD MJ]@XR>UE4PT=7*+&KC/?)YZW0\U,*+RM4K"$>\#-_=K?1)L;G7-I3K8W=.C; MW.!0HQ]VFM'=%H?!5SZ-30XU!3AR,7[$^*HG96?9`+'#E..C[^=-$P\^?IC; M*:8JL._1@H[0G;[>,5E4/K=4+:C>*A>9/HF)4KYRGG1;3Y7\[`FN\Q;@7-\T MV'U!N+P'7Q-PXMU@MT(Y2\?;Q."]YNT?@Y8W%FTR&+Q'FWV_<3)XA+X-:5,Q M1Q]YSL3;G9=5BN1[GW27"+-'T=SS[/G!P/%]UO.3@<%DV(V^\VGDV+4>#0S\ M])\==;E]O&Z.X\#GU/?4'RW,O+;\`3O+#B+H<':^]T;]SE'S1&@A3ASF;&4B_=UT!UUHT3H(9/6?@3K[-+O[>"?W)W`G]]=T(I5_(#YK?,7_50S#Z4:$\.1;B'F&8?HPH MCQ%55H76*2K?QGC3<%-G$K_GR6M7[O"WB'Z:BI[4N:4Z+[_A"AU#9TFQ,L7> M`W<$[NULLKC(HK)@*2[ MKD=$Z)<\4;?$CY3VI*6T/06'3WB^9+S'=4521NM\#(G?;P[GYR;^B MS."8PG,LCDM-:F,ME;V1A9G0V(OT%0F.P3';L">UMHV?(!K@`L-$5`%.0Z$+ MG<'(08.%*3*)#-%UA39*3GG4">*A.IWL[5[?%.D3B4]OLBBN`_7K_(F$K'5\ MOL&[?!@"*O7I[A'+^_AI,^,OA?6TH&)&!Z*'?+23'B'=4 M5%\3D\Y]#1%'SHQCR4Q&F\.IAY^6BUWUB(OTWRBYP@5]MXDN45DV;CY:U_I- M1O,3E'R_8$US9A[#A(T6V('N4@E%OT/QKDBK%)4749:AY--SJXQ]0Z6)7'U4 MR$RO,FI`YC&-)K7-Q!H[!W.Q6"70EP^I-OGRXEK[,W"'DJ/7ACG3\)Y->N"9 M-:\R?MV=*'N_]A,1_)F/+YO95-8;-^B"G$R!>X5$CG-SZU]X]V&,QH+,0O*Q M`@*H3:U-,^/(F3@<'@HSG7W<022!YJ8MPKL_AC!VEZK=!I"6=PL0O8JZ,`:J MG%[0IT)$XOT=9T1O65H]WT85;^-/?0`%E`X'.#&\"O4S*7*'E.T=*O`$P[=I M^?M5@>@1+D0462DB6-0=@%]V]Q-!+T`WDV"737>/W#^?PG&8$G^/W)V(T3XV M]?E?.^)(KG,BV*X^2[ZL'E%Q_QCE^[--WW"=JT=)_T`EHTZ#KQN45V5T5%Y3H&G>%#2L\&>S&?ZG`Y_Q2KQN6+1I7'4/(8/R]C-M8R M=ALWV:8#D;N)6D695B[$657B"8XWA]9,U*33#;K`4%!.!K,XZPH,C=S'``3SM*"BV M$9;K?V-WB17;>1,E'1Q.QFO6R`O;&\FWAR!%FV=+`JB4D';.30AA?9TI'$42 MO/+HPWM'?C(W3U"OS-P)SVK@EQ!\^R9N)T#I^PB^JO3B>"5]7#V3``U^7>41),_1[[M?*C$\T,E9G`Z MGRPQT*1]!QS&/KI/N7[KN^M^">=7$07':MFOW3S<';Z"6QSX+RX)+:6RH*N MT#2Y+NF=1$>Y;"X'LZ5\&!R"%HLX1F6)TZ\'NG0YS<\=Q M0.9>@M?T=]_.`$CG33M=-=KWN&'LV'D*D9"OQJK)^5+6-*#D?<=F/=S+8W#G MT7Y>C[OSGIZ'>WI\_)SW]=24=UX?,17)OW(*W0KTFL?95DM:/#J/_CS8$/3T MTWB^)^BIUEHG:_-1L?.B2/WJ9@B+'XD\!RC-_1#*[,N<"UHSG;X[MBP^_]BF MQ7'[JI_KG7=YH\K5/,L:.%?.G<@+V<;1Q,G+W,J!*VOO_OYP7JYH9LP\KNK[ M3]X3;3XP]S(\I[];.08P.F_E&%7V5?:U3?V:SWD24+!Y6F4(1R;@&7_GK+KO MA0AE3M0G-?I*T*-8T(=BA'_0+4;HBS]ZD"OJ M03WC&N)#=&+_Y4Q/+\&O!?,4G4?>+YS'Z*S[R/-&G;+]A+-;!Q%*'UBA;=GM MUT#10X;\O$!OP.`\F10M!IW[&]>[^]/G3\R!X]]A&1]5MO>53GVV7;DC^A/V=^WOSPF]].ND393WL/=,?SYY)H";_CA]H\N?(MYV/ M(7A^#,$,3N>3"`::=.2`9U]$-XI9Y,GG'UL4D[_>8_HC?TXC&#`XSR):B\'S MB81Y5]3F*'K91Q*T]!=^$#OG]D"C8E\V__K&HWQM^3%R<=_K8 M2FI?9;1PW_FO[T:0_T)^T/R.^:N>.:!!+:^10=#Y@]Z+H#-*A=8I*M_&>--P M4P>E:9JG#WE2XOHO/QZ[^G+>[R(B:,O4$>+ M')N`=!E`7]PE8(0KZ,(:D,4T`7@-\VDU$ET@HL+J.B=S,EH2&R*JY!X4E+0> MS6F10@:3UTL+S6`4)730/V'"R/ M'`"081[N<;Z0XY[X/R_E]/07P&)..5'//HK.3U7M?T/_1W-MY"?_'U!+`P04 M````"``$;FY%S&GO<9L/``"\M0``$0`<`'-U;F0M,C`Q-#`Y,S`N>'-D550) M``-H3F94:$YF5'5X"P`!!"4.```$.0$``.U=ZW/B.!+_?E7W/_CR::YJ&?*8 MF=VD)KM%"*2H2S`+S,S.?=D2M@#5&HN5Y!#NK[^6;(-?^!5(S,2[51,L=TOJ M_DGJ;KW\^;>GA:4]8L8)M:]/SMZ?GFC8-JA)[-GUB<,;B!N$G&A<(-M$%K7Q M]=5LKE:K]ZN+]Y3- MFF>7EY=-]?;$)^5F$N'YZ>E9\X^'^Y'*=DM,LHD;Q)9"&MCGBE7F:<(LG_&B M*5]/$-^0R[>FV#`$B3\VW9<^*!RR8(BDQ05137Z9*40_W$?@)<[=K@R,D%F MQ06#&LP(YN\-N@#.LP^GEQ>G/A^Q'X$D#`+'QOL9?6RZ[R3+1>/TK'%QYC.9 MF"1SP`M50I@<.L4,H>6&98KX1(GAO0BQ("$8F3@"=RE;W.(I%I4*F`A-JFR4!::%!4*6+!U6'ED/F.00),_O@Q[>3JQJIL2SD28P%!" M3$]8]WE3A%_(%IQ?P;!I#>V6&HX<68(_P8IK'5L0`?88>CY;J";ZN1G-(9JY MP[&IV[^JW]$NZW%[)&FDP'X!RT/@(= M80^!-K5-;$.-Y2].+6(JO^D&6;)@;33'6/`:AQPX+"-`+#.0N"B#A/9N@!C0 MS[$@H*U_U\AD(L,I#2$CG].1^9`/F0T)U^A4TV&X5?JI>TL>3(QI!!1(2$?E M4QE4VHC/M:Y%5S4J6:A0-*'!, MUUK]6^VF-8+P6N]J@V%GU.F/U9L:BPPL;+0,>E;J,1V)\R@2__4ZLY2]Y(%#;1Z3%?YIR25C[1!Z_M-Z[[3&';N M6^/.+3P/Q]]K]6>HGXN@09!/Z[+6!/_M]=N`0S!&$"_[[5[,/Z_ M&T"X;*SKV:-<88!MQ@(!F90&SX?3BWALG,?EU-[U$9/S2(_XW]J[6RP0L7B- M4\X0P8S'"&8&3A_B.!4-$VJ<"@0,9BABR$+G8QR=2-!0*[]0^&!&XH.@I#VGTD^P(,M+H M]%68(==_[CMWK7OMH34>=X9U,)AMHD/+/AE!H,0CON[CF^=Z2C57]!T*O#/5 M'5OA<4VP/JBG\_*H>Q70]BI3V;$%G&^M(?@Z]:12OGD+$9NVR)BROB@_:S%& M$PO79C?'>"-"`X[([`2Q)9S0B%-K/O?0$U3\*EOOL=4;?_"I55YH%.)4_3'B MDZB!-UE@Q)9U\HU*\@2-Z5A8[@3KJ6,6:N\8L;4^%I`"F:F]E3?8AO*$W$@& MLAB"UW.OA5&>XN628D26$[Q,PCKR/@OQV,I2<<2[CI"L'2[(0FT-'#"\(,Z" M:P.T5CL$?])T,<=,ZSPMY4Y"KK:A]VR!`44!5,34;M;P%A)L9$&"VE!?-XZ" M8:89#3/39QT!_K-GA9DU/@4"3C,<<69WS;/TD+-6?@%GT#9#WJ"=W3'2`]!Z M^;#L&CS\C\)@>$E9@,2"U`@@08LT$M3X2].7DEEK&0`3$>L:J`).?*C#K'+T ME]BFPZT;7W>5,@APN@IU%"\A"X=8&+O%(=A#ODE,P$6O.T?IS2J[`Z[0N_35 MEHOXQ').!]Q9+!!;AR,N7H=<7OKG9O1\NY<2/@>O3L&3Q9(RH=F)1^QW7?K@ M7EQQ3PV560J+?&KX?`V9U#@[;URB_9/"Z=5(ODHB9P5\!EGRQ_QE[KB6 M(F>ABEJ6^*EQ>MXX_[EDNG9URE5E7_5(N(\C M3T4LQD)<>ZE(\)*/8EW"YRO5)79>'Y*_#E;YOIARH\B.\G>Q>;\;VRQ*5B5Z M54F>>O@\\D=CRYR_!JDWGZ35()&QB2W!_92T^G@7IJ@*79^TS$?9C+J4;>U@ MSP8CN+&!G@GDK0E7)G!KKO\LP^Q>1:'NOKF"-&+/>@(OI.T!H1T@(\*1(M\Q MZBQ]0@(D)YI-+$O.:5^?".8`.?(R]9]=VB4,$]0,K`%FAG3*9SA=WF0. MKQ]#)UZZJ:_*M&IZ12[9";O%$^@:0HTQL+>!?4_X:8[8(6MD, MNH-X4<]IS;?X$5MT*5-&2YY27H9+.DG\A6,LVW>O``K>! M)?C)^@G0,L*GP]WV$-N6"AU14@*L:JLC3 MC,#>8'9+$C0_?R:\KUQGN*%A%<(4-S)+L;/+KJMG58"V3/*,=[ROI"-UC M&"TV0P-/&G1WDU2N>;E5M4:(2% M)S%>8>L1JR;`(YK:8[[5:%+9!O<98H_I#98[65M3>/Z.$>N21[P?C>[(^@TI MM4NX@2PI^@,2#H,`-,%X'KB1KH;C^ MTG.KANKV9[PWTD)K26LYS]!C9L[5T.G^FV.&X.4=S.(E'*EKF5O0YX5$)8MY MH^UV'V']<\IZLVH_?`/_@<.J@BHH%6*5*>--J[EDZ%6JD+>MZ#(A68DBCES) M`\IDW?3IP,+F;+LDXTHI/T&4K<4\>51D^K^\GOP5#>A;U)G-(Z+F4%)6!L?2 MD![0D]P?ZF^U:],%U':D=M'ITZG\,K$O(2./2."!A8RHCIZ11]7V[O4!JO@. M$AY;\$`/99B/Q@SZ!]OUJ7L5T>8FHNUDH=S:P$5TPE#^E1W<=Y5T.[JA M;*,.=1=9TF:7URB\DCMIU+@I#SF;A[^3&P,/K-E9,-;5Z MDRWN353=YX'8C0&XQHQ MU#[-J.Y?N3)'8Q$/IZS.$V8&X5*0;UBV9&RV8(1`,SS$TMUU]S03PKIBG_!"7"$C*I,:,21QNV9&!P]=UVE2GGQCWMN797ZNO-J M+Z";-(4D;%6H3(VJMK7AE143<`.J@U:H4B_;MZJ/F.<"5`>M387>$%)?E5;D MZ?/-I)E,>G735:I>/PYNX:@TUFPW/0X8)SMB9\I\P%:=($RCZ.1>^O70VS0F2VO*]-! M,N_VS-A==N6S.)[9NMBM*M`*(IML4FB.9Y<%%&'(0]'V#`(>[SH_^>!O"XQ- MR^=D.$BS?XZ55.?PY%9066=B8I[?1"Y=[-"W/UC1(>-=[J7M% MD:L02-49U9*(FM>`A_MN1>W;D9L%;;,GM:N!MYN@^ M>\SSJ-1(I[]#)$ZF!)M)LD#>%S."^;ZX1MT]V#)WO#]@-#25M8\[-4 MT-VL.*1%]5H>7DNAK8>4/QBQG!RY8Z. M=`GCPH_,XK=*)KVMG`PCB*-M($09\_9 M5Z,7A$R&^PE+]\-J\/A_4$L!`AX#%`````@`!&YN1>4Z][J0.0``'!D"`!$` M&````````0```*2!`````'-U;F0M,C`Q-#`Y,S`N>&UL550%``-H3F94=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`!&YN10<5MYVE"0``4H```!4`&``` M`````0```*2!VSD``'-U;F0M,C`Q-#`Y,S!?8V%L+GAM;%54!0`#:$YF5'5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(``1N;D6?$CROBQ,``),N`0`5`!@` M``````$```"D@<]#``!S=6YD+3(P,30P.3,P7V1E9BYX;6Q55`4``VA.9E1U M>`L``00E#@``!#D!``!02P$"'@,4````"``$;FY%VGJ0Y'2>``#I-@P`%0`8 M```````!````I(&I5P``&UL550%``-H3F94 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`!&YN10GW";U#00``ZQ0%`!4` M&````````0```*2!;/8``'-U;F0M,C`Q-#`Y,S!?<')E+GAM;%54!0`#:$YF M5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(``1N;D7,:>]QFP\``+RU```1 M`!@```````$```"D@?XW`0!S=6YD+3(P,30P.3,P+GAS9%54!0`#:$YF5'5X C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#D1P$````` ` end XML 20 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK TRANSACTIONS (Details) (USD $)
0 Months Ended 1 Months Ended
Jun. 24, 2014
Jul. 31, 2014
First Issuance [Member]
Jul. 31, 2014
Second Issuance [Member]
Stockholders Equity [Line Items]      
Shares of common stock issued 660,000 30,000 140,000
Value of shares of common stock issued $ 3,300,000 $ 150,000 $ 700,000
Share price $ 5    

XML 21 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details) (Subsequent Event [Member], USD $)
Nov. 11, 2014
Subsequent Event [Member]
 
Subsequent Event [Line Items]  
Face amount of remaining net insurance benefits required to be delivered to the company under the Del Mar ATA $ 309,400,000
XML 22 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
NEW ACCOUNTING PRONOUNCEMENTS
6 Months Ended
Sep. 30, 2014
NEW ACCOUNTING PRONOUNCEMENTS [Abstract]  
NEW ACCOUNTING PRONOUNCEMENTS

(2) NEW ACCOUNTING PRONOUNCEMENTS

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09 – Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2016. Early adoption is not permitted and companies can transition to the new standard under the full retrospective method or the modified retrospective method. The Company does not believe adoption of this ASU will have a material impact on its financial statements.

 

In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements.

 

              The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.
XML 24 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2014
Mar. 31, 2014
Condensed Consolidated Balance Sheets [Abstract]    
Preferred Stock, shares authorized 10,000,000 10,000,000
Preferred Stock, par value per share $ 0.001 $ 0.001
Preferred Stock, shares issued 0 0
Preferred Stock, shares outstanding 0 0
Common Stock, shares authorized 500,000,000 500,000,000
Common Stock, par value per share $ 0.001 $ 0.001
Common Stock, shares issued 43,185,941 43,015,941
Common Stock, shares outstanding 43,185,941 43,015,941
XML 25 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
Sep. 30, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]  
Life settlement policies, face value $ 217
Life Settlement Contracts Investment, Ownership Percentage 100.00%
XML 26 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Sep. 30, 2014
Nov. 14, 2014
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2014  
Entity Registrant Name Sundance Strategies, Inc.  
Entity Central Index Key 0001171838  
Current Fiscal Year End Date --03-31  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2015  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   43,185,941
XML 27 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefit Contracts) (Details) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Mar. 31, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]          
Beginning Balance     $ 12,243,411 $ 12,243,411 $ 12,243,411
Additional investments            
Accretion of interest income 592,653    1,156,151      
Distributions of investments            
Impairment of investments            
Total $ 13,399,562   $ 13,399,562   $ 12,243,411
XML 28 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Condensed Consolidated Statements of Operations [Abstract]        
Interest Income on Investment in Net Insurance Benefits $ 592,653    $ 1,156,151   
General and Administrative Expenses 583,006 310,809 1,199,372 1,344,674
Income (Loss) from Operations 9,647 (310,809) (43,221) (1,344,674)
Other Income (Expense)        
Other, net       6,303   
Interest Income 4,478    8,820 21
Interest Expense (17,031) (30,709) (33,172) (60,782)
Total Other Expense (12,553) (30,709) (18,049) (60,761)
Loss Before Income Taxes (2,906) (341,518) (61,270) (1,405,435)
Income Tax Provision            
Net Loss $ (2,906) $ (341,518) $ (61,270) $ (1,405,435)
Basic and Diluted:        
Loss Per Share $ (0.01) $ (0.01) $ (0.01) $ (0.03)
Weighted Average Number of Shares Outstanding 43,163,575 42,261,441 43,090,561 41,781,441
XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK TRANSACTIONS
6 Months Ended
Sep. 30, 2014
STOCK TRANSACTIONS [Abstract]  
STOCK TRANSACTIONS

(7) STOCK TRANSACTIONS

 

During July 2014, the Company issued 30,000 shares of common stock for $150,000 and issued 140,000 shares of common stock for $700,000.   The $700,000 in cash was received prior to March 31, 2014.

 

On June 24, 2014, the Company entered into a private stock offering subscription agreement to issue 660,000 shares at $5 per share for a total of $3,300,000, which subscription was due and payable on August 15, 2014.  The Company has been advised that there will be a further delay in the payment of this subscription as a result of the time and issues involved in a foreign probate of the subscriber's estate, and there is no assurance that this subscription will be paid.

XML 30 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYBALE-RELATED PARTY
6 Months Ended
Sep. 30, 2014
NOTES PAYBALE-RELATED PARTY [Abstract]  
NOTES PAYBALE-RELATED PARTY

(6) NOTES PAYBALE-RELATED PARTY 

 

              During the six months ended September 30, 2014, the Company borrowed $740,000 from related parties and paid back $100,000, bringing the total notes payable-related party loan balance to $730,000 at September 30, 2014.  The notes do not incur interest, are payable on demand and are not collateralized.

XML 31 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN (Details) (USD $)
Sep. 30, 2014
Mar. 31, 2014
GOING CONCERN [Abstract]    
Accumulated losses $ 372,059 $ 310,789
Working capital deficit $ 2,218,624  
XML 32 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Details) (USD $)
0 Months Ended 1 Months Ended
Jan. 14, 2014
Jun. 07, 2013
Oct. 29, 2013
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]      
The face value of net insurance benefits purchased under asset transfer agreement   $ 400,000,000 $ 400,000,000
Total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.   20,000,000  
The total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.   8,000,000 12,000,000
Face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.   12,000,000  
Interest rate   4.00%  
Restructuring charges accrued   4,000,000  
Structuring and Consulting Agreement, terms   The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.
Total purchase price   24,000,000  
Maximum purchase price payable by promissory notes   12,000,000  
Advance to consultant for services     25,000
Qualified net insurance benefits received $ 90,600,000    
XML 33 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)
6 Months Ended
Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
NEW ACCOUNTING PRONOUNCEMENTS
              The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.
XML 34 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
6 Months Ended
Sep. 30, 2014
GOING CONCERN [Abstract]  
GOING CONCERN

(8) GOING CONCERN

 

The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. At September 30, 2014, the Company had accumulated losses of $372,059, working capital deficit of $2,218,624, and has yet to receive cash payments on interest income on Investment in NIBS. These factors raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

 

The Company's continued existence is dependent on its ability to generate sufficient cash flow to cover operating expenses and to invest in future operations. Management is actively pursuing opportunities to expand existing operations. The Company does not anticipate having adequate revenues from operations until three to four years, and until a revenue stream has been established, the Company will require debt or equity funding to fund its current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is possible.

XML 35 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
6 Months Ended
Sep. 30, 2014
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS

(9) SUBSEQUENT EVENTS

 

On or about November 11, 2014, the Company, Del Mar and Europa have tentatively agreed to extend the delivery date of the remaining $309,400,000 in Qualified NIBs due under the Del Mar ATA until January 31, 2015, for which documentation is presently being prepared.

XML 36 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVESTMENT IN NET INSURANCE BENEFITS (Tables)
6 Months Ended
Sep. 30, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]  
Schedule of Investments in NIBs
   

September 30, 
2014

 

March 31, 
2014

Beginning Balance

  $ 12,243,411     $ 12,243,411  

Additional investments

    -       -  

Accretion of interest income

    1,156,151       -  

Distributions of investments

    -       -  

Impairment of investments

    -       -  

Total

  $ 13,399,562     $ 12,243,411  
XML 37 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYBALE-RELATED PARTY (Details) (USD $)
6 Months Ended
Sep. 30, 2014
Mar. 31, 2014
NOTES PAYBALE-RELATED PARTY [Abstract]    
Borrowings from related parties $ 740,000  
Repayments to related parties 100,000  
Total notes payable-related party loan balance $ 730,000 $ 90,000
XML 38 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Operating Activities    
Net Loss $ (61,270) $ (1,405,435)
Adjustments to reconcile to cash from operating activities:    
Share Based Compensation - Options 212,242 659,867
Advance for Investments in Net Insurance Benefits (691,557) (6,414,063)
Other Current Assets (28,600)  
Accrued Interest Income (280)   
Prepaid Expenses (5,625)   
Accounts Payable 117,911 (6,286)
Accrued Expenses 17,780 20,782
Investment in Net Insurance Benefits (1,156,151)   
Net Cash from Operating Activities (1,595,550) (7,145,135)
Investing Activities    
Proceeds from Notes Receivables 550,000   
Net Cash from Investing Activities 550,000   
Financing Activities    
Proceeds from Issuance of Common Stock - net of issuance costs    6,826,775
Proceeds from Issuance of Notes Payable-Related Party 640,000   
Common Stock Issued for Cash 150,000   
Common Stock to be Issued    752,500
Net Cash from Financing Activities 790,000 7,579,275
Net Change in Cash (255,550) 434,140
Cash at Beginning of Period 375,212 545,417
Cash at End of Period 119,662 979,557
Non Cash Financing Activities    
Notes Receivables Exchanged for Advance for Investment in Net Insurance Benefits 100,000   
Fair Value of Warrants Issued as Stock Issuance Costs    $ 139,251
XML 39 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE RECEIVABLE
6 Months Ended
Sep. 30, 2014
NOTE RECEIVABLE [Abstract]  
NOTE RECEIVABLE

(5) NOTE RECEIVABLE 

 

On October 23, 2013, the Company made a loan totaling $650,000 in the form of a note receivable to Del Mar. The note incurred interest at 3%, compounding annually. On April 28, 2014, the Company received full payment of the $650,000 Del Mar note receivable entered into on October 23, 2013. Of the $650,000, the Company received cash payments totaling $550,000; and $100,000 was applied to advances for investment in NIBs.

XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 23 111 1 false 5 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.sundancestrategies.com/role/sund-daei1 Document and Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.sundancestrategies.com/role/sund-ccbs Condensed Consolidated Balance Sheets false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.sundancestrategies.com/role/sund-ccbsp Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.sundancestrategies.com/role/sund-ccsoo Condensed Consolidated Statements of Operations false false R5.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.sundancestrategies.com/role/sund-ccsocf Condensed Consolidated Statements of Cash Flows false false R6.htm 101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.sundancestrategies.com/role/sund-oabop ORGANIZATION AND BASIS OF PRESENTATION false false R7.htm 102 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS Sheet http://www.sundancestrategies.com/role/sund-nap1 NEW ACCOUNTING PRONOUNCEMENTS false false R8.htm 103 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS Sheet http://www.sundancestrategies.com/role/sund-iinib1 INVESTMENT IN NET INSURANCE BENEFITS false false R9.htm 104 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS Sheet http://www.sundancestrategies.com/role/sund-afiinib ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS false false R10.htm 105 - Disclosure - NOTE RECEIVABLE Sheet http://www.sundancestrategies.com/role/sund-nr NOTE RECEIVABLE false false R11.htm 106 - Disclosure - NOTES PAYBALE-RELATED PARTY Notes http://www.sundancestrategies.com/role/sund-nprp NOTES PAYBALE-RELATED PARTY false false R12.htm 107 - Disclosure - STOCK TRANSACTIONS Sheet http://www.sundancestrategies.com/role/sund-st1 STOCK TRANSACTIONS false false R13.htm 108 - Disclosure - GOING CONCERN Sheet http://www.sundancestrategies.com/role/sund-gc1 GOING CONCERN false false R14.htm 109 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.sundancestrategies.com/role/sund-se1 SUBSEQUENT EVENTS false false R15.htm 202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) Sheet http://www.sundancestrategies.com/role/sund-sosapp1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) false false R16.htm 30301 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Tables) Sheet http://www.sundancestrategies.com/role/sund-iinibt1 INVESTMENT IN NET INSURANCE BENEFITS (Tables) false false R17.htm 40301 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) Sheet http://www.sundancestrategies.com/role/sund-iinibnd1 INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) false false R18.htm 40302 - Disclosure - INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefit Contracts) (Details) Sheet http://www.sundancestrategies.com/role/sund-iinibndsoiinibcd1 INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefit Contracts) (Details) false false R19.htm 40401 - Disclosure - ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Details) Sheet http://www.sundancestrategies.com/role/sund-afiinibd ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Details) false false R20.htm 40501 - Disclosure - NOTE RECEIVABLE (Details) Sheet http://www.sundancestrategies.com/role/sund-nrd NOTE RECEIVABLE (Details) false false R21.htm 40601 - Disclosure - NOTES PAYBALE-RELATED PARTY (Details) Notes http://www.sundancestrategies.com/role/sund-nprpd NOTES PAYBALE-RELATED PARTY (Details) false false R22.htm 40701 - Disclosure - STOCK TRANSACTIONS (Details) Sheet http://www.sundancestrategies.com/role/sund-std1 STOCK TRANSACTIONS (Details) false false R23.htm 40801 - Disclosure - GOING CONCERN (Details) Sheet http://www.sundancestrategies.com/role/sund-gcd1 GOING CONCERN (Details) false false R24.htm 40901 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.sundancestrategies.com/role/sund-sed1 SUBSEQUENT EVENTS (Details) false false All Reports Book All Reports Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 2 3. Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: Removing column '12 Months Ended Mar. 31, 2014' Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows sund-20140930.xml sund-20140930.xsd sund-20140930_cal.xml sund-20140930_def.xml sund-20140930_lab.xml sund-20140930_pre.xml true true XML 41 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE RECEIVABLE (Details) (USD $)
0 Months Ended
Jun. 07, 2013
Apr. 28, 2014
Notes Receivable [Member]
Del Mar [Member]
Oct. 23, 2013
Notes Receivable [Member]
Del Mar [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Face value of loan   $ 650,000 $ 650,000
Interest rate 4.00%   3.00%
Collection note receivable   550,000  
Advances for investment in NIBs   $ 100,000